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Abstract 
 
 Overweight and obesity (OWO), specifically abdominal obesity, are linked with 
cardiovascular and metabolic disease risk (CMR) at every stage of life. The prevalence of OWO 
nearly doubles in Canadians between childhood/adolescence and adulthood, suggesting that 
normal weight (NW) status is not stable through the life course and that there is a period in 
adulthood when fat mass (FM) increases. Emerging adulthood (EA; 18-25 years) has been 
identified as a potential critical period when FM accrues, the degree to which is potentially 
influenced by childhood and adolescence FM accrual. EA is also a period which favors trunk fat 
depots and when CMR likely commences or increases from child and adolescent levels. 
However, there is a paucity of longitudinal data describing the patterns and predictors of FM 
accrual during EA. Furthermore, there is also a lack of information showing how EA fat mass 
trajectories relate to adult cardiometabolic health. Thus, the primary purpose of this thesis is to 
describe patterns and predictors of total body fat (TBF) and trunk fat (TrF) mass accrual and 
OWO status in EA. The second purpose is to identify if trajectories of FM accrual in EA 
influence later adult CMR. The thesis will also explore sex differences. 
 In study 1, 126 participants (59 male) were drawn from the Pediatric Bone Mineral 
Accrual Study (PBMAS) (1991-2011). Participants of the PBMAS were aged 8 to 15 years at the 
initial measurement. Serial measures of participants included chronological age (CA), biological 
age (BA - years from peak height velocity (PHV)), body mass index (BMI), and percent total 
body fat (%TBF). Study 1 is divided into two papers - 1a and 1b. The results from paper 1a 
based on this study indicated that fat mass increased from PHV into EA. At PHV, 9% of males 
and 14% of females were OWO by BMI, rising to 65% and 32%, respectively, 15 years after 
PHV (approximately 27 years in females, and 29 years in males). The prevalence of OWO by 
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%TBF, increased from 29% to 45% in males, and from 33% to 59% in females over the same 
period. Differences in values of %TBF and BMI at PHV between those identified as NW had 
disappeared by 19-22 years (p>0.05) (i.e. fat mass between NW and OWO youth became more 
similar with age). OWO status at PHV did not predict OWO status during EA (p<0.05). These 
results indicate that EA appears to be a major period of transition from NW to OWO status. In 
addition, sex and FM metrics showed differences in ages when NW individuals became OWO. 
 Study 1 also attempted to address the potential discrepancy in OWO identification and 
age at onset of OWO by different metrics in paper 1b, using the same PBMAS cohort. 
Longitudinal measures, including anthropometrics and dual x-ray absorptiometry from 1991-
2017 were used to create hierarchical random effects models. Coefficients from the models were 
then used to develop growth curves, and these were compared to known cut-points. The age at 
onset of OWO was considered that age at which the predicted line crossed metric specific cut-
offs. Age at onset of OWO in males was identified as 23.5 years by BMI and 21.5 years for % fat 
mass (%FM). Waist circumference (WC) cut-offs for OWO classification were not reached by 
39 years. In females, onset was at 22.5 years by BMI, 15 years by %FM and 33.5 years by WC. 
Cut-points for BMI failed to identify 21.4% of OWO males and 56% of OWO females identified 
by %FM. The discrepancy in age at OWO between measures suggests that the most conservative 
indicator of age at onset is sex specific. BMI identifies OWO in males sooner than %FM. The 
opposite is true in females; however, BMI likely misses “over fatness” - more in females. WC 
may not be as appropriate for indicating risk in young adults and youth as in older adults. 
 Using the same participants identified in study 1, study 2 created longitudinal models of 
fat accrual during EA and beyond (18 to 30 years of age) and identified concurrent and 
childhood/adolescent predictors of FM accrual, including measures of physical activity (PA) and 
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energy intake (EI). It was found that childhood and adolescent TBF and TrF (0.30 ± 0.05, 
p<0.05) predicted EA accrual in both sexes and that concurrent PA (-0.06 ± 0.02, p<0.05) was 
significant in males only. These results underscored the importance of maintaining lower 
amounts of TBF and TrF mass during childhood and adolescence, and maintaining high level of 
PA in EA in order to mitigate TBF and TrF mass accrual and reduce the risk of transitioning 
from NW to OWO during EA.  
In study 3 (1991-2017) participants of the PBMAS, now aged 32 to 40 years of age, were 
invited back for reassessment. Blood analysis was used to create a Continuous Cardiometabolic 
Risk (conCMR) score for each participant. Multi-level models of TrF and TBF accrual were 
created looking at the same predictors as study 2, with the addition of cardiometabolic risk 
(CMR) group. Childhood TBF and TrF z-scores were again found to be the most significant 
predictor of TBF and TrF accrual, this time from 18-39 years. PA was also significant. CMR 
group did not influence the trajectory of TBF or TrF accrual, potentially due to the homogeneity 
of the group and the small sample size.  
 In conclusion it was found that FM continues to increase steadily from late adolescence 
through EA leading to a marked increase in the prevalence of OWO in young adulthood. Greater 
trajectories during EA are related to higher levels of FM accrual in childhood and adolescence, 
and higher scores on individual CMR factors in later adulthood. The results suggest that 
maintaining high levels of PA throughout the life span is beneficial to adult health directly and 
through its mitigating effect on FM accrual in EA, and indirectly by limiting FM accumulation in 
childhood and adolescence.  
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1 
 
 
 
 
CHAPTER 1  
 
INTRODUCTION AND RESEARCH AIMS 
 
 
1.1 INTRODUCTION 
 
Canadian rates of obesity have more than doubled over the past 40 years. Almost 1 in 4 
Canadian adults have obesity, 1 in 7 youth (5-17 years) have obesity and 1 in 3 youth have 
overweight or obesity (OWO) (1–3). OWO in adults, adolescents and children correlates with 
several chronic diseases including coronary heart disease and type II diabetes, as well as to risk 
factors for these diseases such as hypertension, dyslipidemia, and insulin resistance (4–7) . While 
some data suggests a plateau of combined OWO rates in the last decade, obesity remains a major 
Canadian public health concern. Still more concerning are the rates of abdominal obesity which 
demonstrate a stronger relationship with health consequences than total body obesity in diverse 
age groups (8–10). Between 1981 and 2007/09, the prevalence of abdominal obesity in Canada 
rose from approximately 11% to 37% in adults and from 2% to 13% in adolescents (12-19 years) 
(3,11). Youth rates (children and adolescents) of OWO warrant extra attention as fat mass (FM) 
accumulated by adolescence is often retained into adulthood, and the cardiovascular disease 
(CVD) risk associated with OWO is cumulative (8,12,13).  
Alterations to the normal growth and development processes during critical periods can 
result in permanent change to systems and organs, or entrain future form, function or dysfunction 
(14). Critical periods associated with FM accrual include: intrauterine growth, indexed by birth 
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weight (BW); post-natal growth; the period of adiposity rebound in early childhood; and the peri-
pubertal period or adolescence (14–16). There has been a large amount of attention placed on 
preventing OWO during these critical periods, as having OWO at one period increases the risk of 
having OWO in subsequent periods or of transitioning upward from overweight to obese, or to a 
greater degree of obesity (17–21). Although the prevalence of overweight youth has dropped 
slightly over the past decade, the prevalence of obesity has remained high, despite a variety of 
available interventions and preventative programs (1–3,22–24). The most recent estimates of 
OWO from Statistics Canada (2015) suggest that 23% of 12 to 17-year-old Canadians have 
OWO. This number almost doubles to 42% in young adults (20-34 years) (25,26). Longitudinal 
data on Canadians from 1981 to 2002/04 show the same trend of increasing prevalence of OWO 
with age, as 85% of overweight adults were NW youth (27). Combining these two pieces of 
evidence, the suggestion is that a large number of NW Canadian youth are at risk of accruing 
OWO adults and that onset occurs at some point between late adolescence and young adulthood. 
Thus the period of emerging adulthood (EA; 18 to 25 years) (28) appears to be another potential 
critical period for fat mass gain, onset of OWO and, by association, an increased CVD risk 
(28,29). 
During EA, fat mass continues to accrue, the incidence of OWO increases and the 
likelihood of shifting from OWO to NW status is low (30,31). Although EA has not previously 
been considered a “critical” period for FM accrual, it may have a stronger and more permanent 
influence on later adult OWO status than the adolescent critical period, as the establishment of 
long-term health behaviors characterizes this period (28,32,33). Furthermore the stability of 
OWO increases with age; for example, body mass index (BMI) at 35 is strongly predicted by 
BMI at 18 years, but only moderately predicted by BMI at 13 years and younger (34). Increasing 
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BMI should be particularly concerning because of its strong correlation with %TBF (35,36); and 
its significant tracking coefficient (>0.7) over the period of EA (37); yet, there is little 
information on the factors that contribute to FM gains in EA (29,38).   
The life course perspective suggests that an individual’s health trajectory can be set by 
earlier exposure to beneficial or adverse circumstance (39). According to this approach to 
chronic disease, exposure to biological and socio-environmental factors at any stage of life can 
have long-term effects on health (40). It has been repeatedly demonstrated that rapid, early or 
excessive FM gains during critical periods entrains excess FM and obesity in later life (41–43); 
but the life course perspective also acknowledges that social environments and human agency 
can alter trajectories of FM and disease, and provide compensatory mechanisms for altered form 
or function (40,44). For example, poor intrauterine development may alter endocrine properties 
and increase the risk of future metabolic illness; but a social environment consisting of a healthy 
diet and regular activity can modify this disease trajectory and assist in the maintenance of health 
(33,45). Roughly two-thirds of Canadians become OWO by adulthood, having been NW youth 
(27), but the extent to which OWO in adulthood is predetermined by earlier life antecedents 
(such as low PA, high energy intake and high FM accrual) or personal health behaviors in EA is 
not clear. Furthermore, the implication of FM accrual and health behaviors during EA on future 
cardiometabolic health is unknown.  
 Cardiometabolic risk (CMR) is a term that refers to a comprehensive list of factors that 
contribute to the development and onset of cardiovascular disease and type II diabetes (46). 
These factors include elevated blood pressure, abdominal fat (above healthy waist circumference 
cut-offs), elevated triglycerides (TG), total cholesterol, insulin resistance (IR) and lowered high 
density lipoproteins (HDL). The presence of these risk factors often accompanies excess 
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adiposity which leads to inflammation of adipocytes (fat cells). Adiposopathy is the term given 
to inflamed “sick” fat cells (47). Metabolic syndrome (MetS) is the clustering of three or more 
CMR factors, the presence of which increase the overall lifetime risk of CVD (48). 
Adiposopathy is more likely to occur in association with elevated visceral and abdominal (trunk) 
body fat than with elevated subcutaneous or peripheral fat, respectively (47). In adults, lower PA, 
higher caloric intake and higher measures of adiposity demonstrate significant relationships with 
CMR levels (4,49–51). Although the occurrence of CVD and MetS are still rare in children and 
adolescents, CMR factors have been found, and these risk factors, similar to adults, correlate 
with higher total and central adiposity and lower PA (5,52). As such, the elevated CMR found in 
OWO adults may have origins associated with a lack of child/adolescent PA, poor 
child/adolescent diet and elevated child/adolescent FM (indexed by BMI); or low adult PA, adult 
diet and high adult FM.  
The relationship between OWO and health status within each critical period of growth 
(and later periods) is complex. Predictors of adult weight and health status have been previously 
identified; some, such as predisposing genetics, are fixed, while other factors, such as lifestyle 
behaviors and the factors influencing those behaviors (i.e. social and environmental factors), are 
modifiable (53,54). Early lifestyle factors (diet and PA), rapid or early FM gains and pubertal 
timing are associated with child and adolescent obesity and CMR (8,22,55–57). These same 
childhood and adolescent factors are associated with adult obesity and cardiometabolic health, in 
addition to adult FM and adult lifestyle (58–61).  In contrast, some data suggests that the link 
between child and adult obesity is reliant on tracking of weight status. Figure 1.1 illustrates the 
possible mechanisms linking factors across adolescence and adulthood. The complex 
relationship between factors is often bi-directional. 
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. 
There is a lack of information about EA and how it may play a mediating role between 
adolescence and young adulthood. Insufficient data may be due to a lack of longitudinal data 
spanning the period from childhood to adulthood. Discrepant findings may be due to the method 
of defining OWO, as not all measures and cut-offs provide the same estimates, nor are all metrics 
equally accurate at representing FM (62–65) . 
In adulthood, BMI is the most commonly used measure of OWO because it is non-
invasive in nature, inexpensive, and accurate at high levels of FM; however, it has demonstrated 
lower specificity and sensitivity in identifying high levels of FM in youth with BMI in the 
normal ranges (65). This is because there can be great variation in the adiposity of adolescents 
despite similar values of BMI. As such, using BMI as a surrogate of adiposity and as an indicator 
of health risk is likely to overlook normal BMI-high adiposity, especially in youth with mid-
range BMI values (65). Similarly, BMI cannot identify trunk fat mass (TrF), which has an even 
Figure 1.1 Schematic of possible relationships between PA, CMR and FM at each 
period. Solid black and grey lines represent associations with strong evidence. Dotted 
lines are less-studied associations that may represent intermediate steps in emerging 
adulthood 
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stronger relationship with CMR than general adiposity (66,67); or lean mass (LM), which has a 
reciprocal relationship with metabolic health (insulin sensitivity, metabolic flexibility) (68). 
Healthy adolescents demonstrate significant gains in FM (females more so than males) and LM 
(more so in males than in females), and the beginning of a re-distribution of fat from the 
periphery to the trunk which corresponds with the onset of puberty (69–71). Lean and fat mass 
gains contributing to weight gain continue into and through EA, meaning that not all BMI gains 
during these periods represent the same health risk (72). Recent literature suggests that measures 
other than, or in addition to, BMI that can partition FM from LM should be used for clarifying 
the relationship between growth, body composition and health (65). Therefore, the overall 
purpose of this dissertation is to explore fat mass accrual during the period of EA - contributing 
factors, associated outcomes, and the potential for EA to be an additional critical period for 
weight status and health.  
 
1.2 RESEARCH AIMS AND HYPOTHESES 
 
Study 1, Paper a: Longitudinal patterns in BMI and percent total body fat development from 
peak height velocity through emerging adulthood into young adulthood 
Aim: To identify if EA is a critical period for fat accumulation by examining the 
prevalence of OWO status from PHV to +15 years after PHV (CA approximately 12-27 
years in females, 14-29 years in males).  
Hypothesis: The prevalence of normal weight will decrease with age with a significant 
change occurring during the period of EA.  
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Study 1, Paper b: At what age do normal weight Canadian children become overweight adults? 
Differences according to sex and metric.  
Aim: To examine the age of onset of overweight by sex and three metrics: body mass 
index, fat mass and waist circumference. 
Hypothesis: The period of EA will be highlighted as a time of onset of OWO by all 
metrics, but that there may be age-of-onset differences by sex and by metric. 
Study 2: The influence of childhood and adolescent fat development on fat mass accrual during 
emerging adulthood: a 20-year longitudinal study. 
Aim: To identify predictors of fat mass gains in EA including factors during childhood 
and adolescence. 
Hypothesis: Having a greater fat mass during childhood and adolescence will predict 
greater TBF and TrF accrual during EA.  
Study 3: Fat accrual during early adulthood and continuous cardiometabolic risk score in the 
fourth decade: a longitudinal analysis. 
 Aims: To identify the effects of EA fat accrual trajectories on subsequent 
cardiometabolic risk scores in early adulthood (25-39 years). 
Hypothesis: Those with higher TBF, and even more so TrF, trajectories during EA into 
early adulthood will have higher cardiometabolic risk scores in early adulthood. 
 
.  
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CHAPTER 2  
 
 
 
LITERATURE REVIEW 
 
 
The following chapter provides an overview of the literature relevant to this research topic, 
including: an overview of the underlying paradigm of life course health guiding the research; a 
discussion on growth and maturation; a report on the prevalence of OWO and metrics used to 
measure OWO; a summary of the mechanisms and etiology linking OWO with cardiovascular 
and metabolic disease; and an overview of the relationship between physical activity (PA) and 
adiposity. The final section of this chapter elaborates on the known critical periods of growth and 
clarifies the current understanding of the interlinkages between PA, diet, FM accrual, and 
cardiometabolic health.  
2.1 LIFE COURSE HEALTH 
 
The Adverse Childhood Exposures (ACE) study in the early 1990’s revealed the link 
between negative childhood experiences and adult disease and called into question the traditional 
view of proximate causes of adult disease (73). Since then it has been identified that the stress of 
physical, psychological and sexual abuse, parental neglect, divorce and even family relocation 
can manifest in adulthood as cardiovascular disease, metabolic abnormalities and premature 
death (74–76). Many of these relationships originate from the chronic overload of the acute 
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stress response system, the hypothalamic-pituitary-adrenal (HPA) axis, and the resulting up 
regulation of catecholamines, and cortisol release in response to minor stressors (15,42,77). 
Downstream in this pathway is the elevated release of inflammatory agents which alter body 
systems, contributing to the onset of overweight and obesity (OWO) and related disease. The 
ACE findings build upon and affirm the health paradigm known as the life course framework. 
The life course framework suggests that the prenatal stage is a period of significant risk exposure 
and posits that health is a dynamic and cumulative condition rather than a static and temporary 
state (40,77,78).   
The life course framework underlies much of the obesity literature as it acknowledges 
that a comprehensive understanding of chronic diseases, such as obesity, is reliant upon the 
identification of multiple determinants, including prenatal and childhood/adolescent experiences, 
genetics/heritability and environmental exposures (40). A life course model operates on one of 
two hypotheses. The first is the biological programming (or embedding) hypothesis: stating that 
adult disease risks are the outcomes of programming in utero and in early infancy. The classic 
example of programming in regards to OWO and CVD risk is intrauterine development and the 
thrifty genotype hypothesis (79). This hypothesis states that poor maternal nutrition or, 
alternatively, high maternal body mass index (BMI) or fat mass (FM), gestational diabetes 
mellitus (GDM) and insulin resistance (IR), have long lasting implications for the health of the 
offspring, such as increased risk of adult OWO, high blood pressure and diabetes (14,80). In this 
case, the metabolic processes relating to insulin-glucose imbalance, insulin sensitivity and 
hyper/hypoglycemia of the mother affects and permanently alters the metabolic and endocrine 
function of the fetus (14,79–82). This hypothesis is revisited in section 2.7.1. The second 
hypothesis is the cumulative exposure hypothesis, stating that repeated exposure to adverse 
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physical and social environments over the life course will cluster, perpetuate, and link one period 
to another in a pathological process in which risk is additive (Figure 2.1) (40,83) . 
Infancy, childhood, and adolescences are critical periods which are markedly associated with 
adult health (14) . The alteration in normal development during a critical period can change the 
structure or function of the body, organ, system or tissue; for example, rapid “catch-up growth” 
following low birth weight is linked with early signs of adverse cardiovascular health, adiposity 
and abdominal adiposity by early childhood (84). 
Obesity research has demonstrated that there is a cumulative effect of FM from one stage 
to the next, as high and low birthweight (BW), early onset of OWO, rapid gains in FM and 
elevated FM during critical periods can independently relate to adult OWO, lipid profiles, insulin 
Figure 2.1 Cumulative exposure contribution to accumulated risk. (Figure adapted and redrawn 
from Darnton-Hill, I., Nishida, C., & James, W. (2004). A life course approach to diet, nutrition 
and the prevention of chronic diseases. Public Health Nutrition, 7(1a), 10 
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sensitivity and CVD risk (85–87). These early life risk factors have also demonstrated a 
summative risk: the more exposures, the greater the risk. The likelihood of childhood OWO, 
adult OWO and adult cardiometabolic diseases are elevated in those exposed to early life 
stressors such as domestic violence, food insecurity, parental depression, housing transitions and 
insecurity, potentially due in part to their combined effect on the HPA axis (85,88,89). Studies 
have also found that children with OWO who become adults with NW are at no greater risk of 
hypertension than adults who have NW who never acquired OWO. This suggests that for some 
parameters, adult OWO has a greater implication on adult health than does childhood OWO (90). 
Negative exposures such as childhood/adolescent OWO combined with positive future exposures 
such as PA and dietary interventions, may result in weight loss and improved health status in 
adulthood (91,92). Studies also demonstrate that OWO in adults who also had OWO as children 
have the highest risk (90) . This demonstrates the cumulative critical periods hypothesis, 
suggesting that the negative exposure (childhood OWO) manifest as an amplified negative 
outcome (adult health) when paired with successive negative exposures (adult OWO or low PA).  
A life course framework underpins the research questions of this thesis. The dynamic 
character of health is acknowledged in the analyses of longitudinal data which encompasses 
critical periods of growth. The assessment of growth can provide valuable information about 
health. Alternatively, when growth is not accounted for it can confound the interpretation of 
health-related measures. Thus, it is essential to consider the implications of the processes of 
growth and maturation. Exploring or controlling for age and time-dependent factors such as 
height or FM necessitates a foundational understanding of the age and maturation-related 
anthropometric and morphological changes in order to infer deviation from a healthy trajectory 
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and to parse the effects of normal biological processes of growth from external influences such 
as diet and PA (69).  
A more thorough discussion of how growth, maturation and the environment interact 
during critical periods to promote or mitigate FM gain and CMR is provided in Section 2.7.  
 
2.2 GROWTH AND MATURATION 
 
The period of life spanning conception to young adulthood demonstrates rapid changes in 
body composition. The timing and tempo of growth have major implications for adolescent 
health status as well as long-term health (83). As such, the processes and alterations of growth 
are highly monitored (69). Height (cm), weight (kg) and BMI (kg/m2)-for-age and sex are often 
used to measure growth status and identify altered growth to ensure that optimum growth is 
occurring (93–95). An individual’s status, according to each of these metrics, is used to identify 
nutritional deficits or disease leading to deviations from optimum growth (95). The emergence of 
the OWO epidemic created an urgent need to identify excess growth in FM and standards by 
which to classify OWO status. BMI became this criterion (96). Adult height is static and adult 
weight gain is often a result of increased FM; as such, BMI and corresponding cut-offs of OWO 
are accepted as indicators of excess fatness and linked to poor health (96,97). Attempting to 
identify OWO in children is more complicated as one must consider the effects of normal growth 
and maturation. Children and adolescents (up to young adulthood) experience non-linear height-
to-weight and sex specific changes in body composition (98). This can result in erroneous BMI 
classifications of OWO which may not correlate with adiposity or the underlying health 
consequences, particularly because FM accounts for only 50% of BMI changes between 5-18 
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years (99). BMI correlates well with %TBF in 20-39 year olds (r=0.790 and 0.84 in males and 
females, respectively) (35), and in 5-19 year olds (r2 =0.63 and 0.69 for males and females, 
respectively); however, large confidence limits on the BMI-%TBF relationship suggest large 
individual variation in fat mass at a given BMI (36). Pediatric sex-specific BMI-for-age, and 
percentage (%) total body fat (TBF)-for-age references and OWO cut-offs have been developed 
to better reflect the normal and abnormal changes in BMI and body fat occurring in childhood 
(95,100,101). The effect of growth and maturation can also mask the influence of other external 
factors such as PA or diet on FM accrual. As such, any conclusions drawn about body 
composition, overweight status, or relationships between change in body composition and 
external factors must consider growth and maturation, especially during and surrounding the 
period of rapid growth in adolescence.  
2.2.1 Development 
Development refers to the biological differentiation of cells, and the acquisition and 
refinement of behavioral (social, cognitive) competency (69). Behavioral development includes: 
understanding aspects of socially acceptable behaviors; cultural symbolism and significance; 
intellect and sense of humor; aspects fully established by adulthood. Full biological development 
or differentiation is attained when a tissue or system is fully capable of carrying out its function. 
Like maturation and growth, there can be great inter-individual variability in the rate of 
development. 
2.2.2 Growth 
Growth refers to a change in size of a part, or the entire body (69). Children grow bigger 
and taller with chronological age (CA), due to one or more cellular processes. Processes include: 
hypertrophy - increase in cell size; hyperplasia - increase in cell number; or accretion - increase 
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in intracellular-substance. Although all three cellular processes govern growth, one may 
predominate over the other two at different stages of growth. For example, fat cells will increase 
primarily through hypertrophy for the first year of life, while hyperplasia of fat cells will 
dominate through childhood and adolescence (69). The timing of growth is not the same in all 
tissues or in all individuals; however, the patterns of growth of systems and tissues generally 
follow one of four curves: the neural curve (e.g. brain, spinal cord and head), the lymphoid curve 
(e.g. lymph nodes, glands, tonsils), general curve (e.g. height, weight or body mass, FM, etc.), 
and genital curve (e.g. reproductive organs). The respective patterns are shown in Figure 2.2 in 
which the y-axis represents the percentage of adult size attained and the x-axis represents the 
time from birth to 20 years of age. The general curve is followed by most of the body systems, 
particularly those relevant to this review, the musculoskeletal system or somatic growth. 
 
Figure 2.2 Scammon's curves of systemic growth. (Figure adapted and redrawn from Scammon 
R.E., 1930, The measurement of the body in childhood. In The measurement of man. 
Minneapolis, MN: University of Minnesota Press, p 193). 
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The most frequently measured components of growth are height (standing surface to top 
of the head), sitting height (sitting surface to top of head; trunk length) and weight (body mass 
including lean, fat, and bone mineral mass). Somatic growth follows a sigmoidal pattern with 
rapid growth in the first year of life followed by deceleration to a relatively stable velocity during 
childhood (4 to 8 years of age). The rate of growth accelerates again (although not to the same 
velocity as year one) with the commencement of puberty during the adolescent period of growth. 
The assessment of healthy growth can be carried out by plotting serial measures of height and 
weight on to reference curves. Although simplistic in their execution, measurements of growth 
are susceptible to error. Error can occur because of changes in the technique of those taking 
measurements, activities and time of day (individuals will be shorter after activity and in the 
evening due to compression of intervertebral discs), or hydration and diurnal variation in weight 
(93) . 
2.2.3 Maturation 
Maturation is defined as a process, or one’s point of progress, towards the adult (mature) 
state of the body’s systems, tissues, organs etc. (69). This process includes the maturation of the 
nervous system, such as decreasing plasticity and development of prefrontal cortex; maturation 
of the musculoskeletal system, such as ossification of bones; maturation of the endocrine system, 
such as the transition from preferential use of fat to use of carbohydrate during aerobic exercise; 
and sexual maturation, such as changes in the pattern of hormonal release and the development 
of secondary sex characteristics (98).  
Rates of maturation differ between individuals, between systems and between tissues. 
Individual differences are often referred to as an individual’s timing and tempo of progress (69). 
Timing refers to the discrete age at which maturational milestones are met, such as the age of 
 
 
16 
 
menarche. Tempo refers to the rate at which an individual moves from one event, or milestone, 
to the next. The attainment of one milestone may not have the same timing as subsequent 
milestones; for example, an individual may have a slow tempo in the rate of breast development 
but reach a subsequent milestone such as menarche at an early age.  
There are a variety of methods used to estimate maturity. The most common are skeletal 
age (SA), secondary sex characteristics, age at peak height velocity (PHV) and age at menarche 
(93). SA uses radiographs of the wrist and hand which are analyzed by comparing a subject’s 
scans to age-specific reference scans. Ossification of the bones occurs in a predictable, universal 
and irreversible process towards the adult state. As such, an individual’s radiograph can be 
matched to a reference scan and a SA can be determined. The assigned SA will be the same as 
the CA on a matched reference scan. An estimate of maturation is then the difference, or ratio, of 
the assigned SA to the individual’s actual CA. For instance, if a 12-year-old girl has a radiograph 
that matches the reference radiograph of a 14-year-old, her SA is 14 and her maturation estimate, 
or Biological Age (BA), is +2 years. In this case she is likely maturing earlier than her peers 
(93). 
The estimation of maturity status from the evaluation of secondary sex characteristics 
relies on visually identifying the individuals’ stage of secondary sex characteristic development. 
Individuals are placed in one of five progressive stages of pubertal development based on 
observed characteristics (self-observations, parental observation or observation by a medical 
professional). Characteristics include: the assessment of pubic hair, genitalia (males), axillary 
hair, testicular volume (males), voice change (males), facial hair (males), and breast development 
(females). Stage 1 of each characteristic is considered pre-pubertal with no observable changes 
present from the pre-pubertal state. Stage 5 is the mature state. A weakness of this method for 
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maturity assessment (other than being highly invasive) is the inability to compare between the 
sexes as stages are not equivalent in timing between sexes (i.e. pubertal hair stage 2 in females 
does not equate to pubertal hair stage 2 in males) (93). Furthermore, stages within an individual 
are not necessarily the same; pubic hair 3 does not necessarily mean that breast stage 3 has been 
attained. Finally, stages of secondary sex characteristics are discreet and as such using this 
method as a maturational estimate does not recognize the tempo of the continuous process of 
maturation. Estimation of maturation from secondary sex characteristics does not allow for an 
estimation of the length of time an individual has been in each stage and, as such, an individual 
who has just entered a stage will be classified the same as an individual almost leaving the stage, 
even though they may be quite different in terms of maturation (93).  
Age of PHV is the point at which stature is changing the most rapidly during 
adolescence. Like other maturational milestones, this will occur in all individuals and within a 
predictable pattern (69). 
When longitudinal measures are taken close together across the adolescent growth spurt, 
the age when PHV is occurring can be measured. Individuals can be classified as before or after 
PHV; or be assigned a BA (number of years before or after the attainment of PHV). This allows 
for individuals to be aligned by a common maturational milestone (at PHV BA=0) rather than by 
chronological age (CA). On average, males reach PHV around 14 years of age and females at 
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around 12 years of age (Figure 2.3). 
 
If serial measures are not available, there are also several commonly used predictive equations 
that estimate when PHV will occur or has occurred. These are based on sex and age specific 
anthropometric ratios of height to sitting height (102,103). In this case, the timing in years from 
PHV is used as a BA. The accuracy of this prediction equation, however, depends on the time 
from the actual event when measurements occur. The prediction works best within a narrow age 
range surrounding PHV (from -2 to +2 years from PHV) in individuals with a normal 
maturational tempo (102).  
Age at menarche can be used to classify females as pre/post menarche or years before or 
after menarche like attainment of PHV. Menarche occurs around 13 years of age, after 
attainment of PHV, and is a relatively late occurring maturational milestone.  
Figure 2.3 Typical velocity curve for height (or length) in males and females. (Figure adapted 
and redrawn from Tanner, Whitehouse and Takaishi, 1966, “Standards from birth to maturity for 
height, weight, height velocity, and weight velocity: British children, 1961-I”, Archives of 
Disease in Childhood 41:454-471). 
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2.2.4 Somatic Growth 
There has long been a keen interest in the study of human growth and its variations as an 
indicator of health (95). This interest led to the creation of growth curve references 
(representation of the spread of data in a population) and growth curve standards (indicator of 
healthy optimal growth) (e.g. Figure 2.4) (69,95). On a growth reference chart, the middle line, 
the 50th centile, indicates that 50% of children at a specific age will fall at values above the line 
and 50% at values below the line. Comparing an individual’s growth to the growth reference and 
identifying their status and/or progress can provide an indication of their health. Status considers 
the placement of an individual within the spread of population data and infers inter-individual 
(between individuals) variation. Progress can then be considered in terms of intra-individual 
(within individual) change from one measurement occasion to the next, or inter-individual 
progress - the point of progress towards maturation compared to reference data (98). These terms 
are more thoroughly discussed in sections 2.2.4.1 and 2.2.4.2.  
2.2.4.1 Status 
Growth status is a single, time-dependent achievement of size, maturation or 
development and requires comparison to a standard, or comparison of one individual to other 
individuals. Reference charts plot the distribution of sex- and age -specific growth data so that an 
individual’s status can be expressed relative to a representative population. These charts are 
commonly used during infancy and childhood to assess status or growth, measured by length-for 
age percentile charts (up to 36 months). From 2 to 20 years, stature-for-age, weight-for-age and 
BMI-for-age (Figure 2.4) are used to plot an individual’s status and/or their progress.  
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For example, using the WHO BMI charts (Figure 2.4), a 12-year-old female with a BMI of 23 
kg/m2 would be at the 90th percentile indicating that 10% of the population has a higher BMI 
and 90% have a lower BMI. Stability or divergence from one’s centile is considered a 
characteristic of progress. 
2.2.4.2 Progress 
Progress considers the change between two or more consecutive measurement occasions 
in the same individual. Size in the first year of life is poorly correlated with adult size as fetal 
development is highly dependent on maternal characteristics; however, by the age of two the 
correlation (under optimal environmental conditions) increases to approximately 0.80 and is 
reflective of genetics and other environmental influences (104). A small-for-gestational-age 
infant under the 5th percentile at birth can experience catch-up growth in the first year of life 
thus achieving the 50th centile status by one year of age. A child’s growth centile will normally 
Figure 2.4 CDC Body mass index-for-age percentile charts for a) females and b) males. 
(Reprinted with permission as part of the public domain. See Appendix M for copy of 
authorization). 
a) b) 
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stabilize after the first 1-2 years of life, often remaining within a small range around a constant 
centile for the remainder of their life (98). This process of centile stabilization is known as 
canalization (104). 
Significant departure from one’s centile during childhood is likely due to nutritional and 
other environmental influences causing growth restriction; whereas departure from one’s centile 
during adolescence does not have the same implication. “Centile Crossing” is common during 
adolescences as it is related to the timing of maturation and inter-individual variation. This is 
because the 50th centile lines represent the average size and timing of maturation. As such, those 
who mature earlier than average are more likely to cross growth centiles as they approach their 
adolescent growth spurt, indexed by PHV. Alternatively, a decrease in centile is seen in late 
matures because same aged peers have already begun their growth spurt (104). A return to one’s 
pre-adolescent centile is common towards the end of adolescence. 
Estimating the progress of an individual over time can be addressed using anthropometric 
measures. Serial measures of height can identify PHV, and thus be used to assign a maturational 
age or BA (as described previously). For example, a growth rate of 5cm/year from 9-10 years, 12 
cm/year from 10-11 years and 7cm/year from 11-12 years identifies acceleration from up to the 
10th year and deceleration following the 11th years. This identifies the 10th-11th year as the year 
that encompassed PHV. The equation for proportional allotment can be used to estimate the 
exact age at which PHV is occurring.  
Age of peak velocity (APV) = 𝐴 + [
𝑉𝐴𝑝𝑒𝑎𝑘−𝑉𝐴𝑏𝑒𝑓𝑜𝑟𝑒
(𝑉𝐴𝑝𝑒𝑎𝑘−𝑉𝐴𝑏𝑒𝑓𝑜𝑟𝑒)+(𝑉𝐴𝑝𝑒𝑎𝑘−𝑉𝐴𝑎𝑓𝑡𝑒𝑟)
] − 0.5 
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Figure 2.5 Developmental curves of a) height distance, and b) height velocity for males and 
females. Distance curve used with permission from Malina, Bouchardand Bar-Or, 2004. Growth, 
Maturation and Physical Activity, Figure 3.6, p49. See Appendix N for copy of authorization to 
use. Velocity curve adapted and redrawn from Tanner, Whitehouse and Takaishi, 1966, “Standards 
from birth to maturity for height, weight, height velocity, and weight velocity: British children, 
1961-I”, Archives of Disease in Childhood 41:454-471. 
 
Velocity curves are better representations of statural, body mass and fat mass growth than the 
curve of distance because growth is not linear. 
2.2.4.3 Statural Growth 
Velocity growth curves demonstrate three distinct peaks or growth spurts: periods of 
increased growth rates, specifically seen in height and weight. The first spurt occurs prenatally 
during weeks 20-30 and reaches approximately 120 cm/year (104). At birth, an infant is 
approximately 30% of their final adult stature. In the first year of life, statural growth continues 
to be rapid, at a rate of approximately 25 cm/year, followed by 11-12 cm/year in the child’s 
second year. By the age of 18 months in females, and 24 months in males, an individual will 
have attained approximately 50% of their adult stature. The rate of growth decelerates from birth 
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to adolescence with an overall velocity close to 5 cm/year (98). There is a second small growth 
spurt occurring at 6-8 years known as the juvenile or mid-growth spurt. The final spurt is the 
adolescent spurt (or PHV) occurring between 11.3 and 12.2 years (take-off at 8.2 to 10.3 years) 
in females and between 13.3 and 14.4 years (take-off at 10.0 to 12.1 years) in males (Figure 2.5) 
(69). 
 Males begin their adolescent spurt on average 2 years later than females, and thus 
experience an additional 2 years of preadolescent growth at a velocity of roughly 5 cm/year (69). 
The adolescent spurt has a velocity of approximately 8 cm/year in females and 10 cm/year in 
males. Females stop growing approximately 2 years earlier than males (16 years versus 18-19 
years, respectively), in addition to having a lower peak rate of growth (2 cm/year greater in 
males). The difference in adult stature (~13cm) between males and females is largely explained 
by these sex differences occurring during adolescent growth. There are also sex differences in 
other body components that similarly become more prominent in adolescence. 
2.2.4.4 Body Mass 
The development of body mass (weight) is similar in pattern to that of stature. Rapid 
gains in infancy and early childhood, a two-fold increase by one year and a four-fold increase by 
year two, followed by stable rates of gain during mid to later childhood. The growth of body 
mass is often tracked using BMI growth charts which consider mass relative to height (Figure 
2.4). Acceleration of body mass gains occurs with the onset of adolescence as both FM and fat 
free mass (FFM) accrual increase rapidly during this period. Peak body mass velocity occurs 
roughly 0.2-0.4 years after PHV in females and 0.3-0.9 years after PHV in males. The increase 
of body mass is comprised of gains in lean, bone and fat mass in both sexes, but the relative 
contributions of each component differs between the sexes. Females gain more FM while males 
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gain more LM and bone mass (i.e. greater statural growth). Peak bone mass precedes peak body 
mass. Peak LM occurs approximately 0.3 years after PHV in both sexes followed by peak body 
mass. While gains in FFM often levels out, FM gains may continue into adulthood and, as such, 
so too does body mass. 
2.2.4.5 Fat mass 
Subcutaneous fat is the first fat depot to be accrued, beginning in utero. Subcutaneous fat 
represents 15% of body mass at birth, increasing to 30% by one year. Skinfolds are a measure of 
subcutaneous fat, and these measures decrease from approximately 6-9 months to a nadir around 
6-8 years. The point when fat mass accrual returns to a positive velocity immediately following 
the nadir is known as the adiposity rebound (AR). The AR corresponds with a reversal and rise 
in the BMI curve. The terms BMI rebound and AR are sometimes used interchangeably; 
however, it has been demonstrated that it is most often FM that is altering BMI during this time 
rather than LM (105). It has also been demonstrated that an earlier AR is associated with greater 
FM at the time of rebound, more rapid gains following the AR and greater FM in adulthood 
(106). This is why the AR has been indicated as a critical period for fat mass accrual (see section 
2.7.3). 
The patterns of FM accrual are similar to BMI curves from childhood to young 
adulthood. From the AR through adolescence, FM continues to rise. Once adolescence is 
complete some individuals’ FM will plateau while the majority of individuals will continue to 
have incremental gains of FM into early adulthood and beyond (107). There are significant sex 
differences and individual differences in the magnitude of FM gains throughout the life span due 
to genetic, hormonal, and external influences such as stress, diet and PA (108) (see Section 
2.2.5). 
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2.2.5 Periods of growth and sex differences 
Growth is often divided into periods, or phases, with distinct characteristics, albeit within 
somewhat arbitrary CA boundaries. These periods overlap with the critical periods described in 
Section 2.1. There cannot be firm chronological boundaries, especially during the years of 
adolescence, because of the great inter-individual variability in timing of onset and completion of 
each phase (109). The first period, the prenatal period, is the exception as it has consistent 
boundaries. During this period, the process of development predominates. The embryonic tissues 
differentiate from stem cells to their tissue specific cellular form and function. This period is 
especially important to a life course perspective of health because this perspective emphasizes 
that exposure to certain stimuli during intrauterine development has long-standing implications 
for later life health (i.e. biological programming). The thrifty genotype hypothesis, or fetal 
origins hypothesis, developed by Hales and Barker, illustrates the importance of this period in 
regard to future health (see Section 2.9.4.1.) (79). 
The second and third periods are infancy and childhood, respectively. Infancy, or post-
natal growth, is a period of extremely rapid increases in many body systems, particularly the 
neuromuscular system. As already indicated, somatic changes of increased stature, muscle, bone 
and fat mass are also occurring at a rapid rate in infancy which slows to a steady pace in early 
childhood.  
Sex differences in stature are very small during this period with a difference of only 1 cm 
by the age 5 favoring males. FM will be consistently higher in females than in males during early 
childhood with males having approximately 15% TBF and females approximately 17% TBF by 
the age of 5. From 6 years of age onwards, females have higher rates of FM gain leading to a sex 
difference in FM of approximately 6% by 10 years of age (Figure 2.7) (104). 
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  During early childhood, sex differences in FFM and %FFM are small; however, by 
adulthood females have, on average, about 70% of FFM, 50% of LM and 150% of TBF of adult 
males (69). Many of the sex differences in fat, bone and lean mass become evident just prior to 
the final growth period of adolescence and the beginning of emerging adulthood (EA). 
The adolescent period follows late childhood with the onset of the somatic growth spurt. 
Although puberty refers more specifically to the development of reproductive capacity and 
secondary sex characteristics, there is significant synchronization between puberty and 
musculoskeletal maturation. Just prior to puberty, males can be slightly heavier than females. But 
due to an earlier onset of puberty seen in females (by approximately 2 years), males are often 
shorter and lighter than females at ages 11, 12 and 13. Aside from an earlier onset of the pubertal 
growth spurt in females and the slightly higher maximum rate reached in males, the pattern of 
Figure 2.6 Development of %TBF in a) female and b) male adolescents. (Reprinted with 
authorization. Silva, Baxter-Jones, & Maia, 2016. Fat Mass Centile Charts for Brazilian 
Children and Adolescents and the Identification of the Roles of Socioeconomic Status and 
Physical Fitness on Fat Mass Development. International Journal of environmental Research 
and Public Health, 13[2]. This is an open access article distributed under the Creative Commons 
Attribution License which permits unrestricted use, distribution, and reproduction in any 
medium, provided the original work is properly cited. [CC BY 4.0]). 
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statural growth is very similar between sexes. The pattern of FM accrual, however, diverges 
during adolescence and the previously small sex disparity in FM enlarges. Beginning as early as 
8 years (Figure 2.7), females will see increases in FM and in %TBF while males will see 
increases in FM but often decreases in %TBF from about 12-17 years (Figure 2.6) (109). 
The sex difference in pattern of %TBF is because FFM, and specifically LM, increases at 
a much greater rate in males during adolescence than in females. Males also continue to accrue 
LM for almost 2 years longer than females (similar to patterns of height). Throughout 
adolescence, males will also have greater bone mineralization (contributing to total mass) even 
when controlling for LM and age (110). The continuous gains in FFM found in males compared 
to plateauing gains of FFM in females, combined with greater FM gains in females throughout 
adolescence, leads to a greater fat-to-lean mass ratio in females than in males (Figure 2.7). 
 During the periods of infancy and childhood, both sexes have more fat deposited in the 
subcutaneous fat depots than visceral (deep) depots, and in the extremities than in the trunk. 
Adolescence is a time when the distribution of fat (where the fat is laid down) begins to change 
and noticeably differ between sexes. The accrual of TrF and visceral fat are characteristic of the 
adolescent period. Adolescent females will accrue more absolute TrF (g) than males but also a 
greater amount of extremity fat; and, although males will also accrue TrF they will 
simultaneously begin to lose extremity fat. This results in males carrying a greater percentage of 
TBF on their trunks in comparison to females. Furthermore, males’ skinfolds decrease over 
adolescence while females’ skinfolds continue to increase, so while females may have a greater 
amount of TBF, subcutaneous fat makes up a larger percentage of TBF in females than in males. 
These sex differences continue and broaden during subsequent periods of emerging, early and 
mid-adulthood (69,111,112).  
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Emerging adulthood (EA) is a socially constructed stage of life in which the majority of 
physiological changes to the body associated with adolescent or pubertal growth have ceased and 
yet weight and fat gains begun in adolescence may continue (28). This period has been referred 
to as the volitional period in which there is broad individual variance, more so than at any other 
time in the life course, as individuals experiment with different adult habits, choices, and 
lifestyles. This is especially true in industrialized countries where this period of prolonged 
adolescence is socially sanctioned (32). As such, there is a lack of predictability in growth due to 
individuals experimenting with lifestyle choices including those related to health behaviors such 
as dietary intake, alcohol consumption, sleep/awake schedules and PA behavior. Increasing rates 
Figure 2.7 Changes in fat, fat-free mass and percent body fat in males and females from birth 
to young adulthood. (Reprinted with permission from Malina, Bouchard and Bar-Or, 2004. 
Growth, Maturation, and Physical Activity, ch.5, p113. See appendix for copy of 
authorization).  
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of obesity, and an almost negligible numbers of individuals moving from obese to non-obese, are 
observed over this transitional period from high school to young adulthood (27,31,107). There 
are suggested links between childhood and adolescent factors such as PA, FM and health and the 
growth and health status of emerging and early adulthood (31,113–118). The role of EA on FM 
and lifestyle in predicting adult health cannot be fully elucidated without consideration of 
childhood and adolescent lifestyle and body composition. In turn, both body composition and 
lifestyle (i.e. PA) are heavily influenced by the auxological (growth) processes and adult health 
is influenced by genetics, hormones and environmental factors interacting throughout the life 
course. 
 
2.3 OVERWEIGHT AND OBESITY 
2.3.1 Regulation of fat mass accrual and Onset of Overweight and Obesity 
The most simplistic reason for overweight (OW) and obesity (OB) is the “calories in- 
calories out” theory; the idea that if you eat too much or burn too little you will gain excess fat. 
This theory is supported by studies of caloric restriction and increased PA leading to weight loss, 
and correlations between moderate-to-vigorous PA and lower adiposity (91,119–121). The onset 
of OWO in early adulthood also supports this theory as a large number of individuals acquire 
OWO in late adolescences and emerging adulthood when the caloric demand for growth 
processes decreases but the caloric intake remains unaltered (107). Habitual food intake that was 
once required to meet the body’s energy demands for growth becomes excessive after growth is 
complete. As a result, excess calories are stored as FM, bringing about the onset of OWO.  
Some argue that this theory of OWO is an oversimplification. Studies in support of a 
more complex cause cite no association or an inverse relationship between OWO and caloric 
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intake, suggesting that there are likely metabolic, genetic, epigenetic, and endocrine contributors 
to this disease (15,122,123).  
Single-nucleotide polymorphisms (SNPs) are genetic variations of single nucleotide 
building blocks; for example, the presence of cytosine instead of thymine in a string of 
DNA(124). Recent technological advancements have allowed for Genome-Wide Association 
Studies (GWAS) identifying over 300 SNP’s related to BMI, waist-to-hip ratio and other 
measures of adiposity; however, these SNPs cannot account for the entire phenotypic expression 
(124). For example, it has been suggested that only around 30% of the variance in BMI can be 
explained by related SNP’s, yet other estimates suggest a genetic basis for obesity between 40 
and 70% (124). Single gene deficiencies causing obesity are rare and as such it is must be 
considered a polygenic disease in which individuals’ predispositions to FM gains interact with 
environemental and lifestyle factors (69,125,126) (see Section 2.9).  
There is a significant heritability component to an individual’s body mass and/or FM . At 
birth, the correlation between parental and child body mass is low, and the correlation increases 
to about 0.3-0.4 (low to moderate) following the adolescent growth spurt. This is because the 
first year of growth reflects the intra-uterine environement rather than genetics or extra-uterine 
environment. Early twin studies demonstrate concordance rates of BMI and body mass between 
monozygotic (identical) twins that are twice that of dizygotic (fraternal) twins, suggesting a 
strong genetic influence on adiposity (127). The correlation of weight between monozygotic 
twins increases from birth to early adulthood to values at 19 years of 0.92. Although not as 
strong as the link between parental and child height (60%), the age and sex adjusted phenotypic 
variance in FM accounted for by heritability is 25-40% (69,128). 
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There are also familial similarities in the characteristics and behavior of adipocytes in 
terms of proliferation, hypertrophy (cell number and capacity), level of lipolytic activity and fat 
depots. In vitro studies of twins demonstrate greater variablility in fat mobilization (release of fat 
for oxidation) cascades between dizygotic than between monozygotic twins. Heritability 
coefficients for subcutaneous fat distribution (upper, lower or abdominal body fat) as well as 
visceral abdominal fat are approximated at 50%, even after adjutsing for TBF (69). Waist to hip 
ratio has demonstrated similar heritability, with estimates ranging from 22% to 61% (129). 
Furthermore, findings from the Quebec Family Study found that heritability was even higher for 
visceral fat (56%) than for subcutaneous fat (42%) (130) which is concerning as visceral fat has 
significant implications for cardiovascular health. Genetic underpinnings suggest that visceral fat 
may be a less modifiable characteristic (see Section 2.4.3). 
2.3.2 Age at onset of OWO 
The age at onset of OWO may reflect different underlying causes. From a very early age, 
those individuals who will become obese have a different trajectory of growth, even before they 
are overweight (107), and those with metabolically normal obesity tend to have an earlier onset 
(131). In one study looking at never, early and late onset OWO groups, those with an earlier 
onset of OWO (before 25 years) compared to a later age of onset (after 25 years) had higher 
levels of adult BMI in addition to higher BMI from the age of 2 in females, and 8 years in males 
(107). An earlier study examining subcutaneous adipose tissue of adults and children 
demonstrated those with weight-for-height above the 97th centile by 1 year, and those adults who 
identified as having been obese children, had higher levels of %TBF, a greater number of 
adipocytes, but smaller size of adipocytes compared to late childhood or adult onset obesity 
(132). It is known that smaller and more numerous adipocytes have a lower correlation with IR 
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and type II diabetes, are less likely to become inflamed, and thus less likely to lead to 
cardiovascular and metabolic disease in comparison to large adipocytes (47,133). As such these 
differences in the timing of OWO onset suggest that while those with earlier onset OWO may 
become larger, the fat accumulated may be healthier. This adipocyte dimorphism is delineated by 
Salans et al. (1973) as hyperplastic obesity - early onset with small adipocytes - versus 
hypertrophic obesity - late onset with larger adipocytes (134). The relationship of adiposopathy 
(sick fat cells) leading to CMR with late childhood or adult onset of OWO may be stronger than 
with early childhood onset (i.e. by 1 year), and yet OWO and CMR also demonstrates 
antecedents in early fetal development.  
Altered fetal development leading to dysfunction of the endocrine and fetal 
hypothalamic-pituitary-adrenal axis can occur due to various forms of early stress or through 
trans-generational mechanisms from conditions such as maternal obesity and gestational 
diabetes. These maternal conditions expose fetuses to endogenous glucocorticoids such as 
cortisol, elevated insulin and glucose levels, and exposure to inflammatory agents (135–137). 
This results in an elevated risk to the fetus such as IR, future OWO and adult vascular disease 
(138,139) (see Section 2.7.1). Alternatively, an early onset of OWO in childhood from an 
overconsumption of calories and a sedentary lifestyle may be benign in terms of health. This 
theory is supported by findings that childhood BMI may have a protective effect at a given level 
of adult BMI and that the link between childhood BMI and adult disease is dependent on 
tracking of BMI (140). With that said, OWO also has a cumulative effect on morbidity and as 
such children with OWO that have stable OWO have had a more chronic and long term assault 
on the cardiovascular and metabolic systems and are likely to present with higher CVD risk 
profiles (17,20,140).  
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2.3.3 Measuring body composition and adiposity 
Body composition is measured using a variety of methods. Each measure is used to 
estimate the volume or percentage of fat mass comprising total body mass. Body composition 
can be expressed by a two, three or four-compartment model in addition to singular units or 
compartments such as weight/body mass (kg) measures or BMI. Two compartment models parse 
the body into FM and FFM components. The three compartment models partition fat from fat-
free and total body water (or fat, lean and bone). The four compartment models partition fat from 
fat-free (non-bone) and bone mineral and residual mass (69). Some of the most common used 
body composition methods include dual x-ray absorptiometry (DXA), bio-electrical impedance 
(BIA), computed axial tomography (CT), hydrostatic underwater weighing or air displacement 
plethysmography, magnetic resonance imaging (MRI) and skinfolds.  
Underwater or air displacement weighing estimates the volume of the body and, using 
assumed density characteristics of body tissues, estimates FM and %TBF. The underwater 
weighing technique (hydrostatic weighing) was once considered the gold standard of body 
composition and has been used to develop regression equations for estimates of body fat based 
on skinfolds, and as a validation method for other methods of measuring body composition 
(141). However, hydrostatic weighing has since been replaced by MRI as the gold standard of 
body composition assessment. The issue with hydrostatic weighing is that the density of FFM is 
assumed to be consistent but can change with time or show discrepancies between sexes, fitness 
levels, hydration and (most relevant for this dissertation) by age and degree of maturation of an 
individual. The variation in body density can result in variance of calculated %TBF by 
approximately 3.9% (141) . 
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Bioelectric impedance analysis (BIA) operates on the electrophysiological theory. This 
theory posits that water containing tissues such as blood and muscle conduct electricity better 
than fat mass. The volume of FFM is estimated by analyzing the magnitude of electrical 
conductivity and the combined resistance of water and electrolyte containing tissues (141). As 
with other methods that rely on underlying assumptions (e.g. electrical resistance of body water), 
there is the possibility of error, particularly in children and adolescents in whom some of these 
assumptions are yet to be verified (69).  
DXA estimates bone mineral content (BMC), lean mass (LM), and fat mass (FM) for 
both total body (TB) and regional (e.g. hip and spine) body components (141). Estimates of FM 
and LM content are made from known constants at which each body tissue absorbs or attenuates 
x-ray photon beams. A 2-dimensional posteroanterior image is provided representing body 
structures, which can then be divided into different compartments. Theoretically, the hydration 
of the individual can again compromise the accuracy of estimates by DXA; however, in a study 
conducted by Going et al. (1993), when subjects were intentionally dehydrated there were only 
small losses in accuracy for up to 3 kg water loss. Furthermore, the loss of weight with 
dehydration was mostly attributed to losses in LM by DXA, not FM (141). 
MRI estimates FM and FFM using an external magnetic field applied to the body. The 
nuclei of the cells of the body absorb MRI energy like magnets. When the electromagnetic wave 
is turned off, the body tissues releases the absorbed energy as a signal which is then used to 
develop an image of the chemical composition of the body which is then translated into body 
composition estimates (141). This method is now considered the gold standard. 
Computed Tomography (CT) also estimates fat, bone and lean mass. Like DXA, the CT 
scan uses known properties of different tissues and the attenuation of x-rays passing through the 
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body to indicate the volume of different components. CT and MRI scans provide a cross-
sectional anatomical image and as such can be used to identify the location of fat (subcutaneous 
versus visceral) (69). 
The concerns with radiographic methods such as MRI, CT and DXA include the cost of 
the method, accessibility to the machines, and exposure to radiation (CT and DXA only). CT 
exposes individuals to ionizing radiation and as such, repeated measures or measures on children 
and pregnant individuals are not advised. MRI does not use ionizing radiation and DXA uses far 
less radiation than the CT (141). 
 One of the least expensive and most accessible methods for estimating body composition 
is skinfold assessment. Using skinfolds, equations based on regression equations calculated from 
hydrostatic weighing are then used to estimate FM. Correlations with %TBF are high (r=0.7 to 
0.9) while correlations with FFM are low (0.2). Multi-site skinfold equations provide the most 
accurate predictions and demonstrate higher correlations with TBF as measured by radiographic 
methods. Skinfolds measure subcutaneous fat rather than visceral fat. There can be a high degree 
of error associated with this measure depending on the reliability of the measurer and the 
measurement tool (caliper). With that said, skinfolds are useful for monitoring change over time 
when the measurer is kept constant (69). 
Weight status can also be indicated using anthropometric measures. Body composition 
measures indirectly estimate FM whereas anthropometry such as weight-for-age, or weight-for-
height (Body Mass Index, BMI; kg/m2) use ratios of indices known to correlate with FM (69). 
Individuals’ ratios are considered in relation to reference data to draw conclusions about health. 
Values may be assigned a centile (i.e. 85th centile for OW by BMI) or compared to a cut-off 
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value (>25kg/m2 for OW by BMI) that corresponds to OWO cut-offs. Cut-offs are (ideally) 
developed with strong associations to FM as well as to health-related consequences of FM.  
2.3.4 Definition of Overweight and Obesity 
According to the National Institute of Health (NIH), overweight in adults is defined by a 
BMI of 25 kg/m2 to 29.9 kg/m2, whereas obesity is defined as having a BMI of 30 kg/m2 or over 
(21). As such an OB individual is also OW. OB is then delineated according to increasing 
severity: Obese I, II and III. These are the same definitions used by the WHO and the 
International Obesity Task Force (IOTF) (142). Health Canada adopted these same weight 
classification guidelines in 2003 to correspond with the WHO criteria. Healthy weights 
guidelines were altered from those of 1988, which indicated that a BMI < 20 kg/m2 “may be 
associated with health problems for some people”; a BMI 20-25 kg/m2 was “a good weight for 
most people”; a BMI 25-27 kg/m2 “may lead to health problems in some people”; and a BMI > 
27 kg/m2 was associated with “increasing risk of developing health problems” (143).  
BMI was first developed as an indicator of body fatness under the assumption that 
expressing weight in proportion to height should indicate something about body build, body 
fatness, and obesity (144). This ratio is useful because it is independent of height and because 
adults’ BMI demonstrates a strong relationship with body fat. In 1972 Keys et al. proposed the 
use of the term Body Mass Index to identify this ratio. They indicated that this metric was 
preferable to other weight-to-height indices tried previously (144). BMI has since demonstrated 
strong associations with estimates of TBF and %TBF by skinfolds and by DXA in adults 
(r2=0.68 to 0.83) and by DXA in children and adolescents (TBF r2=0.85 to 0.89) (63).  
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BMI cut-offs corresponding with excess body fatness in adults are identified as 25 kg/m2 
for overweight and 30 kg/m2 for obesity. The associations between BMI and fatness in children 
and adolescents are different and are reliant on age and maturation, as the linearity of the 
relationship between weight and height changes as a result of normal growth and development 
(69). Adult cut-offs of OWO are inadequate for use in children due to these fluctuations, and so 
pediatric BMI-for-age reference charts have been developed. There are currently three different 
sets of reference values. The set of references developed by the Center for Disease Control and 
Prevention (CDC) are based on American national survey data collected between 1963-1994 
(145). The set developed by the WHO is considered the “gold standard” in growth up to 5 years, 
as it was based on a cohort of children raised in optimal conditions. This set was released in 2006 
followed by a supplementary set for 5 to 19-year-olds in 2007 (146). 
The final set of cut-offs was produced by Cole et al. (2000) for the International Obesity 
Task Force (IOTF) (Figure 2.8) (101). This set was developed to transition smoothly into adult 
Figure 2.8 Pediatric cut-offs for overweight and obese by age and sex defined to pass 
through a BMI of 25kg/m2 and 30kg/m2 respectively at 18 years of age. (Figure adapted 
and redrawn from Cole et al. 2007. Establishing a standard definition for child overweight 
and obesity worldwide: international survey. BMJ, 320{7244]). 
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cut-offs assigning pediatric BMI cut-off values that were statistically equivalent to adult, 25 
kg/m2 (overweight) and 30 kg/m2 (obese) (65,101). IOTF reference curves are based on growth 
reference data - a large international sample with values describing the growth of a population - 
rather than on growth standards - growth in optimal conditions as seen with the WHO cut-offs 
(3,64).  
Adult BMI cut-off values are constant across studies and countries, while any of the three 
cut-offs (WHO, CDC, IOTF) can be used for children and adolescents. This makes prevalence 
estimates and comparisons between studies, and countries complicated and difficult. The IOTF 
references underestimate obesity in Canadian children compared to the WHO and CDC as its 
cut-offs are at higher values of BMI, likely due to the use of different samples and different 
curve construction methods (146). Again, the WHO curves represent the way children should 
grow, and the IOTF curve represents the way children in specific populations did grow, 
suggesting Canadian children are likely bigger than they should be. The largest discrepancy 
between references is seen between the ages of 5-11 (2).  
The Dietitians of Canada, the Canadian Pediatric Society and the College of Family 
Physicians of Canada recommend that the WHO growth charts be used for individual tracking of 
growth and tracking of the prevalence of OWO in Canadian, due in part to the underestimation 
by IOTF classification. This practice is used in multiple regions in Canada, including in the 
province of Saskatchewan (147,148). Conversely, the IOTF curves are the reference of choice 
for many academic and clinical studies, as well as scientific pediatric journals (e.g. International 
Journal of Obesity).  
Pediatric BMI cut-offs are a major advancement for nutritional health monitoring of 
children and adolescents; however, there are still concerns regarding the validity of BMI as a 
 
 
39 
 
measure of body fatness or adiposity. BMI correlates not just with FM but also with LM, skeletal 
muscle mass and bone mass and is unable to parse weight into these respective components 
(65,149,150) . Changing mineralization and water content of lean and bone in children further 
complicates the ability of BMI to estimate fat (65,141) . Although BMI has a strong correlation 
to %TBF in children, the strength of this relationship is reliant on the tendency for children with 
low BMI levels to have low levels of FM and children with high BMI levels to have high levels 
of FM. In children with mid-range BMI, the levels of FM can vary drastically (65). Freedman et 
al. (2009) illustrate this in findings that a BMI over the 95th centile demonstrates 70-80% 
sensitivity (true positive) and a 95% specificity (true negative) for excess adiposity in children, 
while the sensitivity and specificity at lower values of BMI (85th-95th centile) are less accurate 
(99). With that said, the correlation between a BMI over the 85th centile and adiposity is high 
enough to have notable health implications for both male and female children and adolescents. 
This is illustrated in the diagnostic performance of BMI to identify metabolic syndrome (MetS; 
clustering of CVD and diabetic risk factors) and other cardiovascular health risks. Laurson et al. 
(2014) found that in children identified as having “normal weight (NW)” by CDC BMI 
standards, only 1.7% of females and 0.8% of males presented with MetS, compared to 9.2% of 
females and 6.8% of males identified as having overweight, and 24.6% of females and 35.4% of 
males identified as having obesity (151). These results also illustrate sex differences in the ability 
of BMI to identify FM, likely because of sex difference in body composition development; for 
example, from 5-18 years, BMI will increase in males by 50%, but most of these gains are due to 
FFM accrual. The relative contribution of FFM in females is notably lower (99). The 
consequences of this sexual dimorphism are also illustrated in the study by Laurson et al. (2014) 
whose finding indicate that with the same BMI classification, females have a greater health risk 
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than males (e.g. higher MetS in NW females than NW males). BMI increments are more likely 
associated with LM in males and FM in females, and FM will have greater health implications. 
This is likely why Freedman et al. (2009) suggest that while BMI in children is moderately 
sensitive and specific for excess body fatness, the use of alternative or additional measures to 
BMI may be essential for discerning actual adiposity and for identifying the associated risk (99) . 
2.3.4.1 Critique of BMI for defining OWO 
Obesity is a condition in which the accumulation of FM surpasses threshold values and 
begins to negatively affect one’s health (152). A substantial body of research now documents the 
associations between OWO and numerous health consequences including Type II diabetes, 
cardiovascular disease, non-alcoholic fatty liver disease (NAFLD), and stroke. Yet the strength, 
or even the direction, of the association between OWO and health can be altered depending on 
the criterion being used to classify OWO. This is because the risk associated with OWO has a 
stronger association with FM and to the distribution of fat, than with BMI or lean mass. 
BMI can be extremely accurate and, in some cases, more accurate at predicting health 
risk than more specific measures of body fat. For example, in a recent study from the Mayo 
Clinic, BMI was associated with a higher hazards ratio (2.7) for CVD mortality than %TBF or 
FM index (fat to height indices) (1.6 and 2.2, respectively) from hydrostatic weighing and 
skinfolds (153); however, on an individual level BMI is still flawed, providing insufficient or 
even incorrect evidence of health concerns. For example, a recent study by Tomiyama et al. 
(2016) examined the classification of CMR by stratifying over 40,000 participants’ data by 
standard BMI classifications. Of those classified as OW, over 33% were metabolically healthy 
(e.g. no dyslipidemia, insulin insensitivity, etc.) as were 29% of OB and 16% of OB type II and 
III individuals. Furthermore, over 30% of those classified as NW were cardiometabolically 
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unhealthy. This data implies that almost three-quarters of a million Americans have CMR that is 
misclassified.  
BMI measures in children can similarly draw erroneous conclusions. Lower BMI values 
in childhood correlate with a lower likelihood of future OWO, and yet a normal BMI does not 
predict the absence of future OWO or health risk (99). Assessment and tracking of FM and 
health risk in children would likely benefit from the inclusion of measures that can provide 
information about the characteristic and location of excess weight (99,154).  In light of the 
criticisms against BMI, McCarthy et al. (2006) produced %TBF cut-offs associated with the 85th 
and 95th centile from the IOTF pediatric BMI cut-offs by Colet et al. (2000) (Figure 2.9) 
(100,101). These cut-offs identify %TBF values indicating overweight (>85th centile) and obese 
Figure 2.9 Pediatric cut-offs for overweight and obese by age and sex (Figure adapted and 
redrawn from McCarthy et al. 2006. Body fat reference curves for children. International 
journal of obesity. 30(4), p598-602). 
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(>95th centile) and are frequently used in studies examining pediatric fat mass, especially fat 
mass in relation to health outcomes.  
Another suggestion stemming from the criticisms of BMI is that measures that 
specifically identify elevated levels of abdominal (trunk) fat should be used. Abdominal fat can 
be estimated by waist circumference (WC), magnetic resonance imaging (MRI), skinfolds, dual 
x-ray absorptiometry (DXA), or indices such as waist-to-height or waist-to hip-ratios (155,156). 
This is important as trunk fat is strongly implicated in health risk and is associated with an 
atherogenic (promoting atherosclerosis) risk profile(8).  
Findings by Laurson et al. (2014) demonstrate the inability of BMI to identify excess 
abdominal adiposity in children. Of those females identified as NW by CDC BMI cut-offs, 4.5% 
had WC values over the WC cut-offs linked with the National Cholesterol Education 
Program/Adult Treatment Panel III (ATP III) curves. Meanwhile, 37% OW and 2% of OB 
females did not have WC over cut-offs. In males, no NW individuals had high WC values, but 
neither did 87% of those classified as OW and 35% of those classified as OB (151). These results 
make a similar point to that of Freedman et al. (2009) that the validity of BMI to identify 
adiposity (and even more so abdominal adiposity) will vary with degree of BMI. This 
discrepancy is important to note because abdominal fat has demonstrated stronger links to MetS 
and CVD morbidity than BMI (157–159). 
 
2.3.5 Prevalence of OWO in Adults by BMI 
Recent world-wide estimates suggest that 37% of adults are OWO and that annual 
attributable deaths surpass 3 million (160,161). Canadian rates are equally alarming. The results 
from the Canadian Health Measures Survey (CHMS) from 2011-2012 suggested that 25% of 
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Canadians over 18 years are obese (about 6.3 million people) (152), and approximately 62% of 
adult males and 46% of adult females were OWO (26,152,160). Tracking the data from 2003 to 
2014 suggest that rates of OWO have risen roughly 5% in males and 5% in females over the last 
decade (26). More recent estimates from the 2014 Canadian Community Health Survey (CCHS) 
estimate that out of almost 28 million adults surveyed, approximately 35% were considered OW 
(BMI over 24.99-29.99 kg/m2) and almost 27% were considered obese (BMI 30kg/m2 or over) 
(162). As such, the most recent estimates suggest that roughly 62% of Canadian adults 18 years 
and over are OWO. Provincial rates in Saskatchewan are even higher than the national average 
with 32% of adults classified as OB (31% in Saskatoon). The most recent data from the 2015 
Canadian Community Health Survey using direct measures of BMI estimate that just over 70% 
of Saskatchewan adults are OW or OB (162).  
2.3.6 Prevalence of OWO in Children and Adolescents by BMI 
Canadian data (2015) estimates that the prevalence of OWO more than doubles from 
childhood (under 18 years) to adulthood (over 18 years) (approximately 25% to over 60%) 
(25,26). Longitudinal data from the FELS study in the Unites States suggests that the most 
common ages for OWO onset are 10-15 years, and 20-25 years (20% of total OWO onset) in 
females, and 20-25 years (23% of total OWO onset) in males (107). The incidence drops from 
this age onward, suggesting that 50-60% of those who will become OWO in adulthood will have 
done so before the age of 35.  
The prevalence of childhood and adolescent OWO remains high nationally and 
internationally despite some reports indicating that there may be stabilizing or declining trends 
(2,163,164). Analysis of data from 34 Organization for Economic Cooperation and Development 
(OECD) countries (2015) indicates that approximately 24% of boys and 22% of girls are OWO. 
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There appears to be a stabilizing trend in high-income countries over the past few decades but 
authors note that rates differed by sex, age, socioeconomic status (SES) and ethnicity (165). 
Other data, such as those from the Global Burden of Disease study (2013), suggests that numbers 
of OWO youth continue to rise even in developed countries (160). A 2013 report on Canadian 
preschoolers in Newfoundland and Labrador found that provincial rates of OWO had dropped 
between 2001/02 and 2009/10 (from 39% to 36%) and in one region the rates of OW in 2009/10 
(14%) dropped below those of 1988/89 (22%); however, there was also one region (with the 
highest baseline OWO prevalence) which continued an upward trend (164). Canadian 
surveillance data up to 2013 concluded that childhood OWO had plateaued or decreased over the 
past 15 years. Authors acknowledge that trends differ somewhat by sex, age, SES and the 
method of data collection (1).  
2.3.6.1 Differences in prevalence by collection method 
The method used for the collection of data can alter the outcome and the accuracy of the 
data and make analysis of secular trends difficult. Direct measures provide the most accurate 
estimate of OWO in a population but these measures are more expensive, require trained 
personnel and tend to result in smaller sample sizes (152,166). Self-reported data such as BMI 
provides an inexpensive and easily conducted measure allowing for a very large sample size. As 
such, self-report is often used for large scale surveys such as the CCHM and CHMS. Authors of 
CCHM and CHMS warn readers to be aware of differences in collection methods between 
surveys when assessing OWO prevalence and secular trends (152). For example, comparing data 
from 2003 (self-report data) to 2004 (direct measure data) CCHS estimates an increase of almost 
12% in the prevalence of OWO in youth 12-17 years from 14% to 26%. This type of jump is 
seen again between 2014 (self-report data) and 2015 (direct measure data) from 23% OWO to 
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45% OWO in 12-17 year. Self-report tends to under-represent OWO rates (2) . The method of 
collection is likely responsible for the lower prevalence in 2003 and 2014 using self-report 
compared to prevalence in 2004 and 2015 using direct measures. Parents also tend to misreport- 
over reporting BMI by underestimating their child’s height. This results in an overestimation of 
the prevalence of OWO in young children by parental report (2,167). The 2002/03 parental 
reports of children 2-5 years and 6-11 years estimated 15% and 6% higher prevalences, 
respectively, than the directly measured estimates the following year (167). Interpreting the trend 
is made even more difficult as the over-report by parents in children under 12 is accompanied by 
an under-report by self-report in 12 to 17-year olds. A more accurate representation of secular 
trends can be obtained by comparing self-report to self-report, and direct measures to direct 
measures. When data collected the same way are compared it is apparent that there are increasing 
numbers of youth with OWO. It is observed that the prevalence of OWO by self-report increased 
by almost 4% from 2005 to 2014 in youth 12-17 years from 19% to 23% (24% to 29% in males 
and 15% to 17% in females).  
 There have been attempts by Statistics Canada and the Canadian surveys to use an 
adjusted self-report measure in order to compare between self-report data and direct measure 
data. Adjusted self-reported numbers are based on correction equations, and may provide a more 
accurate estimate than self-report alone without comprising the large sample size or the ease of 
data collection (152,166). The equation used by Statistics Canada was developed using the 2005 
Canadian Community Health Survey data. A sub-sample of respondents had height and weight 
data collected using self-report and direct measure. The two measures were compared to identify 
responder bias (166). The adjusted self-report results from the CHMS 2011-2012 suggest that 
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26% of males, and 23% of females over 18 are OB; (an increase of 6% from self-reported data in 
both sexes) (152).  
Although the self-reported and adjusted self-reported are lower than the directly 
measured prevalence, all three methods show increasing values in adult and child  
OB from 2003 to 2011/12 (152) and from 2004 to 2015 (162). As such OWO remains a public 
health concern in Canada due to the health implication of excess weight and the stability of 
OWO from one stage of life to the next (2,168).  
2.3.7 Abdominal Fat and Health 
In adults, clustering of CMR is found in those with higher TrF, even in those with a 
normal BMI (155). Stratifying OWO individuals by high and low waist circumference reveals 
disparate risk assessments; for example, high WC carries an odds ratio of the risk of MetS of 
1.85 in OW women and 2.35 in OB women compared to having a low WC. Children and 
adolescents with more trunk or trunk-to-extremity fat often have more TBF, have higher 
cardiometabolic risk factors in adulthood, and are more likely to gain weight over the short term 
(169,170) . Conversely, lower limb fat has been suggested as being beneficial in regards to these 
same risk factors and has demonstrated a relationship with lower levels of blood glucose and 
insulin, and a lower prevalence of dyslipidemia and undiagnosed diabetes (157,171–177). Higher 
android-gynoid ratio (a ratio of fat on the trunk to fat on the lower body) is associated with 
higher CVD in NW children (178); a higher trunk-to-extremity fat by DXA is related to higher 
levels of CMR in NW adolescent females (179); and waist-to-height ratio was found to be a 
better indicator of increased cardiometabolic risk than BMI in a large meta-analysis of adult data 
(180). 
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In 2003 Health Canada adopted newly developed WC cut-off guidelines. This switch was 
prompted by the high correlation of abdominal fat with CMR and the inability of BMI to identify 
high abdominal fat (a BMI within normal weight parameters may be accompanied by a high and 
risk inducing WC) (181). These WC guidelines align with those of the WHO and state that there 
is an increased health risk associated with a waist circumference ≥102 cm in adult males, and 
≥88 cm in adult females. These are the same values promoted by the Adult Treatment Panel III 
(ATP III). The ATP III is a set of guidelines used for prevention, identification and treatment of 
high cholesterol and other related cardiometabolic risk factors (182). Previous body-shape 
indicators of increased risk used by Health Canada included waist-to-hip ratios of  ≥1 in males 
and ≥0.8 in females (143).  
Many countries (Italy, Cuba, Australia, and Britain) have developed WC or waist-to-
height/hip ratios percentile curves for children and adolescents. The purpose of these cut-offs is 
to identify adiposity related to health outcomes. Canadian WC percentile curves have also been 
developed identifying the 5th, 10th, 25th, 50th, 75th, 90th and 95th centile (183). Although those 
along a higher centile have greater health risk than peers with a lower centile there is no 
recommended cut-off. In Australian children, a WC value over the 85th centile identified those 
with the highest percentiles for %TBF, TG and systolic blood pressure (SBP) (184). Authors of 
these papers all identify the need for a WC reference for children like that created for BMI by 
Cole et al. (2000) (101). The preference would be for one that is based on longitudinal data with 
the ability to link WC during childhood to health outcomes in later life (183). One attempt to 
create this type of “health-related” cut-off in Spanish youth found that the 70th percentile of WC 
identified elevated metabolic and cardiovascular risk outcomes during childhood and 
adolescence. Authors suggest that the 70th percentile was the optimal threshold (185). A 
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Canadian threshold of the 75th centile would yield cut-off values ranging from 66.5 cm for 11-
year-old males, to 79.6 cm for 18-year-old males; and from 64.2 cm in 11-year-old females to 
73.8 cm in 18-year-old females (183). These WC cut-off values are much lower than those 
developed by Joliffe & Janssen (2007) based on the adult cut-offs from the ATP III and 
International Diabetes Federation (IDF), but not dissimilar from the mean WC of Canadians ages 
12-19 identified by Janssen et al. (2011) from 2007-2009 CHMS data, particularly the 18-year-
old cut-off.  Janssen et al. (2011) identified a mean WC of 77.5cm (95% CI, 74.9cm, 80.1cm) in 
males, and 74.8cm (95% CI, 72.8cm, 76.7cm) in females.   
2.3.8 Overweight and obesity trends by abdominal fat indicators 
Over the past 30 years, the secular trends in adult BMI has been accompanied by 
increasing cardiometabolic risk factors such as fasting glucose and diabetes prevalence 
(186,187). The data is more discrepant in children regarding the relatedness of BMI to other 
health risk factors. It is unknown the degree to which CMR factors are dependent on BMI and 
BMI trends. The known risk of abdominal obesity over and above BMI suggests that OWO 
prevalence and trends may not provide the full picture of current and future health risk (8,9,154). 
Trends in high blood pressure in American children appear to be declining while incidence of 
Type II diabetes is increasing and both are co-occurring with increasing BMI, abdominal obesity 
and skinfold thicknesses (188–190). In British youth, the prevalence of OWO is higher in 
children when using indicators such as WC and waist-to-height ratio than when using BMI 
(191). While BMI prevalence appears to have plateaued in British youth, the “at risk” by waist-
to-height and obesity by WC have not (191). Similarly, the prevalence of MetS (excluding high 
WC criteria) in adults is higher in those who surpass NIH WC cut-offs (>102cm in men; >88cm 
in women) than in those who are categorized as OW by WHO BMI cut-offs (MetS prevalence 19 
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% versus 22% in men; 23% versus 18% in women) (192). A major public health concern may go 
unnoticed if only BMI trends are followed. Increases in abdominal obesity are potentially 
mediating or masking the relationship between BMI and health risk. While BMI may be 
beginning to plateau in Canada, other measures such as WC and their comorbidities may not be 
(193) and, as such, an assessment of WC or other measures of abdominal obesity should 
accompany BMI (194). 
Waist circumference has increased even more than BMI since the 1980’s in Canada, and 
observed increases in adult WC cannot be accounted for by increases in BMI alone (194,195). 
Pediatric WC percentiles in the UK increased more than BMI percentiles from the 1970’s to 
early 2000’s, with greater increases in centiles for girls than for boys (196,197). Canadian WC 
and skinfolds are higher at a given BMI than they were in the 1980’s (194). Specifically, 
comparing WC data from the CHMS 2007/9 to those from 1981, WC measures at a BMI of 25 
kg/m2 (or pediatric equivalent) demonstrated a 1.1 cm increase in men, a 4.9 cm increase in 
women, a 1.6 cm increase in boys, and a 4.1 cm increase in girls. Skinfolds were similarly higher 
by 9% in men, 12% in women, 14% in boys and 14% in girls between 1981 and 2007/09 (194). 
The positive linear relationship (slope) between BMI and WC was higher in 2007/9 than in 1981 
in males and females, as was the median value of each age group (194). These secular changes 
have resulted in 14.6% of Canadian males and 30.6% of Canadian females aged 12-19 years 
having WC at levels considered to have increased-risk in 2007/2009 according to WC cut-offs 
linked to the adult ATP III criterion (198,199). American data suggests an independent increase 
in WC (over and above changes in BMI) of 0.86 cm (0.53-1.19), with greater gains in adults <49 
years than >49 years, males more than females, and in OB more than NW or OW populations 
(197). Similar secular trends were observed in developmental curves of adolescent BMI and 
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skinfolds using two Saskatchewan longitudinal studies conducted 30 years apart. The 
Saskatchewan Pediatric Bone Mineral Accrual Study (PBMAS) data from the 1990’s 
demonstrated significantly greater skinfold thickness (including abdominal SF) but not BMI in 
comparison to the Saskatchewan Growth and Development Study (SGDS) data from the1960’s 
while controlling for height, maturity and sex (200). Again, this suggests that fat indices are 
increasing, independent of BMI; and, while ½ to ¾ of the secular trend of increase in youth WC 
may be explained by increases in BMI, there are trends in WC that are independent of BMI 
(193). 
2.3.9 Summarizing OWO measures 
 BMI use is widespread and will likely continue to be the tool of preference because of its 
population level correlation with health concerns, the ease and low cost of application, the 
consistent use across time, and the ubiquitous use internationally. These characteristics allow for 
optimal analysis of health in large data sets, for trend analysis, and for comparisons between 
populations. With that said, the inability of BMI to parse FM from LM, and total (or lower) body 
fat from TrF cannot be ignored. This is especially important during the years of growth and 
development. The years of childhood and adolescence see changes in body composition, sexual 
dimorphism, and changes in BMI that do not relate equally to changes in fat mass, lean mass and 
bone mass between sexes or between individuals (69,201). This is important to note because it is 
not just weight or BMI gains per se that are cause for concern but rather fat mass gains and 
specific fat depots that contributes to the comorbidities of OWO. There is also a suggestion that 
the age at onset of OWO may have different implications on health. 
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2.4 OBESITY AND CARDIOVASCULAR DISEASE 
2.4.1 Overview 
In recent history, the onset of OWO was solely in adulthood. More recently the onset has 
moved to childhood and adolescence, although this still remains less common than adult onset 
(69). The prevalence of OWO increases with age and those with more FM at an earlier age tend 
to put on more FM and become larger in adulthood than those with less FM at an earlier age 
(25,26). Metabolic dysfunction and CMR factors that were once the concern of older adults are 
being found in children and adolescents. Stability of lifestyle factors and weight status (OWO) 
contribute to increasing CMR levels as the child with OWO grows into an adult with OWO 
(202,203). The evidence is clear that CVD and metabolic risk factors can, and do, arise during 
the developmental years (204,205). According to The International Diabetes Federation (IDF) 
criteria, 2% of Canadian and 9% of American youth have MetS, with an estimated 50% of 
American and 38% of Canadian children and adolescents having at least one risk factor for CVD 
and MetS (49,206,207). The prevalence in adults is much higher, with between 11% and 22% 
(depending on the definition used) of Canadians and 22% to 34% of Americans over 18 years 
presenting with MetS. The prevalence increases with increasing age (49,206). The most common 
risk factors in Canadians are low HDL’s and high abdominal fat or high WC (49).  
2.4.2 Definitions of Cardiovascular disease, Metabolic Syndrome and Cardiometabolic Risk 
 The direction and strength of the association between BMI and health remains 
controversial, whilst the literature on the association of abdominal fat with health is unequivocal. 
The type of fat mass and its location are critical in the etiology of OWO related disease (see 
Section 2.4.1). Disease is not an inherent property of FM per se; rather, the clustering of 
cardiovascular and metabolic disease risk factors that often accompany OWO are consequent of 
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adiposopathy (inflammation and dysfunction adipocytes) (155). OW adults can be metabolically 
healthy and NW adults can present with cardiometabolic abnormalities. These metabolic 
differences have been attributed to differences in PA levels, physical fitness and waist 
circumference (131,155,208,209), factors which exert their influence independent of BMI or FM. 
Nonetheless, CVD risk factors such as hypertension, hyperglycemia, IR, and morbidity such as 
diabetes and liver disease are far more common in OB adults than in NW adults (133).  
  There are a variety of mechanisms by which obesity relates to these risk factors and to 
CVD (7). One of the most significant and direct links between obesity and CVD is the 
development of atherosclerosis (46). Atherosclerosis is the hardening of the arteries and plaque 
formation on the inside or lumen of the blood vessels. Plaque formation is the result of genetic 
predisposition, sedentary lifestyle, poor diet and/or inflammation. Each of these factors correlate 
with OWO (Figure 2.1). Unaddressed atherosclerosis will almost inevitably lead to CVD (e.g. 
coronary heart disease, myocardial infarction, hypertrophic cardiomyopathy) (210–213). CVD 
risk is often expressed in mathematical terms as seen in the Framinham Risk Assesment score 
and similar metrics. Equations are developed in which presence/absence or level of risk factors 
(age, cholesterol, smoking, etc.) are assigned a numerical value. Values are summed and the total 
points are associated with a percent risk over a score of zero. The percent risk identifies the 
elevated risk of experiencing a cardiovascular event, such as coronary heart disease or stroke, 
attributable to current risk factor status (214,215). Older individuals, males and those with a 
smoking history are at higher risk.  
 There is an interplay between the risk factors and the presence of CVD and Type II 
diabetes (T2DM) such that one condition is often complicated by the presence of the other, and 
magnified by the presence of additional risk factors (46). Type 2 Diabetes Mellitus (T2DM) is a 
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progressive condition of IR resulting from chronic hyperglycemia and insulin insensitivity. It is 
linked with myriad contributing factors, many of which are the same as those contributing to 
CVD including sedentary lifestyle, genetics, obesity and poor diet (216–219). There is an 
increased relative risk of both CVD and T2DM when a clustering of risk factors are present (46). 
The term and concept of MetS (a subgrouping of cardiovascular and diabetic risk factors) is used 
to express this relative risk. The presence of MetS is predictive of IR (and thus T2DM), and is 
linked to abdominal obesity which is the highest risk morphology of OWO.  
The criterion for Mets includes visceral obesity (measured by WC), dysglycemia, 
hypertension, elevated TG and low HDL-C (Table 2.1) (220). The specific cut-offs for each 
factor varies by definition (WHO, IDF, National Center for Environmental Prediction-NCEP: 
ATP III), but a recent harmonized set of criteria has simplified and universalized the 
interpretation and diagnosis of MetS (221). According to the IDF, the waist circumference cut-
Table 2.1 Definition of the Metabolic Syndrome- Criterion for diagnosis. (Table adapted and 
redrawn from the International Diabetes Federation consensus worldwide definition of the 
metabolic syndrome, 2006. https://www.idf.org/e-library/consensus-state 
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offs for elevated risk are ≥ 94 cm for males, and ≥ 80 cm for females. The values are the same 
for Asian, South Asian, South and Central American and African females but 4 cm lower for 
African men (220). The IDF also notes that the inclusion of additional metabolic measures such 
as Homeostasis-Insulin Resistance (HOMA-IR; fasting insulin/fasting glucose), and the presence 
of inflammation (C-reactive Protien) can increase the predictive power of MetS risk for CVD 
and T2DM (46).  
The presence or absence of risk factors are considered dichotomous, and the presence of 
3 or more factors indicates MetS. While the IDF previously considered an elvated WC to be 
obligatory for a MetS diagnosis, recent harmonization of diagnosis receommendations now 
suggest that while it is a useful screening tool and MetS risk component, it is no longer a 
mandatory criterion (221). The presence of MetS increases the relative risk of both CVD and 
diabetes; and the presence of MetS in conjunction with other traditional CVD and diabetes risk 
factors (obesity, age, sex, smoking, inactivity, unhealthy eating) indicates one’s cardiometabolic 
risk (CMR). CMR is the result of the global CVD risk determined from traditional assessments 
like the Framingham Risk Assessment, combined with additional risk present in those with 
MetS. The term CMR was developed to encompass and capture the presence of all CVD and 
T2DM risk factors of which OWO is one (46). CMR profiles provide an overall picture of health 
rather than an absolute risk measurement. These profiles are clincially important for identifying 
patterns and potential for disease (46).  
Children and adolescents rarely meet the entire criterion of MetS or CVD. Because risk 
factors are not present at high enough levels to constitute a diagnosis of MetS, many authors 
have begun to use a continuous metabolic risk score to identify an elevated risk of MetS in the 
absence of the full constitution (169,222–224). This method regresses metabolic variables of 
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blood pressure, TG, cholesterol, HOMA-IR, and waist circumference onto CA and smoking 
status. The standardized residuals are saved and summed to create a continuous risk score. BMI 
z-score can be added, or WC taken out of the equation depending on the research question (225). 
A high score is indicative of a greater CMR risk factor profile (169,223).  
 The following will discuss what is known about the pathophysiology of obesity which 
leads to CMR factors of elevated blood pressure, cholesterol, blood sugar and insulin, and how 
these CMR factors contribute to CVD.  
2.4.3 Biology and Pathology of Adipocytes and Obesity 
  Adipocytes are the fat cells of the body. Their primary use is as a collection facility for 
energy, stored in the form of TG. Fat cells cluster in the body as fat depots; for example, as 
subcutaneous fat (under the skin), and visceral fat (around organs). These clusters are held 
together by connective tissue structures made of collagen. Clusters are well innervated and 
vascularized. In addition to energy storage, adipose tissue is also an important endocrine organ 
responsible for secreting beneficial hormones such as leptin and adiponectin for growth, appetite, 
immune function and metabolism (47).  
Adipocytes follow four stages of differentiation. The first stage of adipoblast, or 
precursor adipocyte cell, is formed during the embryonic stage. Adipoblasts differentiate into 
pre-adipocytes and then to very small adipocytes, at which stage small lipid droplets are present 
(69). The final stage of differentiation is the mature adipocyte. Newborns are estimated to have 
approximately five billion adipocytes with a diameter of about 30-40 µm. During childhood and 
adolescence, adipocytes increase in number and size to approximately 30-50 billion with a 
diameter of 80-100 µm in a non-obese adult (69). Hyperplasia and hypertrophy of adipocytes 
occur with increasing body size and are essential to adequately meet the high energy demand of 
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growth; however, when caloric intake exceeds demand, pathological increases in size and 
number of adipocytes can ensue. Altered growth hormones can also lead to pathological 
processes affecting adipocytes; for example, elevated insulin will lead to increased adipocyte 
size and number in addition to excess fat mass (69,226). Elevated growth hormone will increase 
number and total mass but not the size of adipocytes, whereas a deficiency will result in an 
increase in cell size and total mass but not number of adipocytes (226). 
When growth is not occuring (adulthood) or not occuring as rapidly (mid-childhood), an 
excess of caloric intake to caloric expenditure ratio is easily attained. Adipose tissue 
accomodates excess calories (stored as TG) by enlarging (hypertophy) or by multiplying 
(hyperplasia) (69). Many of the detrimental metabolic consequences of weight gain can be 
mitigated if the adipocytes are able to proliferate as many small adipocytes tend to be more 
metabolically healthy than fewer large adipocytes; however, in a portion of the population, 
adipocytes are unable to effectively multiply. In some individuals (more so in males than 
premenopausal females) there may also be an inability of subcutaneous fat to exapand 
adequately, and so fat deposition favors deep (visceral) depots (158) .  
The distribution of adipocytes in the body is partially under the control of genetics with 
high correlations for visceral fat and abdominal fat between family members (see section 2.3.1). 
Candidate genes have been identified that upregulate visceral fat accumulation through increased 
number of deep glucocorticoid receptors, or alternatively by promoting peroxisome proliferator-
activated receptor-y (PPAR-y). PPAR-y are agonists which promote hyperplasia of subcutaneous 
adipocytes (69,133,227). Treatment with agonists of PPAR-y increase hyperplasia of 
subcutaneous tissue, decrease inflammation (C-reactive protien levels), and lower ectopic liver 
fat (133,227). These findings suggest that genetics play a role in adipocyte health.  
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Hypertrophied adipocytes will at some point reach a tipping point or a ceiling for size. 
When this capacity is exceeded, inflammation begins. Enlargment of adipocytes from chronic 
overfeeding strains the mitochondria and the endoplasmic reticulum of the enlarging adipocytes, 
eventually damaging these cellular structures. Furthermore, adipocytes produce adipokines like 
leptin, adponectin, vistafin, and resisten, all of which modulate metabolic processes and alter 
endocrine function. Levels of these adipokines are altered when adipocytes are stressed and, 
most often, high levels of adipose tissue are accompanied by adipocyte stress. This is 
demonstrated in the positive correlation between adiposity and levels of inflammatory 
adipokines and inverse correlation between adiposity and anti-inflammatory adipokines (i.e. 
adiponectin) (124). Metabolic and endocrine dysfunction, and adipocyte damage lead to 
dysfunction of body systems, and precede chronic diseases leading some authors to propose that 
obesity is in fact a disease of adiposopathy - an endocrine disease of the fat cells (47,228).  
When adipocytes are damaged, an inflammatory cascade is initiated. Characteristic of all 
cell damage is the release of cellular stress factors. In the case of obesity related inflammation, 
pro-inflammatroy cytokines such as IL-6 and TNF-alpha are released from the oversized-
overstressed adipocytes (229). These cytokines interfere with insulin signalling and further 
aggravate the inflammatory process. Additional damage is done by Reactive Oxygen Species 
(ROS) which are released during excessive feeding (230). These ROS’s initiate a further cascade 
related to IR. 
Eating induces thermogenesis and the release of glucose into the body due to the 
activation of the Sympathetic Nervous System (SNS). Over-activation of the SNS leads to a 
chronic stress response in the body which is linked to inflammation through the HPA-axis, and 
insulin and glucose dysregulation. Overeating leads to continual activation of the SNS, 
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inflammation and the excessive release of free fatty acids (FFA) into circulation. Levels of 
circulating FFA relate linearly with FM and even more so with visceral fat than subcutaneous fat 
(133). Central and visceral adipocytes are very metabolically active with elevated responses to 
catecholamines such as epinephrine, a stress hormone related to and released during 
inflammation, and SNS activation of β-adrenergic receptors throughout the body. 
Catecholamines in turn stimulate hormone sensitive lipase (HSL) which breaks down TG to 
release additional FFA into the blood (7). Visceral adipocytes are also problematic because they 
produce greater amounts of pro-inflammatory cytokines such as TNF-a and interleukins, in 
comparison to fat in other depots. The pathological cascade relating to obesity originates with an 
accumulation of excess body fat. In those who are genetically predisposed or epigenetically at 
risk, adipose tissue has an even greater liklihood of becoming pathogenic - hypertrophying and 
becoming inflammed. It is this adiposopathy and inflammation which is central to the disease 
processes related to CVD (47). 
2.5 DIET 
2.5.1 Energy Intake and Fat Mass 
Fat mass accumulates when there is a caloric imbalance between caloric intake and caloric 
expenditure. A prolonged imbalance of 100-200 kcal/day can lead to the development of OWO 
in children (231,232). The literature suggests the contemporary calorically dense “Western” diet 
has played a pivotal role in the secular trend of increasing OWO rates; however, controversy 
remains as whether or not OWO trends are accompanied by changes in energy intake (233,234).  
It is clear that a reduction in caloric intake can be effective in lowering body weight (234). 
A Cochrane literature review of children aged 6-11 suggests that interventions that include 
dietary changes are effective at reducing BMI or BMI z-score in children, although the authors 
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suggest that the quality of the evidence is low (91). Longitudinal evidence suggests that caloric 
intake is not directly linked with acquiring OWO. One study demonstrated that caloric intake 
decreases from the age of 13 to 27 years but the odds ratio of OWO at 27 years was 0.37 for total 
caloric intake. This suggests that those who acquire OWO consumed fewer calories during 
adolescence (118). 
There are two large studies which convincingly implicate total calorie consumption in the 
etiology of OWO. The study by Berkley et al. (2000) tracked 10,000 9 to 14-year-olds for one 
year and found that children with larger increases in BMI had higher total caloric intake. 
Specifically, an increase of 0.0059 and 0.0082 kg/m2 in females and males respectively, was 
found for each 100 kcal/day increase (235). The second study by Ong et al. (2006) demonstrated 
that in almost 900 infants, an increase of 100 kcal/day at 4 months increased the risk of OWO at 
3 years by 1.46 and at 5 years by 1.25 (236). This suggests that diet during infancy can influence 
future OWO risk. A review of both longitudinal and cross-sectional studies of dietary intake in 
children and OWO concluded that “with the exception of infants, there are no conclusive 
associations between energy intake or diet composition and later overweight development in 
children” (232), whereas an earlier review of ecological data concluded that recent increases in 
energy intake is a “major contributor” to increases in weight (233). Evidence for the success of 
lowering caloric intake for weight loss is more cogent than that for sustaining a lower caloric 
intake to prevent OWO onset. These discrepancies may be attributed to the diversity of dietary 
patterns and macronutrient compositions possible in iso-caloric diets (234).  
2.5.2 Dietary pattern and fat mass 
The WHO continues to implicate diet in the etiology of OWO; however, it is important to 
note that the WHO specifically implicates change in dietary pattern rather than increasing energy 
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intake (237). The type and timing of food ingestion may be more salient than total calories. This 
idea is suggested in a study of 13 to 18-year-olds dietary habits in which having a morning and 
afternoon snack, and a slower speed of eating were significantly related to lower FM and 
abdominal fat, while there was no significant relationship between total caloric intake and FM 
(238).  
Cross-sectional findings suggest that eating while watching television and skipping 
breakfast are risk factors for OWO (239). Longitudinal studies have found that while total caloric 
intake does not significantly increase the risk of OWO, sugar sweetened drinks, snacking, fast 
food, and portion size are related (232,240). For example, data on children aged 4-8 years found 
that patterns of high fried-food intake were consistently associated with higher levels of FM (kg), 
and high intake of dark-green and deep-yellow vegetables were associated with lower levels of 
FM. These relationships were independent of PA, age, sex, size and sedentary time, and were 
adjusted for total caloric intake (241). Similar cross-sectional findings from adolescents indicate 
a significant positive relationship between proportion of fat in the diet with BMI, and TrF (242). 
Authors of this study found that mono- and poly- unsaturated fats were inversely related to fat 
and TrF, while saturated fat was not related. They also acknowledge contradictory literature and 
suggest that the specific role that subtypes of fat may play requires further investigation. 
Variation in other macronutrients may also influence FM. Diets low in carbohydrates and high in 
fat have shown to selectively decrease abdominal fat in addition to lowering total fat mass better 
than low fat diets in obese men and women (243). It has been suggested that low carb diets may 
be more effective in reducing visceral fat than a low calorie/high carbohydrate diet, at least in 
obese subjects with T2DM (244).  
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2.5.3 Diet and CMR 
A meta-analysis of weight loss interventions by Zomer et al. (2016) found that weight 
loss decreased CVD risk irrespective of whether the intervention employed PA, diet or both 
(245). Conversely, dietary counseling of children 5-15 years resulted in a lower presentation of 2 
or more CMR risk factors (TG, low HDL, glucose, BP) in children with OW compared to control 
children with OW, despite the finding that the intervention did not affect the prevalence of OWO 
between groups (246). These findings suggest that diet can influence disease risk independent of 
any influence on FM.  
The nutrient composition of the diet may be also be relevant to cardiometabolic health; for 
example, cardiometabolic health improves in OB children when vegetable protein and whole 
grains consumption is increased (247). Diet may also improve health by affecting the distribution 
of fat, or through other means independent of fat loss or location. For example, low-carbohydrate 
high fat diets increase insulin sensitivity (243) and lower C-reactive protein (an inflammatory 
marker) (248) in OB adult participants, independent of loss of intra-abdominal fat. Also in OB 
participants aged 21-62, a low-carbohydrate versus high-carbohydrate diet demonstrated greater 
decreases in blood lipids and systemic inflammation and a greater increase in HDL cholesterol 
and adiponectin, with similar changes in body weight and composition (same change in hip-to-
waist ratio) (248). High fat diets remain controversial, and although some clear metabolic 
benefits have been documented, conclusive evidence has not (249), and findings are based 
primarily on interventions with adults, not children. It is also important to note, as mentioned by 
Kosinski and Jornayvaz (2017), that much of the literature on high fat diets often incorporate 
lifestyle interventions, and exercise itself is known to confer cardiometabolic improvement.  
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The amount of activity or inactivity one accumulates may mediate the relationship 
between diet and FM. Sedentary time was found to significantly relate to CMR in adolescence 
independent of dietary intake; however, authors of this study suggest that more work needs to be 
done to isolate the role of dietary intake (250). It is more likely that activity and diet work 
together. Longitudinal data from the Amsterdam Growth and Health Longitudinal Study 
(AGAHLS) suggests that those with metabolic syndrome at 36 years had a trend towards higher 
energy intake throughout the time course from 13-36 years, concomitant with decreasing levels 
of high intensity activity (251). The extent to which diet alone could maintain improvements in 
cardiometabolic health in the absence of physical activity (PA) could be substantially less than 
when the two positive lifestyle behaviors operate together.  
2.5.4 Physical Activity Overview 
The health benefits associated with PA are well documented in the literature. A dose 
response is also identified between PA and health even at very small increases in PA level 
(252,253).  Inadequate levels of PA are found in most Canadian adults. Only about 15% of adults 
meet the criteria of 150 minutes per week of moderate-to-vigorous PA (MVPA). These low 
levels of PA are in accord with secular trends of increasing BMI and WC (254,255). Sedentary 
time continues to increase in adults and in children despite the known association between 
sedentary behaviors and health, and there is increasing concern over the association of sedentary 
time and health consequences (256,257). Increasing sedentary time found in children and youth 
is concomitant with secular trends of decreasing active transport, time in physical education 
classes, and minutes of free play (258). These trends are particularly concerning considering the 
evidence of the link between PA in childhood, and PA and health in adulthood (259–261). The 
pathways by which childhood PA influences adult health can be either direct or indirect. 
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Adequate PA during earlier life may delay the onset or slow the rate of development of health 
risk factors, thus directly improving adult health status. Adequate childhood PA may increase the 
likelihood of individuals maintaining adequate PA into adulthood and thus indirectly influence 
adult health (205). The mechanisms behind these pathways may be mediated by lower body 
fatness throughout the lifespan which is often associated with higher PA (52,259,262–264). 
Body fatness and PA are each independently related to CMR factors. 
2.5.5 Physical activity and Fatness 
The question of whether PA prevents OWO has been heavily researched. While findings 
remain discrepant, most studies suggest a correlation between PA and FM. Many studies suggest 
that PA is inversely related to FM gains. One large cross-sectional sample including over 6000 
children from 12 different countries found that moderate PA (0.49), vigorous PA (0.41) and 
sedentary behaviour (1.19) were all significant predictors of OB (265) . Findings from a 
randomized control trial of a PA intervention with 900 12-year-olds followed for 4 years also 
highlighted the importance of PA. At the end of the four years, the school that received the 
intervention had higher levels of PA, lower prevalence of OWO students, and lower gains in FM 
indices in those adolescents who were NW at baseline (266). A review of 32 longitudinal studies 
of adolescent PA and concurrent fat gains similarly concluded that PA or decreased sedentary 
behaviour is protective against FM gains and OWO onset. This supports a growing emphasis on 
PA education and intervention. PA can establish beneficial lifestyle habits and prevent OWO and 
early onset of CMR. 
There are also contradictory findings which suggests that there is no relationship between 
PA and OWO, or that BMI predicts declining PA but low PA rarely predicts increasing BMI 
(267–269). One study of over 8,000 young women tracked over 4 years found that self-reported 
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PA had no relationship to change in BMI (270). Findings from a longitudinal study of 8 to 11-
year-olds found that a higher Fat Mass Index at baseline predicted lower PA and higher 
sedentary time, but not the other way around (271). In a 1-year follow-up of 421 young adults, 
those with lower levels of PA had the highest body weight at base line and the largest increase in 
FM after controlling for change in moderate-to-vigorous PA. This suggests that high BMI begets 
high BMI irrespective of PA level or PA change (272). The relationship between PA and fat 
mass may be bi-directional (205). On the one hand, low PA and high energy intake creates a 
caloric imbalance leading to fat gains. On the other hand, carrying a an excess of body mass may 
be more physically and psychologically strenuous and relate to a greater perception of barriers to 
exercise in comparison to the perception of non-overweight individuals (205,273). Additional 
factors such as social expectation, self-esteem and judgment are related to OWO and PA 
behaviour, especially in youth (274).  
Explanation for differences in the directionality and significance of findings may again be 
dependent on the type of measurement used. BMI is a surrogate for fatness, but this metric also 
includes LM. Muscle mass can increase with PA interventions whereas adiposity and abdominal 
FM often decreases with PA interventions thus confounding findings of a relationship between 
fatness (by BMI) and PA. This is seen in findings from the AGAHLS in which adolescent PA 
was significantly associated with skinfolds but not with BMI (275). This study also found that 
adolescent skinfolds were better predictors of adult fatness by DXA than adolescent BMI (276). 
There is also often a stronger association when measures of PA are objective, such as those 
collected by accelerometer, and when metrics of fatness such as abdominal fat/WC are used 
rather than using BMI as a proxy for fatness (205).  
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The intricacies of the relationship between PA and fat mass add to the complexities of the 
relationship between PA and CMR. Indeed, PA is associated with body composition and CMR, 
which are also independently related (277,278).  
2.5.6 Physical activity and Cardiometabolic Health 
There is a general belief that a decrease in FM is found with increased PA. But the 
relationship between PA and FM is only one facet of the relationship between PA and health 
(279). 
PA elicits beneficial changes in multiple body systems including the musculoskeletal, 
cardiovascular, endocrine, immune and metabolic systems (264). As such, normal levels or loss 
of BMI underrepresents the health benefits of PA. Specific examples of the benefits of regular 
PA include: increased mitochondrial size and function, which elevates fatty acid oxidation; 
improved oxygen transport to working tissues; improved glycemic regulations by mobilizing 
GLUT4 transporter to cellular membranes for glucose uptake and use; stronger myocardium and 
vasculatures, which improve cardiac output, cardiac contractile and volumetric properties; and 
up regulated antioxidant defenses and possible improvements in the number and function of 
innate immune cells (280–285).  
Physiological adaptations to regular exercise improve CMR. While many of the 
improvements may be greater when accompanied by weight loss, there is much evidence to 
suggest that PA mitigates CMR independent of weight loss. Changes in body composition may 
contribute to these improvements. Indeed there are numerous studies, longitudinal, cross 
sectional and systematic reviews, suggesting that PA has the ability to target visceral and 
abdominal fat even in the absence of weight loss (169,202,205,264,279,286). PA also improves 
individual and clustered metabolic risk factors (278,281,287,288). PA has demonstrated an 
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inverse association with SBP, TG, total cholesterol, Total/HDL ratio, IR, sum of four skinfolds, 
and T2DM. For example, in a literature review by Ross and Bradshaw (2009) it was found that 
in 17 randomized control trials of exercise interventions of varying age groups, only modest 
weight loss was reported; however, the majority of the studies found significant reductions in 
visceral fat (289). A systematic review of the pediatric literature found similar results, with 
vigorous PA having the strongest association with body fat, abdominal fat and cardiorespiratory 
fitness (278). Although the review did not find the association between levels of PA and 
clustered CMR to be significant, 1/3 of the studies featured did find a significant relationship 
with one or more risk factors (278).  
Finally, cardiorespiratory fitness is a strong predictor of all-cause and CVD mortality 
(278,290,291). Obese-unfit men carry a higher risk ratio of all-cause mortality (odds ratio=1.9) 
and CVD mortality (odds ratio= 4.1) than lean-fit men. Obese-high fit men have a lower odds 
ratio of all-cause mortality than lean-unfit men, and of CVD mortality than lean and NW-unfit 
men (290). There is a general agreement that cardiorespiratory fitness (CRF) can be attributed to 
a combination of inherited factors and individual PA behaviors, and that vigorous PA likely has a 
stronger association with CRF than does light to moderate PA (277,278,290,291). It is also 
important to consider the implications of the bi-directional relationship between fatness and 
PA/fitness, and how this relationship influences cardiometabolic health. Those with a higher 
genetic ceiling for CRF (healthier mitochondria and more muscle mass) may participate in more 
PA; and higher PA levels can lead to lower fat mass, greater fitness and thus better 
cardiometabolic health (277,292).  
With technology has also come burgeoning evidence suggesting a common genetic 
etiology between cardiovascular health, PA behaviour, fatness and fitness (293,294). 
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Specifically, a negative genetic correlation was found between aerobic fitness and %TBF; grip 
strength and CVD; obesity associated (FTO) gene and PA; and FTO gene and grip strength. The 
relationship between fitness (grip strength) and CVD was highest in those with the greatest 
genetic risk of CVD. The evidence also suggests that fitness is causally related to CVD and that 
maintaining physical strength may mitigate future CVD events, especially in those individuals 
most at genetic risk (293,294). This common origin linking behaviour and physiology may also 
explain why most data places low PA chronologically before fat accrual, but there is other data 
suggesting that fatness comes first (271). A bi-directional relationship or common underlying 
genetic basis suggest that preventative efforts should likely focus equally on weight status and 
lifestyle behaviours.  
Despite large amounts of evidence supporting the association of adult PA with adult 
health, and child PA with child health, there is a dearth of evidence linking child PA with adult 
health. Within a life course perspective, there is a logical unanswered question: Does PA and 
health in earlier life carry any long-term health benefit into adulthood and are adult benefits 
reliant on adult lifestyle and fat mass? The following section will provide an overview of 
findings relating PA to FM during critical periods, health in later adult life, and potential 
moderators and confounders.  
 
2.6 CRITICAL PERIODS – THE INTERPLAY BETWEEN GROWTH AND 
DEVELOPMENT, FAT MASS, PHYSICAL ACTIVITY, AND CARDIOMETABOLIC 
DISEASE THROUGHOUT THE LIFE COURSE 
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Exposure to stressors during critical periods are more likely to lead to chronic 
dysfunction than exposure at other times due to the high malleability of systems, tissues and 
organs during these periods (121). There is clear agreement in the literature that there are critical 
periods of development for OWO, and growing support for the link between early FM gains and 
OWO onset during critical periods, and later cardiometabolic diseases (12,16,295). What has 
been less explored is if mitigating factors of FM, PA, and diet during critical periods can operate 
as an antagonist to the onset of OWO, and by association CMR factors (121); for example, can 
the plasticity of body systems during these periods offer an opportunity in which PA can 
improve function and have a heightened and lasting influence on body composition, adult weight 
status and health (121). PA can act in opposition to fat accrual and promote optimal development 
and function of these tissues and systems, for example by assisting in glucose uptake, lowering 
stress hormones and inflammatory cytokines, and decreasing adipogenesis (121,264). PA may be 
able to “set a trajectory” for later life health, both habitually and physiologically, although this is 
less understood (121). There is also discrepant information on whether the influence of PA is 
strong enough to counter pathological trajectories of FM and CMR set earlier in life.  
2.6.1 Prenatal life - maternal health and physical activity 
The role that early life exposures have on life course health trajectory is demonstrated in 
the associations between BW and later life disease (296). Fetal growth and the intrauterine 
environment are profoundly influenced by maternal characteristics (296). Some of the first 
studies illustrating this were based on data from the Dutch famine during WWII. Fetal outcomes 
such as elevated CVD, glucose intolerance and obesity were documented in the offspring of 
those exposed to the famine while pregnant (297–299). A large pool of evidence now suggests 
that maternal nutrition, BMI pre-pregnancy, parental obesity (both mothers and fathers), 
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gestational weight gain, and parental metabolic health (insulin sensitivity) are influential in the 
healthy development of fetal organs and tissues, as well as in infant growth patterns, offspring 
risk of OB and metabolic consequences (296,300–302). Regular PA is an essential component to 
preventing OWO and promoting health in a variety of populations. PA is also recommended for 
pregnant mothers. Physically active pregnant women (before and during pregnancy) gain less 
gestational weight and are less likely to develop gestational diabetes mellitus (GDM) or 
hypertension, regardless of pre-pregnancy weight (83,303,304). PA during pregnancy is linked 
with a reduction in the risk of small or large for gestational age infants and reduced infant FM 
without compromising infant FFM (305,306). Specifically, resistance training and aerobic 
activity of pregnant mothers can reduce offspring fat mass and increases lean mass at 1year and 
at 18-24 months as seen in findings by Chu et al. (2012), and Mattran et al. (2011) (301,307). 
Fetuses of mothers who were given a PA lifestyle intervention had a healthier fat distribution 
than fetuses of the control group; specifically, fetuses had greater thigh fat mass, and slower fat 
deposition in the subscapular region in utero (308). Alternatively, offspring of obese and 
(gestational) diabetic mothers have up to 4x the OB risk during childhood, higher levels of fat 
mass (g), %TBF, and BMI, as well as an increased risk of IR, and reduced β-cell (pancreatic 
insulin cells) capacity predisposing to diabetes (236).  
OWO is related to elevated levels of myriad inflammatory proteins (levels of TNF-a, IL-
6, IL-10, C-reactive protein). Maternal inflammatory levels (often associated with OWO) can 
have negative implications for the infant (309). Maternal PA in turn, relates to lower levels of 
these same inflammatory agents, improved IR in mothers and improved offspring outcome such 
as improved fetal nervous system maturation and long-term cardiovascular health (309,310) 
(264,283,311–313). PA during pregnancy may also relate to better control of maternal blood 
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sugar and insulin levels and thus lower levels of fetal exposure to FFA, glucose and insulin, and 
better insulin sensitivity in the offspring (14). In the presence of optimal nutrition, the placentae 
of physically active mothers have higher vascular volume and surface area, and higher rates of 
perfusion and thus improved blood flow and gas exchange between the mother and the fetus 
(314). Fetal exposure to norepinephrine and other exercise induced catecholamines improve fetal 
development of the cardiac autonomic system (315). 
In accordance with the developmental origins hypothesis of life course epidemiology, 
these findings suggests that maternal PA exposes the fetus to positive stimuli (e.g. placental 
blood flow, decreased glucose, exercise induced catecholamines), inducing physiological 
adaptations in the fetus that yield greater health advantages during subsequent stages of life 
(310). These advantages can directly affect cardiometabolic health; for example, through 
improved insulin sensitivity. There are also indirect links between maternal PA and offspring 
health as seen in rodent models in which offspring of active mothers had a greater lifelong 
propensity for PA, as well as greater fat loss induced by exercise interventions (316). The 
different physiological response to PA in offspring of active versus inactive mothers suggests 
that maternal PA can alter the offspring phenotype or expression of the genome if not the 
genome itself, and that the physiological or genomic foundation of PA and fat metabolism are 
related. 
The thrifty genotype hypothesis first introduced by Neel (1962) suggests that negative 
fetal exposures to inadequate maternal nutrition permanently impair vital organs and systems, 
such as the endocrine and metabolic systems, resulting in the onset of diabetes in later life (317).  
Neel proposed that evolutionary genetic modifications interact with the modern environment 
resulting in a mismatch between development and external environment. This mismatch 
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manifests as IR and other metabolic abnormalities such as diabetes (79,318–321). Hales and 
Barker (2001) expand on this theory and propose a thrifty phenotype in which permanent 
physiological adaptations once meant to conserve calories when food was scarce are now a 
liability when food is available in excess and PA is dropping, leading to the obesity epidemic 
(81). It is proposed that these hypotheses also underlie the unequal prevalence of OWO and 
diabetes in ethnic groups who were, up to recently, undernourished or a part of hunter-gatherer 
societies with periods of feast and famine: Australian aborigines, Amerindian, Native Americans, 
Canadian Indigenous, and South East Asians (322,323). These groups of people have undergone 
rapid “westernization” and the genetics are at a mismatch with the environment (322). The final 
addition to these hypotheses is the hefty fetal phenotype hypotheses by Dyck (2001) (81). Dyck 
suggests that in Canadian Indigenous peoples (as well as Pima Indians of the USA), the thrifty 
genes interact with obesogenic environment even before birth. A high birth weight represents a 
survival bias (thrifty gene) that is mismatched with its external environment (intra-uterine) and 
the current prevalence of maternal obesity, gestational diabetes, and obesogenic environment 
after birth (high calories, low PA). High birthweight (BW) infants are at an increased risk obesity 
but also of T2DM diagnosis in later life (81).  
2.6.2 Birthweight and Infancy  
BW is one of the first indices of healthy growth and development and is a surrogate 
measure for fetal growth and the intrauterine environment (296). BW and infant growth are 
indicators of maternal health, child health and child survival (322). One of the first studies to 
identify a relationship between BW and morbidity and mortality was carried out with a cohort 
born in 1911 in Hertfordshire, England. In the study of over 5,000 male babies, those with the 
lowest BW had four times greater death rates from ischemic heart disease than those normal and 
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high BW (324). Since then studies have repeatedly demonstrated a relationship between size at 
birth and later life health and weight status. Evidence remains discrepant as to direction and 
shape of the relationship- a positive linear, negative linear and U-shape curve between BW and 
long term health consequences have been demonstrated.  
High BW infants have an increased risk of OWO in childhood and beyond (325). The 
odds ratio of OWO at age 7 increases 1.03-1.07 per 100 g of BW (302). Seidman et al. (1991) 
found that in infants with BW over 4500 g there was a 4x greater risk of severe OW (>27.8 
kg/m2) in adulthood compared to BW of 3000-3499 g (326). Similarly, a meta-analysis by Yu et 
al. (2011) revealed that a BW >4000 g was associated with an odds ratio of OB of 2.07 compared 
to BW <2500g. One reason for this discrepancy may again be the choice of BMI as OWO 
metric. Indeed, all studies included by Yu et al. (2011) used BMI or deviation from ideal weight. 
While high BW relates to high BMI, a different relationship emerges when measures such as WC 
or DXA are used. High BW is almost always associated with higher LM but rarely with high FM 
or high abdominal fat as suggested in the literature review by Ong (2006) (236,322,327). A 
higher BW may also be protective against metabolic disorder in OWO children. In OB children, 
those with high BW had higher adiponectin (an anti-inflammatory), higher IR and lower hepatic 
IR, lower FFA and insulin during glucose tolerance test, and lower TrF compared to low BW 
obese children. (328). Alternatively, when high BW is a consequence of mothers’ polycystic 
ovarian syndrome, gestational diabetes, or high glucose levels the offspring has an increased 
likelihood of excess fat accumulation, childhood OB and diabetes (81,295,322). While some 
argue that the relationship between BW and later life disease and OWO is dependent on excess 
childhood weight gain, other findings such as those by Wei et al. (2003) found an increased risk 
of T2DM in high BW children after adjusting for current BMI (236,329). With that said, Wei et 
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al. (2003), also indicated that high BW children with T2DM had higher BMI, blood pressure and 
family history of diabetes compared to those with low BW suggesting that concurrent weight 
may amplify the risk conferred by high BW coincident with familial risk (329).  
Low BW consistently demonstrates a relationship with disease but there are different 
suggestions as to the mechanism. Many studies have demonstrated that low BW is linked with 
later life IR, CVD and type 2 diabetes (318,321,322,329). These diseases may have their origins 
in pathological changes to organs and systems occurring in utero such as reduced nephron 
number or beta cell function seen in low BW babies (296). Additional risk may be conferred by 
preferential fat over lean tissue accrual, and more specifically abdominal fat, found in low BW 
infants. For example, Gale et al. (2012) showed that in elderly men, a low BW was associated 
with lower levels of LM and higher levels of FM relative to current weight (330). Similarly, 
adolescents with low BW were shown to have increased levels of abdominal fat, specifically 
visceral fat, in addition to higher IR, even after adjusting for BMI, PA, and socioeconomic status 
(331). Low BW consistently demonstrates a relationship with high %TBF and higher abdominal 
fat compared with NW infants, but this may be a result of excess fat or low LM and can co-exist 
with a low body weight. As such, a high fat-to-lean mass ratio may underlie the pathways to 
disease in what Wells (2007) describes as a high “metabolic load”. Wells posits that normal 
growth is characterized by optimal LM accrual whereas poor growth (indicated by low BW) 
constrains LM and is often expressed as high %TBF (296). Suboptimal fat-to-lean ratio can be 
considered a high metabolic load which predisposes an individual to CMR in later life. 
The metabolic load theory clearly has links to the thrifty (hefty) phenotype theory 
previously discussed, as a mismatch between intra-uterine and genetic programming, and the 
post-natal environment will often lead to excess FM, either leading to or consequent of IR and 
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other cardiometabolic irregularities (79,81,82). Such a mismatch is found in those born with low 
BW who become OB in later life. Findings from McKeigue et al. (1998) showed that in 70-year-
old males born with low BW, the relationship between glucose intolerance and IR with size at 
birth was only significant in those who were OB in adulthood (332). McKeigue et al. (1998) also 
found that insulin sensitivity was better in HBW infants when adult weight status was also high 
(OW) suggesting that continuity of being big may be protective (332). Other studies have found 
that there is a U-shaped relationship between BW and CMR. Specifically, after adjusting for age, 
sex, BA, PA, socioeconomic status, and BMI, those adolescents with either high or low BW had 
significantly higher IR, leptin levels, and visceral adipose tissue (331). There was no relationship 
with inflammatory markers or blood pressure, and an inverse relationship between BW and TG 
suggesting there may be different pathways by which low and high BW confer risk (331). 
Metabolic overload in high BW infants comes when there is continual accrual of FM over LM 
while in low BW infants it likely begins with catch-up growth as catch-up weight is 
predominantly fat (296,332,333).  
 Catch-up growth in low BW infants is one final pathway by which disease outcomes 
correspond to BW. In developing countries, catch-up growth is associated with LM and less so 
with FM in later life; however, in industrialized countries this is not usually the case (296) . 
Wells (2007) suggests that fetal development and early infancy appear to be critical windows 
during which nutritional uptake is earmarked for LM development. As these critical windows 
close, energy intake allocation switches to FM accrual (296). The same is suggested in findings 
from a large epidemiological meta-analysis by Dulloo et al. (2006) in which it is demonstrated 
that catch-up growth is characterized by an affinity for fat accrual, and even more so, abdominal 
fat accrual (333). Authors suggest the term “catch-up fat” phenotype to embody this concept. 
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The partitioning of energy from lean to fat is consequent of reduced insulin sensitivity coincident 
with catch-up growth; hyperphagic compensatory drive preferring energy dense foods; and a 
shift to a more efficient metabolism, that is, suppression of thermogenesis for energy 
conservation. This “thrifty metabolism” and catch-up fat phenotype are involved in physiological 
mechanisms whereby early insulin and leptin resistance develops leading to later life obesity, 
T2DM and CVD (41,333).  
There is substantial evidence that being big and growing fast in infancy and the toddler 
years carry with it a higher risk of adult OWO regardless of BW (334–336). Longitudinal data 
from the FELS study found that rapid weight gain from 0-2 years was associated with risk of OB 
(odds ratio 4.1), higher body fat, %TBF, visceral and subcutaneous fat and %TrF in adulthood 
(336); however, Jones-Smith et al. (2013) found that it was size, not velocity, of growth from 0-2 
years that was most associated with OBO in childhood (337).  Larnkjoer et al. (2010) found that 
the strongest predictor of adolescent %TBF was weight gain from birth to 9 months and that 
weight gain from 0-3 months was negatively associated with adiponectin (an anti-inflammatory 
adipokine), even after adjusting for %TBF (338). A meta-analysis by Baird et al. (2005) supports 
the findings that rapid growth in infancy confers a higher odds ratio of later obesity (odds ratio 
from 1.17 to 5.7); but that being OB as an infant also increases the risk (odds ratio; OR= 1.35 to 
9.38) (339). Finally, findings from Giles (2013) similarly indicate that both size (BMI z-score at 
9 months), and rapid growth (change in BMI z-score from 9 to 12 months), are significantly 
related to %TBF in later childhood (85).  
There does appear to be a difference in outcomes between catch-up growth and rapid 
infant growth. Catch-up growth is contingent on an initial LBW. Longitudinal data from the 
Avon study demonstrates that both rapid growth in the first year (OR =1.0 - 1.10 per 100 g) and 
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catch up growth (OR= 1.09- 6.16) have an increased odds ratio of OWO in childhood (302). The 
study by Bourhours-Nouet et al. (2008) found that in OB children, rapid weight gain from 0 to 2 
years was positively related to insulin sensitivity but the strongest relationship was seen in those 
with a HBW suggesting that rapid growth in HBW infants may be metabolically protective in the 
presence of childhood obesity (328). Alternatively, in the same study those children with LBW 
who became OB by 10 years, and had undergone catch-up growth, had the lowest insulin 
sensitivity, suggesting that rapid growth which constitutes catch-up growth in LBW infants is 
metabolically detrimental (41,328). Interestingly, findings from the longitudinal Stockholm 
Weight Development Study of eutrophic BW infants demonstrated that weight gain from 0-6 
months and 3-6 years were related to adult OB, but only weight gain from 0-6 months was 
associated with young adult CMR (334,335). This suggests that rapid infant growth favors FM, 
predisposing an individual to a greater metabolic load in adulthood; whereas, toddler and early 
childhood gains favor lean mass, creating a more balanced metabolic load in adulthood, even in 
the presence of adult OB (334). Postnatal factors that increase LM and decrease FM could 
decrease the metabolic load and thus mitigate the risk of later life OWO and CMR conferred by 
BW and early rapid growth. 
Prior to ambulation, crying comprises the greatest caloric expenditure. As such, the 
temperament of the child may be relevant to the rate of fat accrual. Babies who cry use a 
substantial amount of energy and thus may compensate by eating, indicated by infants who are 
easily soothed being leaner (340). There is also a growing body of evidence suggesting an 
inverse relationship between breastfeeding and OWO in childhood, adolescence and adulthood. 
Cross sectional data of German 5 and 6-year-olds found that the prevalence of OWO (BMI >97th 
centile) in breast fed babies was almost 2% lower than in formula fed babies with a clear dose 
 
 
77 
 
response related to the length of breastfeeding (341). Similarly, longitudinal data from American 
children indicated that being breastfed at 1 month, and for more than 6 months (versus never) 
was related to a reduced risk of OB at grade 6 by 47% and 42% respectively (342). Breastfeeding 
for longer than 4 months and 12 months decreased the likelihood of OWO at 3 years, and 1-8 
years respectively; and introducing milk other than breast milk before 6 months increases the 
likelihood of OWO at 20 years (343). The mechanism behind the protective effect of 
breastfeeding involves the body’s metabolic response to the milk’s composition which promotes 
slower growth, as opposed to formula which stimulates rapid growth in infancy. Recall that rapid 
growth trajectories in infancy correlate with FM gains and OWO later on (333,343).  
PA has the ability to alter rapid trajectories of fat mass growth (264). There is general 
agreement on the benefits that PA has for children of all ages (344–346). Guidelines for infants 
under 1 year and toddlers 1-2 years have been developed by PatrticipACTION Canada (347). 
ParticipACTION is a national non-profit organization supported and funded in part by the Public 
Health Agency of Canada. They suggest that tummy time for infants and energetic play for 
toddlers is important for healthy growth, motor development and higher fitness levels. There are 
very few studies of PA in infants and what little evidence there is suggests that infant/parent PA 
interventions do little to improve subsequent PA level, CMR or FM (348). Fortunately, the 
incorporation of PA later in life shows promise in mitigating the risk conferred by altered BW 
and infancy status (349).  
2.6.3 Adiposity Rebound and Preschool years 
The next critical period for growth and intervention is the adiposity rebound (AR) - the 
point in early childhood at which a declining adiposity reaches a nadir and begins to increase 
again into adulthood (350). AR typically occurs around the age of 5. There is extensive literature 
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suggesting that an early AR predicts adult OWO and CMR independent of adult BMI and that 
the risk of adult disease decreases with increasing age at the AR (19,351).  
Using longitudinal data, Guo et al. (2000) found that earlier BMI rebound is related to 
having a higher BMI at the age of the rebound. Authors also found that an earlier BMI rebound 
and a higher BMI at the BMI rebound were related to higher maximum velocity of BMI gains in 
adolescence and to maximum BMI values in young adulthood. In turn, maximum BMI velocity 
and maximum adolescent BMI conferred an increased odds ratio of OW from 35-45 years of age 
(87,352). Gardner et al. (2009) found that the weight gained during the preschool years (ages 0-
5) and weight z-score at 5 years contributed to the prediction of composite CMR score and 
weight z-score at 9 years (353). Similarly, Dulloo et al. (2006) and Rolland-Cachera et al. (2006) 
suggested that having a higher BMI z-score at the rebound, or experiencing rapid weight gain 
immediately following the rebound predict adult fatness, BMI, skinfolds, hypertension, glucose 
intolerance and T2DM (106,333). Metabolic consequences are worse when poor weight gain in 
infancy is accompanied by rapid weight gains following the nadir (106,333). This may be 
explained again by Dulloo’s “catch-up fat phenotype” as rapid gains after the rebound act similar 
to catch-up growth by stimulating a disproportionately high rate of fat over lean mass gains 
(333).  
Age at AR may be an early indicator of the timing of maturation (early or late), as earlier 
AR is associated with early menarche and early skeletal maturation (106). Early rebounders also 
have faster rates of fat gains than late rebounders, and OB children tend to have accelerated 
growth of all tissue in comparison to non-obese children (106,354). Alternatively, the 
characteristics of early maturation and excess FM may be phenotypes of a shared origin. 
Adrenarche is the age at which the adrenal cortex becomes matured, usually between 5 and 8 
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years, and is the beginning of the androgen rise that precedes pubarche (pubertal onset) (355). 
Marakaki et al. (2017) demonstrated that premature adrenarche corresponds with greater height, 
more adipose tissue and advance BA at age 7 and 8, and that those with premature adrenarche 
had an earlier age at AR (355). It is important to note that children with and without OB can have 
premature adrenarche. Thus, the authors suggest that an early AR indicates earlier maturation 
rather than OB risk and that accelerated maturation is in turn associated with increased fat mass 
accrual in adulthood (14). Authors also make note of the potential contribution of endocrine 
factors and the impact of altered endocrine functions. The HPA axis controls adrenocorticotropic 
hormone which is responsible for adrenarche but also contributes to IR and OB (42,137). Genetic 
risk determined by the presence of OB-related SNPs, contribute to a cluster of growth patterns 
including rapid weight gain in early childhood, earlier AR and higher BMI at AR. In turn, these 
patterns are known to predict subsequent OB (352). Interestingly, findings by Rolland-Cachera 
(1987), indicate that both children with OB, and adults who had OB but did not have OB as 
children have an earlier AR (356). These findings support the idea that genetic variations that 
impose obesity risk operate through accelerating growth rate and maturational timing in the early 
years (352). 
Literature has repeatedly related PA level with adiposity level during childhood 
(115,119,264). Having a greater fat mass around the age of AR (5 years) is related to lower PA 
and increased sedentary time and over half of preschool children who have OWO are more likely 
to remain so in adulthood (115,357,358). In a recent study of Canadian preschool children it was 
found that a clustering of factors including sleep, sedentary time and PA were associated with 
BMI z-score; however, moderate-vigorous PA was not a significant predictor when controlling 
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for the other factors (359). Evidence is more consistent regarding the relationship between PA 
and health.   
A systematic literature review of the health implications of PA in children 0-4 years 
identified 96 relevant studies representing over 70 000 participants (346). The review by Carson 
et al. (2017) found that PA was consistently associated with positive health outcomes including 
fitness, adiposity, and cardiometabolic health, and that more PA is better (346). Using pooled 
accelerometry data from over 20,000 children and adolescents (4-18 years), Ekelund et al. (2012) 
found that more time spend in MVPA was related to better CMR outcomes (WC, BP, HDL, 
insulin, TG) regardless of sedentary time (52). Similarly, a systematic review of the literature by 
Janssen and LeBlanc (2010) found that PA was associated with numerous health benefits for 
children 5-17 years and that there was a clear dose-response with more PA conferring greater 
health benefits (344). Finally, a 12 month longitudinal study of young children found that higher 
levels of PA at 4.5 years was related to higher FFM, BMI (potentially due to higher FFM), 
cardiorespiratory fitness, and lower %TBF (unadjusted means) at follow-up (360). Authors 
suggest that promotion of PA in the younger years may carry into later childhood and have long-
term benefits on body composition and health. This age is especially critical as those who will be 
OWO children and youth are likely to become so before the age of 8, with the majority of weight 
gained before 5 years; furthermore, those who will become OWO have higher weights by age 2 
or 3 than those who will remain NW children and adolescents (57,353,361).  
In summary, the contributing factors to OWO in early life include maternal 
characteristics (OWO), BW early feeding habits, early BMI or AR rebound, PA habits, and rapid 
weight gain. These factors also contribute to fat mass and health in subsequent periods.  
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2.6.4 Childhood and Adolescence 
PA during childhood and adolescence has a protective effect against FM gains (362). As 
PA declines from childhood through adolescence, fat mass correspondingly increases (118). Low 
PA levels are also inversely related to TrF trajectories in adolescence (169). These correlations 
correspond with findings that there is a significantly lower prevalence of adolescent onset of 
OWO in active children than in inactive children (363). Data from a prospective study revealed 
that a lower level of fat mass at 14 years was found in those with higher levels of PA, especially 
moderate/vigorous PA, at age 12 (364). PA has demonstrated a similar inverse relationship with 
%TBF in 8-year-old males and in 13 to 27-year-old males and females (118,365). In one study of 
Australian children with similar caloric intake, the differential factors between children with and 
without OW was PA, and those children who reduced their PA over four years had the greatest 
increases in %TBF (366). There is also evidence that PA during childhood and adolescence has 
protective effects against OWO. The Young Finns Study followed participants for 21 years and 
found that persistently low levels of PA or declining levels PA from 9-18 years carried a risk of 
OWO and abdominal obesity from 30-39 years that was over two times that of those who 
maintained high levels of PA (367). These relationships persisted in women but not in men after 
adjustment for childhood fatness and other confounders.  
 PA during childhood and adolescence also enhances cardiometabolic health, even in 
children and adolescents who have OWO, likely because of its ability to target abdominal and 
visceral fat, improve insulin sensitivity and strengthen the cardiovascular system (208,264,283). 
In youth between 4 and 18 years, time spent in MVPA and frequent interruptions in sedentary 
time are significantly associated with cardiometabolic outcomes such as SBP, TG, HDLs and 
fasting insulin (52,225). Elevated BMI over one’s peers, even one that is “normal” in 
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adolescence predicts coronary heart disease in adulthood even when controlling for adult 
lifestyle and BMI (368). It is also known that fitness, which is related to higher levels of activity, 
decreases the likelihood of OWO in addition to lowering CVD factors such as WC, BP, TG, IR 
and cholesterol in both adolescence and adulthood (69,369).  
As discussed previously, the stability of PA behaviour and fitness may be the link 
between childhood and adulthood health; for example, data from the Oslo Youth Study found 
that the maintenance or increase of adolescent PA levels into adulthood was associated with a 
significantly lower odds ratio of acquiring OWO (117). Jekal et al. (2010) concluded that BMI in 
adolescence had a positive relationship with CMR in adulthood; and fitness in adolescence had 
an inverse relationship with CMR in adulthood (370). Eisenmann et al. (2009) similarly found 
that change in fitness correlated with change in body fatness from adolescence to adulthood (r = -
0.24 to -0.46). Declining levels of PA from childhood to adulthood have repeatedly demonstrated 
a negative effect on health. For example, those with lower levels of fitness and PA in childhood, 
and those with larger declines from childhood to adulthood are at an elevated risk of adult OB 
and IR leading to T2DM (371). Similarly, data from the Young Finns Study demonstrated that 
adult abdominal obesity was related to youth PA, although the relationship was indirect via 
tracking of PA into adulthood (372). Unfortunately, it has been shown that tracking of PA 
between childhood and adulthood is weak to moderate at best with higher coefficients between 
the closest age intervals (27,373,374). The tracking of sedentary behaviour and obesity are 
stronger than that of PA suggesting that the link between adolescent PA and adult OB is more 
likely through adolescent fat mass than through PA stability (372,374). Similar suggestions are 
made by Eisenmann et al. (2005) who concluded that while fitness, fatness and clustered CMR 
all demonstrate tracking coefficients between 0.4,0.6, it is adolescent fatness not adolescent 
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fitness that is related to adult CMR. With that said, there is some evidence that intense PA in 
adolescence, such as involvement in vigorous sport, has the potential to independently influence 
adult MetS. Yang et al. (2009) found that sustained participation in intense sport for 3 years or 
more from 3-18 years significantly and independently reduced the risk of MetS in adulthood 
(375).  
Adult weight status and health have antecedents in childhood and adolescence. 
Preventing childhood and adolescent fatness may be key to preventing, or at least delaying, the 
onset of adult cardiometabolic diseases either indirectly, through tracking of PA and fatness, or 
directly, by limiting exposure to adiposity and early onset of CMR (208). There is also evidence 
that even in the presence of childhood and adolescent OWO, the long-term risk of CVD and 
MetS are not inevitable but are reliant on tracking of OB across the lifespan (62,140). 
Furthermore, most OWO adults were not OWO in childhood and adolescence. This suggests one 
final window at which interventions preventing adult OWO and disease can be employed.  
2.6.5 Emerging Adulthood 
Emerging adulthood is a term first proposed by Jeffrey Arnett in the field of psychology 
(28). This period has somewhat arbitrary boundaries, “from late teens through the twenties,” but 
is conceptualized as occurring roughly between 18 and 25 years. This final developmental period 
is characterized by geographic and psychosocial changes - moving out of parent’s home, 
transitioning out of high school and into college and career, and new independence (28). Self-
identity includes characteristics relating to health and health behaviors. Formation of one’s 
identity as “exerciser/non-exerciser” or “healthy eater/eat whatever I want” can be tried out and 
subsequently adopted or rejected during this time (28,376,377). This viewpoint may correspond 
to viewpoints from childhood modeled by parents and caregivers or may be novel as this period 
 
 
84 
 
is one of new ideas. According to the “habit discontinuity hypothesis” behavioural habits that are 
altered alongside a change in context or a life course change (as is seen during EA) are likely to 
be more successful and permanent (28,378). This is cause for concern as EA is characterized by 
adverse changes in PA and eating habits which can contribute to FM gains also seen during this 
period (32,121,379–382). Furthermore, there is ongoing debate as to whether or not child and 
adolescent FM and behaviour have any independent effect on adult health once adult adiposity is 
controlled (383). This, in combination with the large body of evidence demonstrating that NW 
children and adolescents become OWO adults, suggests that EA may be a crucial period 
influencing the trajectory of life course health.  
There is a scarcity of data on the somatic changes occurring during the period of EA (18-
25 years) despite clear trajectories of BMI and FM that continue (rather than plateau) past the 
age of 18. Longitudinal data from the CARDIA study demonstrated that 5 year weight gains in 
young adults age 18-30 years at baseline were greater from 18-24 years than from 25-30 years in 
males (384). Suglia et al. (2013) followed 8,000 16-year-olds until the age of 29 and found that 
approximately 15% gained weight, 20-35% remained OWO from adolescence, 7-9% lost weight, 
and 50% were NW and stayed NW. Findings from Racette (2005) are even more discouraging as 
authors found that 70% of college students gained weight (90,385). The actual amount of weight 
gain across four years of college is reportedly only 2 to 5 kg; however, most of the weight is FM. 
Bone mass accrual has generally ceased by 18 years and studies have demonstrated that beyond 
the age of 20, it requires a greater than 3 kg flux for significant change in FFM to occur (110). 
Less than 3 kg is predominantly fat mass (97,380,386). Specific to college changes, Gropper et 
al. (2011) found that %TBF changes over the freshman and sophomore year were positive in 
both males and females (~+2%) while change in %FFM were negative (~-2%) (387). Over 4 
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years, gains equalled 2.3kg (2.9%) fat mass in females and 4.9 kg (5.2 %) FM in males, 
accompanied by a loss of almost 1kg FFM in female and a gain of 1.3 kg FFM in males (388). In 
light of the ubiquity of weight gain (and specifically FM gain) during this period, it is not 
surprising that many who enter college with a healthy weight become OW, and adolescents who 
are OW often become OB young adults (17,152,387–390). 
National survey data from the United States (1991-1998) identified that the ages 18-29 
years had the greatest increase in OB prevalence (30). Longitudinal data from 1996-2009 found 
that the 5 year incidence (new cases) of OWO in American youth (baseline 13-20 years; follow-
up 19-26 years) was 13%, while only 1.6% shifted down from OWO to not OW (31). While 
some data suggests that those with NW at 20 years are able to maintain weight, those with BMI 
categorized as OWO experience substantial increases between 20 and 30 years of age (87). One 
factor likely contributing to maintenance of weight status or increasing FM is PA. 
Levels of PA in adolescence and EA correlate with FM and longitudinal data from the 
AGAHLS suggests that high PA confers an odds ratio for high FM of 0.81 (116,118,391). In 
university students (18-22 years), participation in light, moderate and vigorous PA is 
significantly related to BMI and TBF with 58% of the variance in female TBF explained by low 
levels of vigorous PA (392). Unfortunately, there is a clear pattern of decreasing PA during EA 
confluent with the same pattern in adolescence. The AGAHLS demonstrates a decrease in energy 
expenditure of 1500 Mets per week between the ages of 13 and 27 years (393). PA declines even 
further with the experience of early adult life events such as moving in with a partner, getting 
married and having children (391). Once these major life events have occurred there is little 
change in PA levels through mid-adulthood suggesting that EA may be pivotal in establishing 
lifelong PA habits that mitigate potential FM gains (118,393).  
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Altered dietary intake has also been indicated in EA weight gain. For example, fast food 
consumption, which is linked with weight gain, is highest in the 20 to 39-year-old age group of 
Americans (394). In a one week recall, over 50% of Missouri college freshman had consumed 
fried or fast food three times (385). Sugary drinks have similarly been linked with FM gains in 7 
to 20-year-olds, and have the highest consumption levels in 19 to 39-year-old Americans 
(395,396). Furthermore, the intake of beneficial foods for weight and health such as vegetables 
and fruit are extremely low in those entering their freshman year (70% eat fewer than 5 servings 
per day) and in 20 to 29-year-old Americans (average of <1 serving/day) (385,397). Steep 
declines is fruit and vegetable consumption coincide with the 5 year transition from high school 
into college and career (385,397). Dietary habits formed during childhood and adolescence do 
not track well into adulthood. Data from the PBMAS cohort found that between the ages of 13-
18 and 18-27, only 40% of females and 30% of males remained in the same dietary patterns, i.e. 
a pattern of vegetarian diet - high fruit and fiber - or western - highly processed (398). Although 
there is potential for the adoption of new healthy food habits during EA, the data on college 
dietary habits above does not show much promise. The tracking of dietary patterns high in 
cheese, desserts, dressings and sauces were higher than those of leafy greens, eggs and non-
refined grains during the transition from adolescence to young adulthood. A similar trend may 
yet be identified through EA into adulthood (398).  
FM and PA are irrevocably linked with CMR and CVD during EA just as they are in 
preceding periods. The AGAHLS has demonstrated that PA relates to FM from 13-27 years and 
that PA during young adulthood (21 years) relates to CVD risk factors (118,393). FM accrual 
during EA also demonstrated a correlation with CMR in longitudinal data from the 
Saskatchewan Growth and Development Study (SGDS). While adolescent adiposity failed to 
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significantly predict adult CMR, those with the highest CMR from 50-60 years accrued 62% 
more adjusted TBF percentages from adolescence to adulthood than those with the lowest CMR 
(399). Other studies have found that PA habits in EA (18-24 years) mitigated cardiovascular risk 
(carotid artery elasticity) 21 years later, even after adjusting for current BMI and change in PA 
(400). There also appears to be cumulative benefits (or risk) attributable to PA and adiposity; for 
example, data covering the period from 16-29 years demonstrated higher risk of hypertension at 
29 years in chronically OWO compared with persistently NW. Furthermore, those who became 
OWO during transition from adolescence to adulthood had an intermediate level of risk 
supporting the idea of cumulative risk (90). 
A similar intermediate risk relating to stability or transition is illustrated in findings from 
the Harvard Alumni Study (401). A lower risk of CVD was found for college athletes who 
transitioned to non-athletes compared to those who were never athletes, but a higher risk was 
found in those who transition compared to those who remained an athlete or became an athlete 
after college. Finally, those who became active after college had the same risk as those that 
maintained activity (401). These findings suggest that PA has a cumulative and concurrent effect 
on cardiovascular health although the authors emphasize the importance of habitual exercise 
post-college to ensure low risk (401).  
Fortunately, educational-behavioral interventions focusing on healthy lifestyle (including 
PA, fitness, dietary intake) show some promise in limiting weight gain in NW university students 
although the mechanisms are less clear and interventions have failed to produce significant 
changes PA levels or caloric intake (72). 
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2.7 CROSS SECTIONAL AND LONGITUDINAL STUDIES 
 
2.7.1 Characteristics of Cross-Sectional and Longitudinal Studies 
Growth research attempts to answer questions pertaining to changes in human 
characteristics over time and human biological variation, particularly from conception to full 
maturation (69). There are two basic types of study designs that can address such questions: 
cross-sectional and longitudinal. Cross-sectional studies collect data at one time-point on large 
groups of participants from different age cohorts. This allows for the identification of common 
changes with age and the approximate age at which these changes occur (69). For example, PA 
and body composition can be measured simultaneously in 4 age cohorts: 10-year-olds, 11-year-
olds, 12-year-olds and 13-year-olds. The mean BMI (kg/m2) can be identified for each of a low, 
moderate and highly active group for each cohort, and a curve developed to represent the pattern 
of BMI change over the time course. A cross-sectional study can identify independent variables 
that may be associated with outcome variables but cannot speak to the intra-individual 
developmental patterns of factors. Cross-sectional studies can only find correlations (69). For 
example, dietary habits, and PA levels in adulthood can be assessed alongside FM or OWO 
status, but stability of PA levels or continuity of dietary intake from childhood to adulthood 
cannot be assumed.  
Longitudinal studies typically consist of a smaller number of participants measured 
serially over time with a minimum of three measures (402). Longitudinal studies consider 
systematic changes observed across time and identify the within and between individual variance 
of the change (69,403). For example, the BMI of a single cohort could be measured from age 10-
13 years, providing a representative curve of change (in BMI) over time (age). Analysis methods 
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appropriate for longitudinal data analysis (such as multi-level analysis) can account for the effect 
of multiple “predictor” variables on the outcome variable such as BMI. Longitudinal analysis 
also allows for the identification of between-individual variability by allowing the regression 
coefficients of predictors to differ between individuals and between time points (69). For 
example; the influence that age, and PA levels at each age has on BMI growth can be explored. 
Findings based on longitudinal data can infer causation (69).  
2.7.2 Advantages and Disadvantages 
 Cross-sectional studies are often preferable to longitudinal design because they have 
lower participant burden, less researcher turnover, shorter duration and less participant attrition 
than longitudinal studies. The disadvantages of longitudinal design include higher attrition, 
higher cost, and concerns over reliability of measures over time; yet, this design remains superior 
to cross-sectional design for growth studies because of its ability to reflect individual differences 
in growth patterns, identify rate or velocity of change, and incorporate time-dependent variables.  
Cross-sectional and longitudinal studies are used to address similar questions and can 
provide similar conclusions. For example; cross-sectional data collection of females aged 8-27 
suggests that TrF increases with pubertal stage (404). Longitudinal data from the AGAHLS on 
participants followed from 13 to 36 years also found increases in TrF with age, but these findings 
are more valid than cross-sectional findings because the data is derived from serial measures of 
the same individuals while accounting for differences between individuals and between time-
points within individuals (275). The longitudinal AGAHLS study was also able to identify that 
daily PA from adolescence to young adulthood had a beneficial effect on adult body fatness 
(275). These types of findings cannot be produced with cross-sectional data because there is no 
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data (other than retrospective questionnaires) on occurrences or exposures prior to the 
measurement occasion. 
There is an alternative to the cross-sectional and longitudinal design. A mixed-
longitudinal design, or accelerated longitudinal design, is a compromise between the two, and 
may be preferable because it mitigates some of the disadvantages of both the pure longitudinal 
design and the cross-sectional design by using overlapping cohorts. The Saskatchewan Pediatric 
Bone Mineral Accrual Study (PBMAS) is an example of a mixed longitudinal study design and 
is the study from which the data for this dissertation is utilized. The PBMAS has generated a 
unique data set that is able to explore the growth based research questions of this dissertation 
(232,402).  
 
 
 
2.8 SASKATCHEWAN PEDIATRIC BONE MINERAL ACCRUAL STUDY 
 
In 1989 Bailey et al. determined that the peak in annual incidence of fractures in 
Saskatchewan youth corresponded to the age of PHV (405). Authors concluded that the 
incidence could not be explained solely by PA and suggested that different rates of linear growth 
of bone and bone mineralization may contribute. In order to address this hypothesis, Dr. Bailey 
initiated the Saskatchewan Pediatric Bone Mineral Accrual Study (PBMAS) (1991-2017). 
Between 1991 and 1993, 253 children (aged 8-15 years) were recruited from elementary schools 
in Saskatoon, Saskatchewan, Canada (406). Measurements were taken bi-annually for the first 6 
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years, annually between 2002 and 2005, 1-2 times between 2009- 2011 and once more in 2016-
2017. The final wave of measures included a participant age range of 33 to 41 years. Each 
measurement occasion included the collection of dietary and physical activity information along 
with dual-X-ray absorptiometry total body scans. The 2010/11 and 2016/17 waves also included 
blood samples for determining cardiovascular and metabolic profiles. Informed consent and child 
assent were acquired prior to the collection of any data. Consent was also re-obtained for any 
new measurement protocols such as the addition of blood collection. The PBMAS was approved 
by the University of Saskatchewan Biomedical Research Ethics Board (Bio#. 88-102). 
Physical activity was determined using the age appropriate physical activity questionnaires 
for children, adolescents or adults (PAQ-C, PAC-A, PAQ-Ad) (407–409). Over the first 6 years 
of the study, the questionnaire was administered at least three times per year for the first three 
years and two times per year thereafter. Annual visits after 1997 included one administration of 
the PAQ questionnaire. This family of questionnaires provides general information on the 
frequency of PA and intensity. For example, children are asked if they are physically active at 
recess and after school, while adults are asked about participation at lunch hour or after work 
(See Appendix K for questionnaire). A level of intensity is indicated using a 5-point Likert scale 
for each PA occasion where PA is described as “sports, games, gym, dance or other activities 
that make you breathe harder, make your legs feel tired and make you sweat.” A higher number 
indicates a harder level of intensity. The mean score of all items comprises a composite activity 
score. When there was more than one assessment in a year, the mean of all assessments was 
used.  
The dietary intake and nutrition information of participants was assessed using a  
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24-h recall questionnaire. The recall was self-administered with the exception of particpants in 
grade 2 and 3 for which the researcher wrote down verbal answers. A training session on food 
portion sizes was conducted prior to the administration of the recall, and participants were given 
life-size pictures of food items to assist with accurate estimates. Recalls were administered three 
to four times in the first four years and twice a year thereafter (1994–1997, 2003–2006). Only 
one recall was completed in 2010/11, and two were completed in 2016/17 (one in person and one 
over the phone). Yearly averages were calculated for the data analysis. Data from 1991-1997 was 
analyzed using Canadian compatible nutritional assessment software (NUTS Nutritional 
Assessment System, version 3.7 Quilchena Consulting, Victoria, BC, Canada). Total energy 
(kcal·d-1), was calculated. Food Processor version 8.0 and revisions (ESHA Research Inc,. 
Salem, OR, USA, 2003.) was used to estimate total energy and nutrition after 1997.  
DXA scans were performed annually over the first 6 years, and once per assessment 
thereafter. A QDR 2000 scanner (Hologic, Waltham, MA) in array mode was used for all scans 
until 2007. After 2007, the QDR 4500 (Hologic, Inc., Waltham, MA) replaced the QDR 2000. 
Test-retest for validity of the QDR 4500 was carried out using 20 healthy male and female 
university students with two scans on the same day for short-term precision, and over four weeks 
for long-term precision. The precision for total body LM and FM was 4.09% and 2.95% 
respectively. Conversion factors were developed to correct for differences between QDR 4500 
and QDR 2000 machines using results obtained from 9 men and 15 women (410). Analysis of 
total body scans was carried out using global software version 7.10 and body composition was 
analyzed using software version 5.67. 
Since its inception, there have been numerous researcher assistants, graduate students and 
faculty who have contributed to and benefited from involvement in this study. Data collected 
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from the PBMAS participants have generated over 61 published journal articles, and over 100 
conference abstracts and presentations. The clinical significance of the findings from these 
papers is substantial. For example, in key papers by Bailey (1997) and Baxter-Jones (2011) it 
was identified that approximately 26% of bone mineral will be laid down in the 2 years 
surrounding PHV during adolescence, and that the bone laid down during the 4 years 
surrounding the adolescent growth spurt is more bone than most people will lose in their lifetime 
(406,411). Baxter-Jones et al. (2011) identified that total body bone mineral content will reach a 
plateau at +6 years from PHV (110). This is relevant to this dissertation as +6 approximates the 
age at onset of emerging adulthood (18-20 years), and a plateau in bone mineral content suggests 
that bone will not contribute to subsequent weight gain. Descriptions of BA-related LM and FM 
(kg) demonstrate continual gains in both males and females from -4 to +4 year from PHV 
indicating that weight gain prior to emerging adulthood can be comprised of fat, lean or bone 
mass (412).  
Other important and relevant findings from the PBMAS include dietary and PA patterns 
with age. A recent paper by Movassagh et al. (2017) suggests that healthy dietary habits formed 
earlier in life are moderately stable into adulthood and that a “western-like” dietary pattern was 
associated with higher fat mass in childhood and adolescence, and lower total caloric intake but 
higher fat mass in adulthood (398). A vegetarian-style diet was associated with lower caloric 
intake, lower FM and higher levels of PA. Alternatively, PA level in PBMAS participants was 
not related to sugary drink intake, and sugary drink intake was not related to FM development 
(413). PA levels do; however, demonstrate a positive relationship with LM accrual in males and 
females from 8-15 years, and a negative relationship with FM development from 8-19 years in 
males but not in females (412,413). The PBMAS data has demonstrated that levels of PA 
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decrease across adolescence in males and females with moderate tracking across two-year 
intervals and that the most active adolescents had significantly more bone mineral content in 
early adulthood (23-30 years), controlling for height and weight (373,414). The findings of these 
three studies combined suggests that PA is lower in EA than in adolescence although there is 
some stability in level of PA across time; and that higher PA in adolescence has implications in 
adulthood. This also suggests that in early adulthood, a similar BMI may not represent the same 
body composition as those who were active youth have higher relative total bone content and 
lower FM.  
Finally, Sherar et al. (2011) demonstrated that trajectories of TrF mass in PBMAS 
participants from 11 to 26 years was positively related to dietary fat, and negatively related to PA 
in males but not in females (169). Authors propose that this may be because females’ body 
composition changes occur naturally with maturation, and not necessarily because of lifestyle 
factors. This paper also found that blood pressure risk was related to greater TrF accrual in males 
and females, but CMR was related to greater TrF accrual only in females. It was suggested that 
lack of significance of some of the variables could be due to the relatively young adult age of 
participants. This suggestion led to the research purpose for the final paper of this dissertation, as 
authors acknowledged that follow-up at older ages when CMR is higher may improve the ability 
to identify childhood/adolescent risk factors in the development of cardiometabolic morbidity.  
 
2.9 SUMMARY 
 
OWO and cardiometabolic diseases continue to be a public health concern in Canada. 
There is extensive literature suggesting that many of the antecedents of these diseases have their 
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onset in early life during critical growth periods. Fat mass trajectories at any point in life are also 
influenced by myriad factors including genetics, intrauterine development, environment, and 
lifestyle choices such as PA, all of which in turn drive the relative risk and progression of 
cardiometabolic outcomes. Trajectories of FM may, in turn, express underlying genetic risk 
linking the observations of rapid growth in infancy to early AR, rapid childhood FM, and early 
maturation. Analysis of trajectories of FM and identification of early antecedents of distal 
outcomes requires longitudinal data collection and the interpretation of data through from a life 
course perspective.  
Early-onset OWO is often very stable and, as such, much attention had been given to 
prevention of childhood and adolescent OWO; however, there is also evidence that individuals 
who maintain a NW through these years of development become OWO at a later age. As such, 
the focus of prevention efforts may need to shift to encompass the stage of transition from 
adolescences into adulthood as this may represent a period of changing lifestyle, changing 
environment and cessation of growth. EA is a window in which FM can continue to accumulate 
and one in which the prevalence of OWO does indeed increase; and yet there is little research on 
this period and the factors relating to it.  
In conclusion, to understand how to prevent life course OWO and comorbidities, there 
must be a clear picture of the longitudinal trajectories of FM and their predictors during the EA 
period. Both FM and PA have been identified as predictors of cardiometabolic health during 
every stage of life. There may also be an association between childhood factors of PA, FM and 
health, and adult health.  
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The overall purpose of this thesis is to examine the patterns and predictors of FM accrual 
in EA, with a focus on concurrent and earlier life predictors of PA and diet. All studies were 
conducted using data collected from participants of the PBMAS.  
The specific aims are to: (1a), identify if EA is a critical period for fat accumulation and 
onset of OWO; (1b) compare metrics between and within sexes to categorize OWO status; (2) 
investigate lifestyle predictors of OWO in EA, including childhood and adolescent predictors; 
(3) identify effects of EA fat accrual trajectories on subsequent CMR in young adulthood (35-40 
years of age).  
To address these aims, the first study is an observational study illustrating in paper 1a the 
increase in rates of OWO in EA, highlighting the age when this group of NW children became 
OWO by BMI and %TBF cut-offs. Expanding on paper 1a, paper1b explores the age at OWO 
onset in this group by different metrics of BMI, %TBF and WC. This highlights differences in 
the timing of OWO onset by sex and by metric, commenting on the usefulness of each cut-off at 
identifying those at future risk of becoming OWO.  
The second study explores predictors of total and TrF accrual over EA, specifically 
looking at concurrent and childhood/adolescent lifestyle, and childhood/adolescent fat mass 
accrual to address the question of whether adolescent FM, PA and diet have any independent 
effect on FM in later life once concurrent FM in included.  
The third and final study investigates FM accrual during EA with the purpose of 
identifying differences in trajectory of TBF and TrF between those with high and low CMR 
profiles and the contribution of concurrent PA and diet on FM accrual.  
Overall, this collection of studies attempts to address the gap in the literature surrounding 
fat mass accrual in EA. This dissertation will provide information to researchers, clinicians and 
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health policy advisors on the risk imposed by FM (specifically TrF), and elevated FM 
trajectories in EA on cardiometabolic health in adulthood and the times and factors that should 
be targeted to avoid the setting of a detrimental trajectory.  
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CHAPTER 3  
 
 
Study 1- Paper 1a: Longitudinal patterns in BMI and percent total body fat 
from peak height velocity through emerging adulthood into young adulthood. 
 
3.1 DECLARATION OF CONTRIBUTION 
 
I, Erin Barbour-Tuck, am the primary author of this manuscript and was responsible for 
data cleaning, analysis, and interpretation; and writing, editing and formatting the manuscript.  
 
3.2 REFERENCE 
 
 This document has been reformatted from the original version for inclusion in the thesis 
and has been included with permission according to the Copyright Transfer Agreement. Minor 
grammatical changes have been made to improve readability and relationship to the larger 
document. See Appendix O. 
Longitudinal patterns in BMI and percent total body fat from peak height velocity through 
emerging adulthood into young adulthood. Barbour-Tuck E, Erlandson M, Muhajarine N, Foulds 
H, Baxter-Jones A. Am J Hum Biol. 2018 Jan;30(1). doi:10.1002/ajhb.23056. Epub 2017 Sep 13. 
PMID:28901657 
 
3.3 INTRODUCTION 
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It has been suggested that fat mass accrual during key or “critical periods” of growth 
contribute to OWO status in subsequent critical periods (17,168,415,416). These periods include 
intrauterine growth (indexed by birth weight); post-natal catch up growth; the period of adiposity 
rebound; and the period of adolescence. Late adolescence and the period of emerging adulthood, 
has been less studied, despite a tendency for individuals to gain weight and fat mass during this 
time regardless of weight status during childhood and adolescence (28,379,385,388). Thus, 
currently, emerging adulthood is not identified as a critical period for weight gain.  
The relationship of fat mass accrual during critical periods to adult OWO status gets 
stronger with each subsequent critical period. For example, adolescent obesity conveys a greater 
odds ratio of adult obesity than early childhood obesity (34). With the observed increase in 
childhood obesity (55,64,152,160,417) the concern is that adult obesity will also increase. 
Although emerging adulthood may be an additional critical period for the subsequent risk of 
adult OWO status (379–382), there is scant longitudinal data describing trends in fat accrual 
from adolescence through to young adulthood. Emerging adulthood is a dynamic time for many 
lifestyle behaviors. Changes in physical activity, eating and drinking habits are common and 
possibly lead to weight gain (387,388,390). Studies which encompass the first years of college 
indicate that body mass index (BMI) increases in both males and females (385,386), with a 
concomitant increase in the prevalence of OWO status. The literature suggests that many of 
those who enter college at a healthy weight acquire overweight (387,388,390), whilst those who 
enter with overweight have an increased risks of acquiring obese (17,152).  
Identifying weight status in childhood and adolescence is problematic, due to the fact that 
body composition changes due to both normal growth and development, and environmental 
exposure. In adults, OWO status is defined using static BMI cut-offs. During growth, BMI 
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increases from birth to 4 to 6 years of age, drops (adiposity rebound) before rising again and only 
reaches adult values by 19 years of age. This indicates adult cut off values cannot be used during 
growth. Instead, childhood BMI-for-age reference charts have been developed which transition 
smoothly with the adult cut-offs, using the 85th and 95th centiles (101). Since BMI does not 
distinguish between fat mass and fat free mass changes, percent total body fat (%TBF) cut points 
have also been developed (100). 
The timing and magnitude of growth is highly individualized (104), particularly during 
the pubertal period. Because of this, it is recommended that individuals are aligned by maturity 
rather than CA (418). Alignment by maturity is important as maturity status has a major 
influence on fat mass accrual and shows sex differences. To adjust for pubertal confounders 
within CA bands it is common in longitudinal growth studies to align individuals around the age 
of attainment of peak height velocity (PHV). Since this milestone occurs in females at 
approximately 12 years of age and in males at 14 years of age, alignment around PHV provides 
an ideal way to make sex comparisons over time. 
The purpose of this study is to describe the longitudinal trends in BMI and %TBF accrual 
in a group of males and females from PHV to 15 years past PHV (+15) and to examine the 
prevalence of OWO status with age and sex. The secondary purpose is to investigate the 
relationship between weight statuses at different ages from PHV into young adulthood. 
 
3.4 METHODS 
 
 
 
101 
 
3.4.1 Participants and Procedures 
Participants were drawn from the University of Saskatchewan’s Pediatric Bone Mineral 
Accrual Study (PBMAS; 1991-1998, 2002-2011), details of which have been described in detail 
elsewhere (110). In brief, between 1991 and 1993, using a mixed longitudinal cohort design, 
PBMAS recruited 251 children, aged between 8 and 15 years, into 8 age cohorts 
(8,9,10,11,12,13,14 and 15 years). Participants were measured annually from 1991 to 1998, and 
from 2002 to 2005, and 1-2 times more from 2009-2011; by 2011 the oldest participants were 35 
years of age. Informed consent and assent were obtained initially from participants and their 
parents, respectively, of whom 95% were of European descent. To be included in the current 
paper, participants required a measure of PHV and a minimum of one complete anthropometric 
measure and a DXA scan in adolescence (PHV), late adolescence (5 years after PHV) and young 
adulthood (between 22 to 30 years of age). One hundred and eighteen participants (59 males) 
fulfilled these criteria and are included in the present analysis.  
The median number of measurement occasions was 11 (range 3 to 14). Due to the mixed 
longitudinal cohort design, and missed measurement occasions, not all individuals were included 
in each age grouping. Table 3.1 shows the number of participants at each age. This study was 
approved by the Research Ethics board at the University of Saskatchewan.  
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3.4.2 Anthropometry 
Measures taken at each visit included standing height, sitting height (in 
childhood/adolescence) and weight using the protocol outlined in Ross and Marfell-Jones (35). 
Participants were instructed to wear loose fitting gym attire with no shoes or jewelry. Stretch 
stature and stretch sitting height were obtained using a wall mounted stadiometer and were 
rounded to the nearest 0.1 cm. Weight was measured on a calibrated scale and rounded to the 
nearest 0.1 kg. Body Mass Index (BMI) was calculated from recorded height and weight (kg/m2) 
at each measurement occasion.  
Table 3.1 Number of participants measured at each biological age (BA) 
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3.4.3 Biological Age 
Individual curves were fitted to an individual’s annual height velocity data (GraphPad 
Prism version 3.00 for Windows; GraphPad Software, San Diego, CA). Additional height data, 
in some instances, were provided by the schools for data collected prior to 1991. A cubic spline 
was then fitted to the data. The cubic spline procedure preserves the precision of longitudinal 
data by using individual statural data to create a smooth curve with which to identify an 
individual’s age at attainment of PHV; age when greatest statural velocity occurs. A biological 
age (BA) was calculated as the difference between CA at measurement and age at PHV. BA 
groups were assigned by one-year intervals such that the +1 years BA group included those 
between the BA of 0.50 and +1.49 years past PHV. Individuals could only appear once in each 
BA group.  
3.4.4 Body Composition 
Percent total body fat (%TBF) and lean mass were measured by Dual-energy X-ray 
Absorptiometry (Hologic QDR 2000 and 4500; Hologic, Inc., Waltham, MA, USA). %TBF was 
obtained from a total body DXA scan. Between 1991 and 2007, scans were obtained using the 
Hologic 2000 scanner; after 2007, scans were obtained using a Hologic 4500 scanner. In vivo 
coefficients of variation in our lab for body fat measures are 3.0% and 3.4% (195,419). To 
correct for differences between instruments in vivo determined precision across the two different 
Hologic instruments was undertaken using results obtained from 9 men and 15 women. From 
these data, conversion factors were developed so that all outcomes used for analysis represented 
Hologic 2000 equivalent values (410). 
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3.4.5 BMI and Percent Body Fat Categories 
Participants were classified as either normal weight (NW), overweight (OW) or obese 
(OB) at each measurement occasion using both BMI and %TBF cut-offs for children and 
adolescents (100,101). BMI classifications ≥ 18 years were as follows: (i) normal weight (NW) = 
BMI < 25 kg/m2; (ii) overweight (OW) = BMI ≥ 25 kg/m2  < 30 kg/m2; and (iii) obese (OB) = 
BMI ≥ 30 kg/m2. Percent total body fat classifications ≥ 18 years were as follows: NW = %TBF 
< 20.1% in males and < 30.8% in females; OW = %TBF ≥ 20.1% < 23.6% in males and ≥ 
30.8%< 34.8% in females; and OB =%TBF ≥ 23.6% in males and ≥ 34.8% in females (100). 
%TBF references by McCarthy et al. were validated against Lunar DXA measures which have 
been found to be significantly lower but highly correlated (R2 > 0.9) with Hologic 2000 DXA 
measures of absolute and percent body fat in pediatric populations (< 40.0 and > 40.0 kg) and in 
adult samples (> 40.0kg) (420). Although the term ‘weight’ encompasses all components of mass 
(fat or fat free), BMI and %TBF classifications are referred to in this paper as weight status 
categories for ease of reference. Due to low numbers in the obese category, OW and OB groups 
were combined for analysis. 
3.4.6 Statistical Analysis 
Descriptive statistics were calculated for participants at each BA category including 
means and standard deviations (SD) of %TBF and BMI. Missing measures at PHV and +5 were 
interpolated using linear regression procedures; BMI and %TBF with BA was plotted for each 
individual, a line fitted and the missing values extrapolated from the individual’s curve. 
(GraphPad Prism version 3.00 for Windows; GraphPad Software, San Diego, CA). 
Pearson correlation analyses were used to assess relationships between BMI and %TBF 
at PHV and subsequent BA’s of +5, +10, +15 and +20 years. Independent-sample t-tests were 
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used to assess sex and group (NW versus OW/OB) differences in height, weight, BMI, and 
%TBF at +5, +10, +15 and +20 years after PHV; and between sex and within-sex group 
differences in PA and diet at PHV. Dependent t-tests were conducted to assess differences in 
BMI and %TBF between BA categories within each sex. Bonferroni corrections were used to 
control for family-wise error. Chi-squared analysis was used to test for differences in the 
prevalence of NW and OW/OB categories (categories determined by both %TBF and BMI cut-
offs) at each BA between sexes. Logistic regression analyses were conducted to estimate the 
associations between NW and OW/OB at PHV and OW/OB at +5, +10, +15 and +20 years after 
PHV. All statistical analysis was performed using The Statistical Package for the Social Sciences 
(version 22.0; SPSS, Inc., Chicago, IL, USA). Significance level was set at p<0.05.  
 
3.5 RESULTS 
 
 
3.5.1 Participant characteristics 
Participant characteristics at PHV are summarized in Table 3.2. Females attained PHV 
approximately 1.6 years earlier than males (p<0.05). Males were significantly taller and heavier 
at PHV (p<0.05). Females had significantly higher %TBF than males (p<0.05) at PHV. There 
was no significant difference in the prevalence of NW and OWO categories between males and 
females at PHV for either BMI (p>0.05) or %TBF (p>0.05) categories. 
3.5.2 Patterns of BMI 
The pattern of BMI development from PHV (BA=0) to +15 years post-PHV is shown in 
Figures 3.1a and 3.2a. During this time, males increased from 19.5 kg/m2 to 26.8 kg/m2, whilst 
 
 
106 
 
females increased from 18.4 kg/m2 to 23.8 kg/m2. BMI significantly increased from PHV to 8 
years post-PHV (p<0.05) in both sexes. In males, there were no significant changes between 9 
and 15 years post-PHV (p>0.05). In females, there were no significant changes between 9 years 
and 13 years post-PHV (p>0.05). Figures 3.1a and 3.2a also show the BMI cut off lines for 
overweight. Males did not become overweight until 7 years post-PHV (~CA 21 years); in 
females, it was 10 years post-PHV (~ CA 22 years).  
Table 3.3 shows the changes in BMI from PHV to +15 years post-PHV and the 
correlations between the time points. With increasing BA, correlations between BMI at PHV and 
subsequent BMI decreased in males with a slight increase at terminal years: between BA 0 and 
+1 years (r = 0.78, p<0.05), BA 0 and +5 years (r = 0.79, p<0.05), BA 0 and +10 years (r = 0.60, 
p<0.05), BA 0 and +15 years (r = 0.66, p<0.05). A similar pattern was seen in females: between 
APHV= age of peak height velocity; %TBF= % total body fat; NW= 
normal or low risk category by BMI and %total body fat cut-offs 
respectively. Mean (SD); * indicates significant difference between sex 
(p <0.05) 
Table 3.2 General descriptive characteristics of male and female participants at 
peak height velocity (PHV). 
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BA 0 and +1 years (r = 0.96, p<0.05), BA 0 and +5 years (r = 0.813, p<0.05), BA 0 and +10 
years (r = 0.793, p<0.05), BA 0 and +15 years (r = 0.769, p<0.05). Significant differences (in 
both sexes) were found between BMI values at BA 0 and +5 years after BA 0 (males t (55) = - 
17.28, p<0.05; females t (56) = -13.89, p<0.05); and between 5 and 10 years post-BA 0 (males t 
(22) = -4.35, p<0.05; females t (24) = -7.02, p<0.05). No significant differences were found 
between 10 and 15 years post-BA 0 in either sex (p>0.05). 
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Figure 3.2 Group means for (a) BMI and (b) %TBF in males by BA with respective OW cut-offs. 
* significantly different from females at the same BA, p<0.05. 
3.5.3 Pattern of %TBF 
Patterns for %TBF development are shown in Figure 3.1b (females) and 3.2b (males). 
The pattern is similar to that seen with BMI development (Figure 3.1a and 3.2a). However, in 
contrast to BMI, females maintained higher values than males throughout the measurement 
period. These sex differences were significant at BA 0, +5, +10, and +15 years (p>0.05). At BA 
Figure 3.1 Group means for (a) BMI and (b) %TBF in females by BA with respective OW 
cut-offs. * significantly different mean from males at the same BA, p<0.05. 
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0, the mean %TBF for females was 26.8%, which climbed to a high of 37.9% at BA +10 years 
before plateauing at approximately 35%. Males exhibited a lower mean of %TBF than females 
with values continuing to climb from a low of 16.3% at BA +2 years to a high fluctuating 
between 20 and 24% from BA +7 to +15. 
In females, %TBF increased significantly from BA 0 to +5 years (t (56) = -6.21, p<0.05) 
and from +5 to +10 years (t (24) = -5.70, p<0.05) but there was no significant increase from +10 
to +15 years (p>0.05) (Table 3.3). In males, the only significant increase in %TBF between time 
points was from +5 to +10 years (t (22) = -2.334, p<0.05). With increasing BA, correlations 
between %TBF at BA 0 and subsequent %TBF decreased in males: BA 0 to +1 years (r = 0.89, 
p<0.05), BA 0 to +5 years (r = 0.68, p<0.05), BA 0 to +10 years (r = 0.49, p<0.05), BA 0 to +15 
years (r = 0.52, p<0.05). A similar pattern was seen in females: BA 0 to +1 years (r = 0.93, 
p<0.05), BA 0 to +5 years (r = 0.75, p<0.05), BA 0 to +10 years (r = 0.65, p<0.05), BA 0 to +15 
years (r = 0.64, p<0.05).  
3.5.4 Weight Status 
Figures 3.3a and 3.4a show prevalence of weight status categories by BMI cut-offs. NW 
is the most prevalent category (>50% of participants) in females from BA 0 (PHV) (NW = 86%) 
to +7 years and in males from BA 0 (NW = 91%) to +6 years. From this point to young 
adulthood, the OWO categories made up between 15% to 60% in females (40.0 ± 13.7%) and 
44% and 91% in males (62.0 ± 12.9%).  
 Assigning weight status categories by %TBF displayed a different pattern than that seen 
with BMI (Figures 3.3b and 3.4b); females had higher prevalence of OWO than males. The 
percentage of NW females dropped almost continuously from 67% at BA 0 to +10 years with a 
low of 16%.  
 
 
110 
 
 
 
Levels then rose slightly, plateauing with a mean of only 32% (66.0 ± 12.0% OWO) from BA 
+10 to +15 years. Males maintained levels similar to those at BA 0 (71% NW) for longer than 
the females, beginning to drop at +7 years. From this point to +15 years the NW category 
declined slightly (47.0 ± 12.7%).  
When comparing BMI between weight status groups (NW or OWO), females’ BMI was 
significantly different between groups at BA 0, +5 years and +10 years (p<0.05) but not different 
at +15 (Figure 3.3a). In males there were significant differences between groups at BA 0, +5 
years and +15 years (p<0.05) but not at +10 (p>0.05) (Figure 3.4a). BMI in the PHV OWO 
Table 3.3 Body mass index (BMI) and percent total body fat (%TBF) changes with increasing 
biological age (BA). 
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group actually had a lower mean than the NW PHV group at +14 years (results not shown) 
(p>0.05). Comparing %TBF between weight status groups (NW or OWO) by %TBF cut-offs, 
there were significant differences in %TBF between groups at PHV and +5 in males and females 
(p<0.05), but differences were no longer significant at +10 or +15 (p>0.05) in either sex.  
Figure 3.3 Prevalence of Normal Weight in female participants by (a) BMI and (b) %TBF. 
*significantly different mean values of (a) BMI and (b) %TBF between NW group and OWO, 
p<0.05. 
 
Figure 3.4 Prevalence of Normal Weight in male participants by (a) BMI and (b) %TBF. 
*significantly difference mean values of (a) BMI and (b) %TBF between NW group and OWO, 
p<0.05. 
 
The results of the logistic regression indicated that those classified as OWO at PHV by 
BMI cut-offs were not at a significantly greater risk of being OWO than those classified as NW 
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at PHV, at +5 years, or +15 years (p>0.05). Significance was found only at +10 years with an 
odds ratio of 0.1 (p<0.05). Similarly, those classified as OWO at PHV by %TBF cut-offs are not 
at a significantly greater risk of being classified as OWO at +10, or +15 years (p>0.05). 
Significance was found only at +5 years with an OR 0.04 (p<0.05). 
 
3.6 DISCUSSION 
 
This study has shown that on average, fat mass increases after PHV for 8 years (20 years 
of age in females and 22 years in males); it then stabilizes for 5 to 7 years (between 25 to 29 
years), with some indication of a forthcoming increase. The study results suggest that emerging 
adulthood (18 to 22 years of age) is an important time for fat accrual and could be a potential 
critical period for weight gain. The results highlight differences in weight status attributed to 
BMI versus %TBF cut-offs. Finally, it found that being NW at PHV is not protective against 
being overweight in early adulthood. This study of body fat measurement in the same group of 
individuals over time highlights a potentially critical period of weight gain between adolescence 
and young adulthood. 
We have previously reported that the heights and body mass of this cohort were within 
normal reference standards ranges during adolescence (413). This paper indicates that the 
prevalence of OWO at PHV are lower than those reported in other studies 
(64,101,122,160,421,422). Longitudinal studies of European youth have found similar values of 
BMI’s (117) and %TBF (335) during puberty to those found in the present study. Of interest is 
the fact that within a few years of attainment of PHV, the prevalence of OWO was substantially 
higher than those found in other similar aged cohorts (118).  
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3.6.1 Pattern of fat mass accrual 
In the present study, a plateau in fat mass accrual was observed from the end of emerging 
adulthood into the late 20’s. This pattern is comparable to Dutch and Norwegian longitudinal 
data (117,118), although the Dutch sample did not show a plateau during their 20s. Data from the 
Fels longitudinal study of US youth collected between 1929 and 1996 suggests that BMI 
increases up to a maximal value in the early 20s, and then begins to decline (87); however, at a 
10 year follow up in the same study (participants in their early 30s), only the NW BMI group had 
maintained values. The OW group’s BMI increased into adulthood (87).  
3.6.2 Weight Status 
Estimates of the prevalence of adult OWO using BMI in the current study are higher 
(60% in males; 40% in females) than American data from the Fels study (54% males and 34% of 
females) (87,423) and Dutch data from the AGAHLS study (118), and lower than Norwegian 
data from The Oslo Youth study (64% males and 35% females) (117). The adult OWO estimates 
by BMI were also similar to recent findings of a national cross-sectional data survey which 
combined sexes (34% OW and 18% OB) (424); higher than current estimates for Saskatoon 
(31% OB) (152); and comparable to international estimates in developed countries (55% OWO 
males; 45% OWO female) (160). 
In regards to estimates of OWO by %TBF, there is very little longitudinal DXA data with 
which to compare; yet, there does appear to be a consistently demonstrated pattern of a continual 
increase in fat and OWO prevalence from 19 to 25 years whether measured by DXA (70), bio-
electrical impedance (421), or skinfolds (118). Differences in estimated prevalence of OWO may 
be due to differences in sample demographics and geography but may also be due to low sample 
size in adulthood in the present study. In the present study, the group mean for BMI and %TBF 
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surpassed the cut-off for normal weight between +6 and +8 years corresponding to 18-20 years 
in females and 20-22 years in males, again highlighting this period of life as significant in regard 
to the prevalence of OWO status.  
3.6.3 Emerging Adulthood 
  The most dramatic increase in obesity rates in the USA has been between 17 and 19 years 
(30). In Canada, 50-70% of University students are between 17 and 24 years of age (386), and 
the mean age of graduates is 22.7 years (390). The present data indicated that these are years in 
which BMI and %TBF continued to climb, agreeing with previous studies of college-age 
students and US data (379,380,382,387,388). Specifically, the sample increased by 5% in %TBF 
(4 kg/m2 BMI) in males and 6% in %TBF (3 kg/m2 BMI) in females between 18 and 22 years, 
similar to values found in a longitudinal study of American college students in which males 
increased %TBF by 5.3% (1.8 kg/m2 BMI), and females by 2.9% (0.6 kg/m2 BMI).  
In the present study, the differences in BMI and %TBF in those classified as NW versus 
OWO at PHV began to disappear by the age of 20. Although those who are OWO in adolescence 
may be at risk of OWO in adulthood (16), those with normal BMI and %TBF for age “catch –
up” during the transition from adolescence to early adulthood. This data replicates and adds to 
those observed in longitudinal data of American adolescents in which 22-38% of males and 24-
43% of females were overweight, or gained weight from the ages of 16 to 29- some of which 
moved from NW status to OW status (90). Both maintaining or becoming OWO is related to an 
elevated health risk in comparison to maintaining a healthy weight (90).  
 Gains in BMI can be due to increases in lean, fat or bone tissue mass. Cessation of bone 
accrual occurs approximately +5 years after PHV (age 19 and 17 in males and females, 
respectively) (110); therefore, increases in weight seen in this study during the years of late 
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adolescence are likely due to fat or lean mass gains. Lifestyle behaviors such as a decrease in 
healthy food intake and physical activity, and increased alcohol consumption, coincide with 
college years and relate to fat mass gains (386). Weight, fat and BMI gains have been found in 
this age cohort regardless whether an individual goes to college or enters directly into the work 
force (30,32). Others have found that greater increases are seen in those with some college 
education and may be due in part to factors accompanying the transition into university which 
can contribute to weight gain (stress, sleep disturbances, mental health) (30,32).  
3.6.4 Limitations 
Although the study is small in sample size, its power comes from the fact that repeated 
observations are available with individuals measured over a 20 year time period. This study used 
BMI and %TBF from DXA to estimate prevalence of OWO. There is some evidence that 
breaking BMI into fat and lean mass components gives a more accurate measure; however, the 
literature suggests that the use of BMI (especially recently established pediatric references) are 
ideal for clinical practice as they are widely accessible, inexpensive and non-invasive (65). 
Similarly, the use of DXA has been affirmed for its accuracy and its practicality in a clinical 
setting (65,70,425).  
The cut-off points used for this analysis are recommended for comparing data 
internationally and less intended for use on national datasets (101) and are perhaps more accurate 
when used in conjunction with World Health Organization (WHO) standards (426). With that 
said, the IOTF cut-off points were developed using data from six different countries and tend to 
underestimate the OW and OB rates compared to other reference standard such as WHO 
(160,427). Differences between the Lunar DXA used to establish %TBF cut-offs, and Hologic 
DXA used for this study’s data collection, may have introduced error into estimates of the 
 
 
116 
 
prevalence of OWO in the sample. With that said, the Hologic 2000 and 4500 DXA tend to 
underestimate measures of fat compared other DXA scanners (420,428) . 
This sample was almost exclusively European-descent. As such, these data can not be 
generalized to the more ethnically diverse population of Saskatoon. Finally, the sample size 
decreased substantially with age and, therefore, the inablitilty of OWO at PHV to predict OWO 
in adulthood should be interpreted with caution. With that said, 50% of participants were OWO 
by BMI in males and by %TBF in females at the last analyzed measurement between 26 and 30 
years.  
 
3.7 CONCLUSION 
 
This cohort of predominatly NW status adolescents grew up to become predominantly 
OWO young adults. Of particular interest was the notable drop in the prevalence of NW status 
during the emergence of adulthood, the ages of 18-25, suggesting that emergeing adulthood 
could potentially be another critical period for weight gain during growth. The long-term concern 
is that those who become OWO are likely to remain so, or continue to grow larger, which 
corresponds to elevated health risks (429). The next stage of research should focus on tweezing 
out the independent effects of growth during emerging adulthood from the effects of 
environmental exposures known to influence weight gain. 
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LINKS BETWEEN STUDIES 
Study 1 identified the period of emerging adulthood as being potentially critical in the 
onset and development of OWO; compared to a few participants who were OWO as children and 
adolescents, over half of the cohort was OWO by 25 years of age. A discrepancy between 
metrics of OWO was identified such that in males, BMI estimated higher prevalence and earlier 
predominance than %TBF, while in females it was %TBF that produced higher prevalence and 
earlier predominance. These conclusions led to two questions: 1) Does the age at onset of OWO 
differ by metric, and does the most conservative metric differ between sex? And 2) What are the 
factors that influence (predict) fat mass accrual during the period of emerging adulthood? 
Question 1 led to the design of 1b. Question 2 led to the design of study 2. 
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CHAPTER 4  
 
Study 1-Paper 1b: When do normal weight Canadian children become overweight 
adults? Difference according to sex and metric (BMI, %FM and WC) 
 
4.1 DECLARATION OF CONTRIBUTION 
 
I, Erin Barbour-Tuck, am the primary author of this manuscript and was responsible for 
data cleaning, analysis, and interpretation; and writing, editing and formatting the manuscript.  
 
4.2 MANUSCRIPT STATUS 
 This document is under revisions for the Annals of Human Biology, October 10th, 2018. 
This document has been reformatted from the submitted version for inclusion in the thesis with 
minor grammatical changes to improve readability and relationship to the larger document.  
 
 
4.3 INTRODUCTION  
 
Canadian rates of obesity have more than doubled over the past 40 years (2,162,430). 
Overweight and obesity (OWO) in both adults and children correlate with several chronic 
diseases including coronary heart disease and type II diabetes, as well as to risk factors for these 
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diseases such as hypertension, dyslipidemia, and insulin resistance. As such, obesity remains a 
major Canadian public health concern. The most recent estimates of OWO from Statistics 
Canada (2015) suggest that 34% of 12 to 17-year-old Canadians have OWO (162). This number 
increases slightly to 37% in 20 to 24-year-olds, but increases to 50% in 25 to 34-year-olds (162). 
Of interest, therefore, is the age when children with normal weight (NW) become adults with 
OWO.  
OWO are considered by the World Health Organization (WHO) to be a condition of 
excess body fat to the point that health is compromised (142). The most common measure of 
OWO is body mass index (BMI; kg/m2) (431); however, this metric operates on the assumption 
that a higher BMI will be associated with a higher fat mass. Yet at a given BMI, percentage total 
body fat mass (%FM), fat distribution (waist circumference (WC)) and associated health risk can 
vary substantially (155,191,432). Variance in the relationship between BMI and adiposity and fat 
distribution can be a function of sex, degree of fatness, maturation, and chronological age (99). 
The differences between individuals, and between sexes, become more pronounced from the 
onset of adolescence into emerging adulthood (EA; 18-25 years) as pubertal hormones and 
individual genotypes influence the relative amounts of lean and fat mass being accrued 
(35,69,99). Fat mass accrual comprises a greater proportion of weight gain in females, and lean 
mass comprises a greater proportion of weight gain in males (69). The adolescent/EA period is 
also typified by the conclusion of fat free mass accrual, yet continued fat mass accrual beyond 
this period has been recently reported (385,388,433). Many adults with OWO who had normal 
weight (NW) in youth transition and acquire OWO during EA; although the timing of this 
transition varies between sex and by metric(107,434). Using different indices and cut-points for 
OWO, especially during periods of body composition changes, may differentially identify age at 
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onset of OWO. Specifically, BMI screening for OWO may provide false negatives, overlooking 
those with low body weight but high body fat or WC (154).  
Identifying the metric that provides the earliest identification of excess adiposity is 
justified by the cumulative nature of health risk imposed by prolonged exposure to OWO. The 
purpose of this study was to identify the sex-specific differences in the age of onset of OWO by 
BMI, %FM, and WC cut-points.  
 
4.4 METHODS 
 
4.4.1 Study Design and Participants.  
Participants for this study were drawn from the Pediatric Bone Mineral Accrual Study 
(PBMAS). This longitudinal study began in 1991 with an original sample of 220 children and the 
addition of 31 more participants between 1992 and 1993. The PBMAS has been described in 
detail elsewhere (411). Participants were aged 8 to 15 at their initial measurement. After the 
initial 7 years of data collection, 197 participants had at least 2 two serial measurements (median 
= six). Between 2002 and 2005, 169 (77 males) participants returned (median 4 visits). From 
2010 to 2011, 123 (49 males) were retested (median 2 visits) and between 2016 and 2017, 61 (28 
males) returned for one more visit (Table 4.1).  This sample is 95% European-descent (of the 
94% who identified race). Inclusion criteria of participant data for this study were a minimum of 
two measures between 1991 and 2017. There were 237 (108 males) individuals who met the 
criteria and were measured between 8 and 40 years of age on a median of 10 occasions (range 2 
to 15). 
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Table 4.1 Number of participants males (females) measured by age and year of measurement. 
Age 1991 1992 1993 1994 1995 1996 1997 2003 2004 2005 2007 2009 2010 2011 2016 2017 Total 
8 3 (7) 
5 
(11) 
0 (2) 
                          
8 (20) 
9 
10 
(15) 
3 (9) 
5 
(10) 
0 (2) 
                        18 
(36) 
10 
19 
(16) 
10 
(18) 
3 
(10) 
5 
(10) 
0 (2) 
                      37 
(56) 
11 
17 
(12) 
18 
(15) 
12 
(18) 
3 (9) 
5 
(10) 
0 (2) 
                    55 
(66) 
12 
21 
(18) 
17 
(12) 
16 
(15) 
12 
(14) 
3 
(10) 
5 
(10) 
0 (2) 
                  74 
(81) 
13 
17 
(21) 
21 
(16) 
17 
(11) 
14 
(16) 
11 
(14) 
3 
(10) 
5 (7) 
                  88 
(95) 
14 
17 
(16) 
15 
(20) 
20 
(15) 
14 
(11) 
14 
(16) 
10 
(12) 
3 (9) 
                  93 
(99) 
15 3 (8) 
17 
(15) 
14 
(20) 
14 
(15) 
12 
(11) 
10 
(16) 
8 (8) 
                  78 
(93) 
16 
  
3 (7) 
17 
(14) 
13 
(12) 
13 
(14) 
11 
(7) 
8 
(11) 
                  65 
(65) 
17 
    
3 (7) 
13 
(11) 
13 
(12) 
12 
(12) 
9 (6) 0 (2) 
                50 
(50) 
18 
      
3 (6) 
13 
(8) 
12 
(11) 
8 (9) 3 (3) 0 (2) 
              39 
(39) 
19 
        
3 (6) 8 (6) 7 (8) 
4 
(13) 
3 (2) 0 (2) 
            25 
(37) 
20 
          
4 (3) 5 (3) 
6 
(13) 
2 
(12) 
5 (4) 
            22 
(35) 
21 
            
2 (2) 6 (9) 5 (7) 2 (9) 0 (2)           
15 
(29) 
22 
              12 
(9) 
6 
(11) 
6 
(10) 
4 (7)           
28 
(37) 
23 
              8 
(10) 
10 
(8) 
7 (9) 3 (7)           
28 
(34) 
24 
              14 
(14) 
9 
(12) 
10 
(7) 
7 
(10) 
0 (1) 0 (1)       
40 
(45) 
25 
              
8 (6) 
11 
(13) 
8 
(14) 
5 
(12) 
1 (1) 0 (0)       
33 
(46) 
26 
              
3 (5) 9 (6) 
10 
(11) 
7 (8) 0 (4) 1 (4) 0 (1)     
30 
(39) 
27 
              
1 (0) 4 (5) 9 (5) 
12 
(11) 
1 (2) 1 (3) 2 (3)     
30 
(29) 
28 
                  
3 (3) 
11 
(14) 
0 (2) 8 (6) 3 (7)     
25 
(32) 
29 
                    
9 (5) 0 (2) 6 (8) 4 (4)     
19 
(19) 
30 
                    
2 (2) 0 (1) 4 (4) 6 (4)     
12 
(11) 
31 
                    
  1 (1) 
8 
(10) 
2 (3) 0 (1)   
11 
(15) 
32 
                    
    4 (9) 
12 
(7) 
1 (3) 0 (1) 
17 
(20) 
33 
                    
    5 (7) 5 (7) 3 (2)   
13 
(16) 
34                         1 (0) 5 (3) 3 (1) 0 (1) 9 (5) 
35                           1 (1) 3 (5) 3 (2) 7 (8) 
36                             3 (0) 1 (1) 4 (1) 
37                             0 (6) 1 (0) 1 (6) 
38                             1 (4) 4 (2) 5 (6) 
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39                             0 (3) 3 (1) 3 (4) 
40                               0 (1) 0 (1) 
Total 
107 
(113) 
109 
(123) 
107 
(122) 
91 
(106) 
87 
(103) 
75 
(89) 
55 
(65) 
65 
(84) 
59 
(78) 
60 
(74) 
60 
(78) 
3 
(14) 
38 
(52) 
 40 
(40) 
14 
(25) 
12 
(9) 
982 
(1175) 
 
4.4.2  Anthropometry and Peak Height Velocity 
Measures taken at each visit included standing height, sitting height (in 
childhood/adolescence) and weight using the protocol outlined in Ross and Marfell-Jones (35). 
The height data was used to develop velocity curves which were then fit with a cubic spline. A 
cubic spline uses the interpolation of polynomials from neighboring points to create a smooth 
curve. Interpolated velocity values were then used to identify age at peak height velocity (PHV) 
(GraphPad Prism 5, GraphPad Software, San Diego, CA, USA). 
4.4.3 Chronological and Biological Age:  
Chronological age (CA) was determined by subtracting the date of birth from the decimal 
date of measurement. CA categories were composed of 1-year intervals such that the CA 
category of 12 years included all those with age at test ranging from 11.5 to 12.49. Biological 
age (BA) was calculated by subtracting the CA of the participant at the measurement from the 
CA at PHV. BA groupings were constructed using 1-year intervals such that the BA of 1 
included measurements occurring between -0.5 and 0.49 years from PHV.  
4.4.4 Body Composition and overweight/obesity classification 
Total body fat mass (TBFM), bone mineral content (TBBMC) and lean mass (TBLM) 
was assessed using total body dual energy x-ray absorptiometry (DXA) scans (Hologic QDR -
2000, Hologic, Waltham, MA). The coefficient of variation (%) for short-term precision in vivo 
for TBFM was 2.95% (195). Percentage fat mass (%FM) was calculated as 
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(TBFM/[TBFM+TBBMC+TBLM]) * 100. Age- and sex-specific cut-points for OW were used 
for ages 18 years and under as follows: BMI cut-points developed by Cole et al. (2000) (101); 
%FM cut-points developed by McCarthy et al. (2006) (100); WC cut-points corresponding to 
Adult Treatment Panel cut-points developed by Cook et al. (2009) (435) to identify cardio-
metabolic risk, and those aligning with the Canadian 90th percentile by Katzmarzyk et al. (2004) 
(183). Adult OW cut-points used were as follows: BMI cut-points from WHO (Overweight ≥ 
25kg/m2) (142); %FM cut-point developed by Gallagher et al. (2000) using prediction equations 
developed using WHO BMI limits (20-39 years Overweight ≥ 20% in males; ≥ 33% in females) 
(436); WC cut-points based on Adult Treatment Panel cut-points (102 cm for males; 88 cm for 
females) (214).  
4.4.5 Statistical Analysis 
 Growth curves for BMI, %FM and WC were developed using hierarchical (multilevel) 
linear modelling (MlwiN version 3.02, Centre for Multilevel Modelling, University of Bristol, 
Bristol, UK). This procedure has been described in detail previously (402). In brief, parameters 
(BMI, %FM and WC) were measured repeatedly within individuals (level 1 of the hierarchy) and 
between individuals (level 2 of the hierarchy). Analysis models that contain linked variables 
measured at different levels of a hierarchy are known as multilevel random effect regression 
models. Specifically, the following additive random effects multilevel regression models were 
adopted to describe the developmental changes in parameters with age. 
Fixed effects:   
  yij = β0ijConstant + β1jAgeCij + β2AgeC2ij + β3AgeC3ij 
 β0ij = β0 + µ0j + ε0ij 
 β1j = β1 + µ1j  
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Random effects: 
   µ0j                                                                     δ2µ0 δµ01 
 Level 2   ~ N (0, Ωµ) : Ωµ =    
   µ1j                                                                    δµ01 δ2µ1 
 Level 1  [ε0ij]     ~ N (0, Ωε) : Ωε =     [δ2ε0 ] 
 
Where, in the fixed effects, y is the fat parameter (e.g. BMI, %FM or WC) on measurement 
occasion i in the j-th individual; β0ij is a constant (constant = 1); 1j is the slope of the fat 
parameter over time (age centered around 18 years [AgeC]) for the j-th individual; 2 and 3 are 
the coefficients of various time dependent explanatory variables (AgeC2 and AgeC3) at 
assessment occasion i in the j-th individual. 0j, 1j , and 0ij are random effects, whose means are 
equal to zero. They are assumed to be uncorrelated and follow a normal distribution and thus 
their variances can be estimated. 
Models were built in a stepwise procedure, i.e. predictor variables ( -fixed effects) were 
added one at a time, and the log likelihood ratio statistics was used to judge the effects of 
including further variables on the fit of the model. Level 1 variance ε0ij indicated variance within 
individuals over time (δ2ε0). Age center (jAgeCij) was added as both a random (level 2) and a 
fixed variable. This permits individuals to have independent intercepts (δ2µ0) and slopes (δ2µ1) 
and a calculation of the intercept-slope covariance relationship (δµ01). The power functions 
AgeC2 and AgeC3 were introduced into the linear models to allow for the non-linearity of growth 
and were retained whether or not they were significant so as to shape the fat developmental 
curves. The β coefficients in the final models (Table 4.2) were used to develop average growth 
curves for BMI, %FM and WC with accompanying level 2 variance (level 2 variance = 
[(Constant*Constant*δ2µ0 )  +  (AgeC*AgeC*+ δ2µ1 )  + (2*Constant*AgeC* δµ01 )]). A total of 
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six independent multilevel (hierarchical) random effects models were constructed; one for each 
fat metric by sex. Sex- and age-specific overweight cut-points were used to identify the age at 
which growth curves of BMI, %FM and WC crossed over their metric specific cut-points (Figure 
4.1).   
4.5 RESULTS  
 
A total of 2,157 (982 males) measures were available from 237 (108 males) measured on 
a median of 10 occasions between the ages of 8 and 40 years of age (Table 4.1). Table 4.2 
summarizes the results from the six multilevel models for BMI, %FM and WC development by 
sex. For all models, within individuals fat metric increased with increasing age (p<0.05) and 
between individuals there were differences in individuals intercepts and slopes of the curves 
(p<0.05).  In the fixed effects it was shown that, in general, age centered, age centered2 and age 
centered3 were significant independent predictors of fat metric development (BMI, %FM and 
WC) (p<0.05).  
 
 
 
 
Table 4.2 Multilevel regression models for body mass index (BMI) development in males and 
females  
 Variables BMI %FM WC 
  Male Females Male Females Male Females 
Fixed 
Effects 
Constant 
(β0ij) 
22.99±0.31 23.5±0.39 18.45±0.72 32.85±0.67 78.28±0.77 75.41±0.87 
 AgeC (β1j) 0.59±0.02 0.50±0.03 0.24±0.05 0.66±0.04 1.76±0.07 1.22±0.06 
 AgeC2 (β2) -0.02±0.001 -0.02±0.001 0.03±0.01 -0.04±0.004 -0.042±0.002 -0.07±0.001 
 AgeC3 (β3) 
-
0.00008±0.000
08 
0.0004±0.000
1 
-0.002±0.003 0.0002±0.0002 
-
0.0005±0.0001 
0.003±0.0003 
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Random 
Effects 
       
Level 1 
Constant ( δ 
2
ε0) 
1.17±0.04 2.04±0.07 14.72±0.75 10.68±0.49 10.21±0.45 26.19±1.07 
        
Level 2 
Constant 
(δ2µ0) 
10.31±1.45 18.98±2.42 50.57±7.33 54.39±7.07 59.34±8.55 86.88±11.47 
 
AgeC*AgeC 
( δ 2µ1) 
0.04±0.006 0.07±0.01 0.17±0.03 0.13±0.02 0.37±0.06 0.26±0.04 
 
Constant*Ag
eC ( δ µ01) 
0.34±0.08 0.82±0.13 -0.45±0.36 0.20±0.29 2.61±0.60 3.08±0.61 
 
 
Fixed effect values are Estimated Mean Coefficients ± SEE (Standard Error Estimate) of body mass index (BMI, kg/m2), 
percentage fat mass (%FM, %) and waist circumference (WC, cm). Age Centered (AgeC) is age in years centered on 18 
years of age. Random effects values Estimated Mean Variance ± SEE [BMI (kg/m2)]2, [%FM (%)]2 and [WC, (cm)]2 . 
Numerical values are significant at p < 0.05 if EMC/EMV > 2*SEE).  
 
 
 
128 
 
 
Figure 4.1 Mean growth curves and SD (Table 4.2) for body mass index (BMI), percentage total 
body fat mass (%FM) and waist circumference (WC) by sex against cut-offs (144,217,464) . 
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4.6 DISCUSSION 
 
 This study investigated the age of onset of overweight status in a cohort of children who 
were categorized by BMI as NW at study initialization (8 to 15 years).  Previously it has been 
shown that at peak height velocity (females 11.9 years and males 13.5 years), 93% of males and 
87% of females were normal weight by BMI and at 25 years of age 50% of participants were 
normal weight by BMI(433). In the present study, it was found that the average age of transition 
from normal weight to overweight status depended on age and metric used. BMI curves 
predicted an earlier onset in males; in contrast, percentage fat mass (%FM) predicted an earlier 
onset in females. Waist circumference (WC) curves had not crossed the cut-off in males by 40 
years of age but had in females by 33.8 years. The implication of the results is that emerging 
adulthood (18-25 years) appears to be a critical time period for fat gain in normal weight youth 
and that the ability of metrics used to identify overweight status are not equal. 
 There are large individual and sex differences in body composition and, as such, having a 
BMI beyond cut-points does not necessarily match up with the WHO definition of OWO which 
specifies it as a condition of excess body fat (142). From the age of 8 to 18 years, lean mass 
accrual demonstrates a linear relationship with BMI while the relationship of BMI with %TBF 
and WC and of %TBF and WC with age are not linear (70,99,201,437). An increase in unit BMI 
likely corresponds to an increase in lean mass (kg) during the adolescent period; however, as 
sexual dimorphism arises and differences in health behavior and underlying genetics manifest, 
the relationship between BMI, body composition and age becomes inconsistent. The implication 
is that the ability of indices of OWO to identify adiposity are not equal. Differences in the 
observed prevalence of OWO between BMI and %FM has been previously demonstrated in this 
cohort with %FM identifying a greater proportion of OWO than BMI in females but a lesser 
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proportion in males (434). As such it was not surprising that the current study found an earlier 
age at onset of OWO by %FM in females and by BMI in males.  
In 2017, Statistics Canada released national estimates of OWO based on self-report data 
indicating that 22% of 18 to 19-year-olds, and 50% of 25 to 34-year-olds had OWO (162). This 
suggests that a number of youth with NW become adults with OWO during the years of EA. 
Previously published observational data from the current cohort identifies a prevalence of OWO 
similar to self-reported national estimates of BMI from 12-17 years (23.1%), but lower than 
national estimates of youth OWO by measured BMI in 2015 (34%) (25,162). We have shown 
previously in this cohort, the period from 23-30 years is identified as the period when many 
acquire overweight. By this same period, overweight prevalence changed from 30-50% (BMI) 
and 60-50% (%FM) in females, and 50%-70% (BMI) and 30-50% (%FM) in males (434). 
National data is similar, suggesting that rates of OWO almost double between adolescence 
(approximately 25%) to young adulthood (approximately 50%) (1,162). It must be noted that 
differences between ages and metrics in this study may have arisen due to the method of analysis 
- longitudinal data was used but not all participants were included in every measure. With that 
said, the direction of the differences, by both sex and metric, have been demonstrated previously 
and a similar age at onset was identified by Wisemandle et al. (2000) using the FELS 
longitudinal data (107,434). In their cohort, the most common age at onset of OWO was the 
period of 20-25 years.  
National estimates of the prevalence of high-risk WC from 2007/2009 Canadian Health 
Measures Survey place almost 20% of males and 29% of females between the ages of 20 and 39 
in the high-risk category (over WHO cut-offs). This represents an increase in high-risk WC by 
approximately 18% from 1988 to 2007/2009 in adults in this age category (198). In the US, there 
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has been a similar increase in BMI and in WC but only 75% (males) and 50% (females) of WC 
increases can be explained by increases in BMI (193). Longitudinal data from Saskatchewan, 
Canada, has demonstrated that BMI has not increased in youth aged 8-16, while skinfolds (an 
estimate of subcutaneous fat) have (200). Looking specifically at the association between DXA 
derived adiposity and BMI, Sun et al. (2010) found that the correlation between measures of 
BMI and whole-body fat mass in 20 to 39-year-olds was significant with r = 0.79 in males and r 
= 0.84 in females (438). These findings suggest that BMI is correlated with adiposity but may 
not represent the entire picture of the prevalence of excess adiposity and may be overlooking 
consequential body composition.  
Findings from a large cross-sectional NHANES study agreed with Sun et al. (2010) and 
concluded that BMI (and WC) perform well as proxies for adiposity (35,438). Results from the 
NHANES study indicated that both BMI and WC metrics are highly correlated with %TBF in 
adults > 20 years of age, such that 46% of men and 49% of woman had exact agreement between 
%TBF and BMI categories, and 93% of men and 94% of women had agreement within one 
category (35). WC had similar correlations with %TBF- 51% and 42% males and females with 
exact agreement, and 97% and 91% of men and women within one category (35). The agreement 
was highest in those 25-30 years. While these correlations seem high, it also indicates that BMI 
and WC failed to identify over 40% of participants who had OW by other metrics. In the 20-39 
year age group, BMI under-classified almost 30% and 25% of participants with a %TBF at-risk 
or above overweight cut-offs. WC performed slightly better in males, but slightly worse in 
females.  Authors concluded that BMI and WC worked well as indicators of %TBF (35). The 
current findings disagree and suggest that WC does not identify excess adiposity or the onset of 
overweight at the same time as %FM or BMI; and that BMI may be an appropriate proxy for 
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adiposity in males, but not in females. With that said, the cut-offs used in the current analysis to 
identify WC at risk were developed to correspond with BMI values at the 95th centile (OB) rather 
than the 85th centile (OW); while cut-offs of BMI and %BF corresponded to the 85th BMI centile 
(OW).  
Beyond accurately representing the prevalence of excessive adiposity, using an accurate 
metric is important for identifying those who are at potential risk of health consequences (193). 
The associations between %FM and WC with cardiometabolic health have been shown to be 
stronger than, and independent of, the association between BMI and cardiometabolic health, 
suggesting that not all measures are equal in terms of risk assessment (432). Indeed, the study by 
Tomiyama et al. (2016) found that in a sample of over 40,000 American adults, having a BMI 
over 25 kg/m2 did not confer the same cardiometabolic risk for everyone (439). One third of 
those classified as having OW were metabolically healthy (2/3 were unhealthy) while 1/3 
classified as having NW were cardiometabolically unhealthy (2/3 were healthy). This is 
concerning as exposure to cardiometabolic risks (i.e. high blood triglycerides or hypertension) 
are known to be cumulative in their contribution to chronic disease risk such as cardiovascular 
disease or diabetes (383). BMI has demonstrated a similar lack of sensitivity in children for 
identifying excessive abdominal adiposity. The study by Laurson et al (2014) found that almost 
5% of children identified as having NW by BMI had WC values over Cook’s (2009) cut-points 
(151). With that said there is evidence that BMI is a simple method for identifying metabolic risk 
with associations to biomarkers of cardiometabolic risk similar to those of DXA and WC as 
indicated by Sun et al. (2010) (438). It is possible that these association may be different in 
younger individuals as the analysis by Sun et al. (2010) used data from adults over 20 years with 
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a mean age of 41, but beyond early adulthood any weight accrued is likely to be fat mass rather 
than lean mass (97,388).  
It must be noted that differences between ages and metrics in this study may have arisen 
due to the method of analysis and the overlapping cohort design.  Longitudinal data was used but 
not all participants were included in every measure, although the models did adjust for such 
missing data. Furthermore, discrepancy between measures may be due to the use of WC cut-offs 
corresponding with OB centiles of BMI, while the cut-offs used for BMI and %BF in this 
analysis corresponded with OW centile. This may have erroneously delayed the expected onset 
of at-risk waist circumference attainment. Had lower OW cut-offs been used, the age at onset of 
excess WC would have been 22 in females and 34 in males- similar to age at onset by BMI and 
%BF. With that said, the direction of the differences, by both sex and metric, have been 
demonstrated previously and a similar age at onset of overweight status identified (107,434). It 
has also been argued that percentage body fat is not a great measure of adiposity. However, cut-
points for overweight total body fat mass are not available.  
 
4.7 CONCLUSIONS 
 
 There are few longitudinal studies that follow normal weight children into young 
adulthood that can identify the onset of overweight status by various metrics. Our findings 
suggest that BMI classification in males and %FM in females are the screening tools providing 
the earliest indication of overweight status and that identifying onset with current adult WC cut-
offs may not be applicable in childhood and emerging adulthood. WC cut-offs that align with 
childhood values of WC are warranted if they are to be used in younger populations for early 
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CMR identification. The advantage of using the appropriate tool is that individuals at risk of 
health consequences, owing to high fat mass, can be identified earlier, monitored more closely 
and have intervention programs begun earlier.  Despite evidence that BMI can operate as a 
diagnostic of excess adiposity, its value beyond other measures such as %FM at identifying 
health-related information is still unclear. In this cohort of Saskatchewan Canadian children, we 
have found that in the 1990’s the clear majority were normal weight in childhood and 
adolescence; however, on entering emerging adulthood (18 to 25 years) the majority became 
overweight. This suggests that further studies are required to determine the long-term health 
implications of becoming overweight during this critical period of transition from adolescence to 
adulthood. Given that females accrue more fat mass and less lean mass in adolescence, further 
work is required in discerning whether the same metrics to identify overweight status should be 
used when making sex comparisons. 
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LINKS BETWEEN STUDIES 
Paper 1b from study 1 confirmed the findings of paper1a from study 1- that emerging 
adulthood is a period when the onset of OWO occurs in previously normal weight individuals. It 
also confirmed that different metrics indicate different age at onset of OWO in each sex. BMI in 
males and % TBF in females are more conservative estimates - identifying an earlier onset of 
OWO. WC cut-offs were not reached in the measurement period encompassed in this analysis 
(up to age 40); and yet trunk fat has demonstrated strong associations with health consequence, 
beyond TBF or BMI. TBF has demonstrated greater associations with health consequences than 
BMI, and in this study 21% and 56% of males and females respectively, were misclassified as 
NW by BMI when %TBF identified them as OWO. These known associations, in addition to the 
results of study 1b prompted the design of study 2 which sought to identify the contributing 
factors to total and trunk fat accrual during emerging adulthood. 
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CHAPTER 5  
 
 
STUDY 2: The influence of childhood and adolescent fat development on fat mass 
accrual during emerging adulthood: a 20-year longitudinal study. 
 
5.1 DECLARATION OF CONTRIBUTION 
 
I, Erin Barbour-Tuck, am the primary author of this manuscript and was responsible for 
data cleaning, analysis, and interpretation; and writing, editing and formatting the manuscript.  
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5.3 INTRODUCTION 
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Although it is well known that children and adolescents with overweight and obesity 
(OWO) are at a high risk of becoming adults with OWO (30), less is known about the factors to 
which youth with normal weight (NW) are exposed that contribute to their becoming adults with 
OWO (61). Statistics Canada report an almost two-fold increase in rates of OWO from 
adolescence (12-17 years; 23%) to young adulthood (20-35 years; 42%) (25,26). In the 
Saskatchewan Pediatric Bone Mineral Accrual Study (PBMAS) we found at peak height velocity 
(PHV) (11 to 14 years of age) that 9% of males and 14% of females had OWO rising to 65% and 
32% respectively 15 years after PHV (26 to 29 years of age) (434).This underscores the 
importance of identifying contributing factors to weight gain, specifically fat mass gain, during 
the transition out of adolescence into adulthood - the period known as emerging adulthood (EA) 
(18-25 years) (28,61).  
Having OWO during one stage of growth, e.g. infancy, mid-childhood or adolescence, 
increases the risk of having OWO at a subsequent stage. As such, much effort has been put into 
childhood interventions to prevent childhood onset of OWO which would track into subsequent 
ages (23,45). Children and adolescents with healthy or “normal weight” (NW) also become 
adults with OWO; however, there is a lack of data investigating contributing factors in the years 
beyond adolescence, emerging adulthood, during which fat mass accrual and transition to OWO 
occurs (31,61,434). The period of EA is characterized by both TBF and TrF gains, attributed in 
part to changes in lifestyle factors such as decreasing or sustained low PA and negative dietary 
changes (381,386,440). It is also known that having OWO in adulthood is related to elevated or 
accelerated fat mass accrual during critical periods of growth, accrual which is in turn related to 
concurrent PA and diet (16,118,121). 
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Some researchers suggests that a high level of PA and a healthy diet in childhood/ 
adolescence is essential for minimizing rapid or excess TBF and TrF accrual in subsequent 
critical periods (115,441); however, other studies suggest that neither PA nor diet during EA are 
significant once an individual’s BMI or body weight in late adolescence are considered 
(118,386). Similarly, PA during childhood and adolescence may only be protective against later 
life fat mass gains if levels remain stable into EA. While OWO from childhood to adulthood 
tracks well, PA does not (27,45), even when controlling for fat mass during the growing years. 
PA in childhood and fitness in adolescence have shown an association with fat mass in EA 
(45,113). Youth with higher TrF mass have demonstrated greater weight gain, higher levels of 
TrF, and larger waist circumference in subsequent years (169,170). TrF has also been found to 
have a stronger relationship with health than TBF in both sexes at various ages (66) and as such 
the investigation of adult TrF predictors may be more urgent than those of adult TBF. The 
independent influence of childhood and adolescent lifestyle (i.e. PA and diet) and fat mass 
accrual on accrual during EA remains unclear.  
The purpose of this study was to investigate the role of TBF and TrF mass during 
childhood and adolescence on TBF and TrF accrual during emerging adulthood, whilst 
controlling for the confounders of PA and diet during both childhood/adolescence and emerging 
adulthood. It was hypothesized that participants with greater fat mass during childhood and 
adolescence would have greater TFB and TrF accrual during emerging adulthood. 
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5.4 METHODS 
 
5.4.1 Study Design 
Participants were drawn from the Pediatric Bone Mineral Accrual Study (PBMAS), 
details for which have been described in detail elsewhere (110). In brief, this study used a mixed 
longitudinal study design, composed of cohorts aged 8 to 15 years. The sample was racially 
homogenous- 95% were of European decent. Serial measures were initially collected between 
1991 and 1998, repeated between 2002 and 2008 and again between 2010 and 2011. Inclusion 
criterion for the present study was a complete set of PA, dietary and body composition data at a 
minimum of two occasions during childhood and adolescence and one measure in emerging 
adulthood. Of the initial 228 children (113 males and 115 females) recruited, 59 males and 67 
females met the inclusion criteria for the present study. This study was approved by the Research 
Ethics board at The University of Saskatchewan.  
5.4.2 Anthropometry 
Measures included standing height, sitting height and weight, which were carried out 
following standards by Ross and Marfell-Jones (442). Height was measured using a wall-
mounted stadiometer and recorded to the nearest 0.1 cm (Holtain Limited, Crymych, UK). 
Weight was determined using a calibrated digital scale and recorded to the nearest 0.1 kg (Model 
1631, Tanita Corp, Tokyo, Japan). Serial height data was used to develop annual velocities and 
velocity curves were fitted using a cubic spline procedure. A cubic spline uses the interpolation 
of polynomials from neighboring points to create a smooth curve. Interpolated values from each 
individual’s curve were then used to identify age at maximum height velocity or peak height 
velocity (PHV) (GraphPad Prism 5, GraphPad Software, San Diego, CA, USA). 
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5.4.3 Chronological and Biological Age 
Chronological age (CA) was determined by subtracting the date of birth from the decimal 
date of measurement. CA categories were composed of 1-year intervals such that the CA 
category of 12 years included all those with age at test ranging from 11.5 to 12.49. Biological 
age (BA) was calculated by subtracting the age at PHV from the CA of the participant at the time 
of measurement. BA groupings were constructed using 1-year intervals such that the BA of 1 
included measurement occurring between -0.5 and 0.49 years from PHV.  
5.4.4 Body Composition 
Total body fat (TBF, g), trunk fat (TrF, g) and total body FFM (g; bone mineral plus lean) 
were assessed from total body dual energy x-ray absorptiometry (DXA) scans (Hologic QDR -
2000, Hologic, Waltham, MA). The coefficient of variation (%) for short-term precision in vivo 
for TBF was 2.95% and for TrF was 4.88% (443).  
5.4.5 Diet 
Self-reported 24-hour recall measures of diet were administered three times per year in 
the first 3 years of the study and two times per year thereafter. Friday and Saturday were not 
included in the 24-hr recalls. Participants were given a 20-minute training session on food 
portion size estimation prior to reporting. During reporting sessions, the participants were 
provided with life-size pictures of portions for reference. Nutrient composition was estimated 
from the 1988 Canadian Nutrient File and analyzed with the NUTS nutritional assessment 
software (version 3.7; Quilchena Consulting Ltd, Victoria, Canada). Total 24-hour energy intake 
was expressed as an annual average in kiloJoules-d-1.  
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5.4.6 Physical Activity 
Physical activity was assessed using the Physical Activity Questionnaire for Children 
(PAQ-C) or Adolescents (PAQ-A), a minimum of three times per year for the first two years and 
two times per year for the following years of childhood and adolescence. The Physical Activity 
Questionnaire for Adults (PAQ-Ad) was used once per year for measures after the age of 18. 
This family of instruments uses a 5-point Likert scale with higher numbers indicating higher 
levels of PA. These tools have demonstrated good internal consistency and validity with 
moderate relationships with 7-day activity recall, teacher evaluations, and Caltrac motion sensors 
(408,409).  
5.4.7 Statistical Analysis 
The data was split into two-time points: childhood and adolescence and emerging 
adulthood. The childhood and adolescence data included measures from BA of -6 to +6 years 
from PHV (corresponding to CA of 8 years to 17 years) and emerging adulthood data 
(corresponding to CA 18 to 28 years). BA was used to align individuals during childhood and 
adolescence due to the large individual variability in tempo and timing of maturation and the 
known effect that maturation has on PA and somatic variables.  
During childhood and adolescence, individual values and group mean values at each BA 
were used to determine an individual’s z-scores at each measurement occasions. A mean 
composite z-score was then assigned to each participant, calculated as the sum of z-scores for all 
measurement occasions divided by the number of occasions. This process was used to calculate 
mean z-scores for childhood and adolescent TrF, TBF, PA and energy intake. 
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For the EA period, dependent variables were assessed for normality and violations were 
log transformed. Descriptive data are expressed as means by sex (SPSS version 11.5, SPSS Inc., 
Chicago, IL). Independent samples t-tests with Bonferroni corrections were used to analyze sex 
differences between measures at PHV and 17 years CA category (end of adolescent period) for 
PA, energy intake and fat mass variables (p<0.05).  
Random effects models were developed (MLwiN version 1.0, Multilevel Models Project, 
Institute of Education, University of London, London, UK). This procedure has been described 
in detail previously (402). In brief, fat mass parameters were measured repeatedly within 
individuals (level 1 of the model) and between individuals (level 2 of the model). Linked 
variables at different levels of a model characterize multilevel random effect regression models. 
In the present analysis, log transformed TBF and TrF mass during EA (18-28) were described by 
developing gender-specific multilevel regression models as follows:  
yij  = (α+βjxij) +( k1zij + k2zij +…+ knzij) + (µj+ νj xij + εij).  
Where yij is total (trunk) fat mass at the i
th measure in the jth individual, αj is the constant for the 
jth individual, βjxij is the slope coefficient for fat mass by age (x) for the jth individual at 
measurement i (in our model age is centered around 23 years), and k1 to kn are the coefficients 
for time dependent predictor variables (e.g. PA, energy intake, TBFz-score etc.) at the ith 
measurement in the jth individual. uj, vjxij and ij are the random parameters. These parameters are 
assumed to have a mean of zero and follow a normal distribution. εij~N [0, var(εij)] is the level 
one within-individual variance for the i
th measurement in the jth individual and µj~N [0,var(μ)] is 
the level two intercept between-individual variance. µj*vjxij~N [0, var(µj*vjxij)] explains the 
covariance of slope and intercept in the model. 
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5.4.8 Modelling Strategy 
 Predictor variables were added in a stepwise procedure and changes in the likelihood 
ratio statistic were used to judge significance. If variance at level 1 and 2 was reduced and 
predictors had estimated mean (EE) coefficients greater than twice the standard error of the 
estimate (SEE) (p<0.05) they were retained in the model. Age centered was calculated as the 
participants’ CA age measurement minus mean CA in the EA sample (mean CA=23 years) 
which was added to the model as a fixed and random coefficient. Age2 was added to the model 
as fixed effects to better reflect the known non-linear pattern of growth. Following age, height 
and total body FFM, childhood/adolescent PA, energy intake and fat mass z-scores were added 
followed by emerging adulthood PA and energy intake.  
Completed models and significant coefficients were used to create TBF and TrF curves 
(Figures 5.2). The values used in construction of the curves were the maximum and minimum 
values of predictor variables at each CA from the current data set (i.e. PA value of 1 and 5; z-
scores of -1 and +2) and the mean value of variables (i.e. height, total body FFM). 
 
5.5 RESULTS  
 
  Table 5.1 provides the descriptive characteristics of males and females at the beginning 
(PHV) and end (17 years) of the adolescent period. This cohort was predominantly NW by age 
and sex appropriate cut-offs from PHV to 17 years of age (100,434).  
Table 5.1 General descriptive characteristics of male and female participants at Peak Height 
Velocity and at 17 years 
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PA scores decreased across EA from 18 years in females and from 20 years in males 
(Figure 4.1a). Energy intake increased slightly in females (between 7,000 and 8,000 kJ), and 
increased slightly more in males (10,000 to 13,000 kJ) across EA (Figure 5.1b).  
Tables 5.2-5.5 report the models of TBF and TrF accrual for males and females during 
EA. Initial models used aggregated male and female data and found sex to be a significant 
predictor (not shown). Final models were run with sex disaggregated because of this significance 
and because of known sexual dimorphism in fat mass accrual. The coefficient for age centered 
was significant in each of the models indicating that TBF and TrF were significantly increasing 
with each measurement occasion from 18 to 28 years. The level 2 variance matrix indicated that 
in each model, individuals had significantly different intercepts (µj) and slopes of their lines 
(vjxij). There was no significance to the covariance in slope and intercepts (µj * vjxij) in any of the 
models, indicating that the variance in intercept was not related to the slope.   
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The significant (p<0.05) fixed effects contributing to the prediction of TBF and TrF 
during EA included age centered, and total body FFM in both sexes. PA in males but not in 
females, and height in females but not in males were also significant in predicting EA TBF and 
TrF (Table 5.2-5.5, Model 1). 
 
 
Figure 5.1 Patterns of a) PA (PAQ-A scores) and b) Energy Intake (KJ) over emerging adulthood 
in males and females 
Table 5.2 Multilevel regression models for total body fat (TBF) in males during emerging 
adulthood 
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Table 5.3 Multilevel regression models for Trunk Fat (TrF) in males during emerging adulthood 
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Childhood/adolescent TBF z-score was significant for TBF models, and 
childhood/adolescent TrF z-score was significant for TrF models (Table 5.2 -5.5, Model 2). 
Childhood/ adolescent PA and energy intake z-scores were not significant in any model p>0.05). 
 
Table 5.4 Multilevel regression models for total body fat (TBF) in females during emerging 
adulthood 
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The increased TBF and TrF accrual in those with high versus low child/adolescent fat 
mass z-scores are illustrated in Figure 5.2. In males, the difference in low TBF z-score (-1) 
versus high TBF z-score (+2) resulted in a difference of 24.5 kg TBF by 28 years (Figure 5.2 a). 
Z-scores for TrF were very similar, resulting in a difference of 12 kg TrF (Figure 5.2 b). PA was 
a significant predictor in males only. Having a high (5) versus low PA (1) mitigated accrual 
conferred by a high fat z-score by approximately 8 kg TBF (Figure 5.2 a) and by 4.5 kg TrF 
(Figure 5.2 b). In females, the difference in low TBF z-scores (-1.0) versus high TBF z-scores 
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(+2.5) resulted in a difference of almost 12 kg of TBF by 27 years (Figure 5.2 c). Z-scores were 
similar for TrF, resulting in a difference of approximately 3 kg (Figure 5.2 d). 
Table 5.5 Multilevel regression models for Trunk Fat (TrF) in females during emerging adulthood 
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Figure 5.2 Hypothetical curves developed from multilevel model significant predictor coefficients. 
(a) Male total body fat (TBF, grams) (Table 5.2). (b) Male trunk fat (grams) (Table 5.3). (c) Female 
TBF (TBF, grams) (Table 5.4). (d) Female TrF (grams) (Table 5.5) 
 
5.6 DISCUSSION  
 
The purpose of this study was to investigate TBF and TrF accrual during emerging adulthood 
and the degree to which childhood and adolescent fat accrual influenced the trajectory of accrual 
in EA, whilst controlling for known contributing factors. It was found that the strongest predictor 
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of TBF in EA was childhood and adolescent TBF mass, and the strongest predictor of TrF in EA 
was childhood and adolescent TrF mass. PA during EA had a significant negative relationship 
with fat mass accrual in males but not in females. Neither childhood/adolescent nor EA energy 
intake were significant predictors of TBF or TrF.  
It has been suggested that both females and males continue to accrue TBF from 
adolescence into EA with females having more TBF at 17 years and greater rate of increase to 21 
years (45,118). These findings are based on skinfold measurements. The current study similarly 
suggests continuous gains in TBF but without sex differences. Recent waist circumference-for-
age charts (NHANES) and longitudinal data suggest increasing TrF in both males and females 
during a period similar to EA with higher values in males than in females from adolescence into 
young adulthood (45,437). The present data shows similarly increasing TrF in both sexes with 
lower baseline values but greater gains in males compared to females. The discrepancy between 
studies regarding sex differences may be due to methodological differences. Unlike DXA used in 
the current studies which measures both subcutaneous and visceral fat, skinfolds can only 
account for subcutaneous fat mass. This is especially important for TrF measures, as during 
adolescence females tend to deposit more TrF subcutaneously while males deposit more 
viscerally (313,444). Skinfolds, which measure subcutaneous fat, may indicate greater fat mass 
in females while DXA and waist circumference, which estimates subcutaneous and visceral fat, 
indicate greater fat mass in males.  
It has been demonstrated previously that fat mass tracks moderately well from childhood 
to adulthood (13,45). The current models (Tables 5.1 and 5.3) found that those with the highest 
measures of fat mass in childhood and adolescence also had the greatest accrual in subsequent 
years. The finding that higher TrF accrual in childhood and adolescence results in more TrF 
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accrual in adulthood may be more important than those pertaining to TBF, as TrF in adulthood is 
known to confer additional heath risk above TBF (66). Current models support findings by 
Sherar et al. (2007) which suggested that TrF mass during childhood was higher in adults with 
greater cardiometabolic risk (169). In addition, Maffeis et al. (2001) found that waist 
circumference in children with NW and OW (at 8 years) predicted weight gain over four 
subsequent years (170). TrF appears to persists across time suggesting that a phenotype of higher 
TrF during childhood and adolescence may represent an underlying polygenic risk which 
entrains subsequent fat mass accrual in EA (16). Indeed, genomic studies suggest that those with 
a genetic predisposition for adult obesity have accelerated growth (352) and an earlier pubertal 
onset, both factors known to relate to greater TrF during EA (445). Underlying genetics 
influence developmental phenotypes of obesity, and possibly more specifically abdominal (TrF) 
obesity (446). Fortunately, genetics and environment interact. Both factors influence fat accrual 
and obesity, and as such there is opportunity for lifestyle factor such as PA to alter suboptimal fat 
mass trajectories (121) as seen in the current models. 
Emerging adulthood (18-25 years) has been highlighted as a time when TBF and TrF 
mass continue to increase as PA decreases (386). Previous studies have found that those with 
higher PA have smaller increases in weight and BMI during EA, although some suggest no effect 
or an effect which is dependent on fat mass before college (386). Alternatively, data of Dutch 
youth found that the risk conferred by high adolescent %TBF was mitigated by concurrent PA 
(118). Similarly, Tammelin, Laitinene & Nayha (2004) found that decreasing levels of PA or 
remaining at a low PA from 14 to 31 years was significantly related to having OWO at 31 years 
in comparison to those who remained persistently active (441). PA in the current models 
mitigated fat mass accrual, but only in males (Table 5.3 and 5.2). Female models support the 
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work of Kasparek et al. (2008) suggesting that EA weight gains may be contingent upon weight 
in previous growth periods (386). PA is well established as a modifier of fat mass at all ages 
(264), and so the lack of significance found in females may be due to a masking effect from 
other variables such as lean mass, or fitness (113). Females accrue a greater proportion of their 
adult fat mass compared to their adult lean mass during puberty (105). The effect of female 
childhood/adolescent PA is also likely masked by the natural accrual of fat mass and 
simultaneous decline in PA in females over the adolescent period (105,440). There may be sex 
specific effects such that PA has a weaker effect on fat mass accrual in females than in males; for 
example, in 17-year-old males, PA was shown to be independently related with fat mass, while 
in females, mothers’ fat mass and education level but not PA related to fat mass at 17 years 
(447). It is hypothesized that PA may exert its strongest influence in females during earlier 
pubertal years when fat mass accrual predominates and thus PA acts as a mediator on fat mass 
rather than as an independent predictor. This is supported in that current models showed 
childhood/adolescent PA z-scores as a significant predictor of EA TBF and TrF in females (but 
not males) until the inclusion of TBF and TrF z-scores. Conversely, the current analysis 
identified EA PA to be related to fat mass accrual in males. It is hypothesized that this is due to 
lean mass gains which can continue into late adolescence and early adulthood and which increase 
energy expenditure and lower fat mass. The role of PA on fat mass accrual appears to be 
different in males and females, and may be masked by the effect of sex-specific tissue accrual 
experienced during adolescence. Regardless of sex differences, the demonstrated effect of PA on 
fat mass accrual during EA highlights the importance of maintaining PA not just during 
childhood and adolescence but throughout the life course.  
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Finally, it has been shown that energy intake does influence childhood and adolescent fat 
mass in this cohort (395). The lack of significance of childhood/adolescent diet in the current 
models may be due to the strength of the childhood/adolescent fat mass variable which likely 
encompasses and manifests the effect of diet. Energy intake was not significant during EA, 
suggesting that a decrease in PA rather than an increase energy intake is a more important 
contributing factor to fat mass accrual during this period. 
This study is not without limitations. The accuracy of DXA has been questioned in 
growing individuals; however, validation studies demonstrate accuracy in DXA estimates of 
body fat for body weights between 35 and 95 kg which encompasses most body weights in the 
pediatric PBMAS cohort (448). PA and dietary self-report measures are at risk of recall error; 
however, longitudinal studies often consider using the same tools across time in spite of newer 
technology which may become available over the course of the study. Participants in this study 
were predominantly of European descent and, as such, results cannot be generalized to other 
ethnicities.  
 Our results support the argument that childhood and adolescence are important periods 
in which to promote healthy weight and limit fat mass accrual even in those with NW, as these 
periods have implications not just for childhood but also for young adulthood health and weight 
status. PA is a modifiable lifestyle factor capable of mitigating fat mass gain; however, 
consideration should be given to the optimal timing of PA interventions which may be sex 
specific. EA may provide an additional opportunity to alter fat mass trajectories set earlier in life.  
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LINKS BETWEEN STUDIES 
Study 2 identified total and trunk fat mass during childhood and adolescence, in addition 
to physical activity during emerging adulthood to be significant predictors of fat accrual during 
emerging adulthood. These findings suggest that preventing fat accrual early in life will mitigate 
fat gains later in life. Questions remain regarding the clinical implication of accruing large 
amounts of fat mass in emerging adulthood. This led to the design of study 3 which investigated 
differences in total body and trunk fat accrual during emerging adulthood in those with higher, 
versus those with lower cardiometabolic risk profiles. 
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CHAPTER 6  
 
STUDY 3: Fat accrual during early adulthood and continuous cardiometabolic risk score 
in the fourth decade: a longitudinal analysis 
 
6.1 DECLARATION OF CONTRIBUTION 
I, Erin Barbour-Tuck, am the primary author of this manuscript and was responsible for 
data cleaning, analysis, and interpretation; and writing, editing and formatting the manuscript.  
 
6.2 MANUSCRIPT STATUS 
This document has submitted to the Obesity Journal, June 15, 2018. This document has been 
reformatted from the submitted version for inclusion in the thesis with minor grammatical 
changes to improve readability and relationship to the larger document.  
 
6.3 INTRODUCTION 
 
 Over one million Canadians report having Cardiovascular Disease (CVD) and an additional two 
million Canadians have diabetes, of which 90% are Type II Diabetes (449–452). Even more 
concerning are the rates of the Metabolic syndrome (MetS)- the clustering of 3 or more risk 
factors of CVD and Type II Diabetes. The prevalence of MetS in Canadian adults (18-30 years) 
in 2012 was 13%, just over 3 million people (453). The rates of MetS increase with age and the 
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risk of MetS is increased with being overweight and obese (OWO) (206). As Canadian rates of 
OWO remain high it is likely that the rates of MetS, CVD, and Type II Diabetes will continue to 
rise (162,453). Longitudinal data from our lab indicates that greater fat mass trajectories in 
adolescence results in higher cardiometabolic risk in emerging adulthood (18 to 25 years of age) 
(433). Our data has also demonstrated that during emerging adulthood the prevalence of OWO 
increases (434). If OWO is increasing during this period, it begs the question as to whether 
greater fat mass trajectories during emerging adulthood (the third decade of life) increases 
cardiometabolic risk in the fourth decade of life.  
Cardiometabolic risk (CMR) is an umbrella term used to represent the relative risk 
attributed to a comprehensive list of MetS risk factors including low levels of high-density 
lipoprotein cholesterol (HDL), and elevated blood pressure, waist circumference (WC), 
triglycerides (TG), fasting glucose and insulin levels (4,182). Like MetS factors, CMR factors 
often accompany overweight and obesity (OWO) with a particularly strong relationship with 
trunk fat, even independent of total fat or OWO status (5,454). Precursors of CMR are known to 
arise during childhood in association with childhood OW, or in association with central adiposity 
or trunk fat (TrF) (84,393,455–458). Children with higher trunk fat as early as 8 years of age 
have higher CMR in adulthood, despite having normal weight (NW) in childhood (169). 
The evidence is clear that childhood adiposity sets a trajectory of health (or unhealth), 
and that the highest CMR is often found in adults who were exposed to childhood OWO; 
however, this is likely due in part to the strong associations between childhood OWO and adult 
OWO (13,393,455). There is also literature suggesting and that both childhood OWO and adult 
OWO confer CVD risk in adulthood independent of each other (459). For example, adults with 
the highest CVD risk are those who remained OWO from childhood, followed closely by those 
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who transition from NW-to-OWO between childhood and adulthood. Those with an OWO-to-
NW and NW-to-NW transition have similar and lowest risk (459).  This suggests that a higher 
weight in childhood may act as a metabolic buffer, preparing the body to better deal with fat 
mass gains in the future. Those who are NW as children may be at a metabolic disadvantage 
during other typical times of fat accrual, particularly trunk fat accrual, such as emerging (18-25 
years) adulthood (433). We have shown that fat mass gains and the transition from NW to OWO 
often occur during the period of EA and that this may be a key period for fat mass accrual (434). 
As such, the exploration of CMR in adults should optimally incorporate weight and/or body 
composition data from childhood and adolescence.  
EA is a period of transition during which lifestyle factors such as physical activity (PA) 
and diet are often in flux. Both PA and diet are factors related to the onset of OWO, preferential 
deposits of TrF, and CMR profiles in children, adolescents and adults (243,281,447,460). 
Adolescent levels of PA and dietary habits have demonstrated an association with fat mass, CVD 
and MetS in early adulthood (60,385,400). This lab has demonstrated that higher levels of PA in 
males during EA can diminish fat mass gains, while the strongest predictor of both total body 
and trunk fat gains is the level of fat mass during childhood and adolescence (433). These 
findings suggest that the maintenance of healthy lifestyle habits during EA may mitigate CVD 
health risks in early adulthood (25-39 years); however, it remains unclear whether TrF and TBF 
accrual during EA and early adulthood is related to CMR later in life, and to what extent this 
relationship is mediated by child and adolescent fat mass accrual. There is a paucity of 
prospective studies encompassing the time from childhood to adulthood with the appropriate 
variables to examine the relationship between fat mass accrual and lifestyle across the life 
course.  
 
 
160 
 
The Pediatric Bone Mineral Accrual Study is a longitudinal growth study with over 25 
years of serial data. Measurements collected include body composition parameters in addition to 
physical activity and dietary intake. This study is uniquely suited to investigate the role that fat 
mass, PA and diet during childhood, adolescence and EA has on CMR at 30-39 years of age. The 
purpose of this study is to examine trajectories of total body and trunk fat accrual from emerging 
through early adulthood in relation to CMR at the end of the early adulthood period. It is 
hypothesized that those with higher CMR scores at the end of early adulthood will have steeper 
trajectories of fat mass accrual (TBF and TrF) during emerging and early adulthood (18-39); and 
that those with higher CMR will have lower PA levels and higher energy intake during EA, and 
higher fat mass during childhood and adolescence. 
 
6.4 METHODS 
 
6.4.1 Study Design.  
 Participants were drawn from the longitudinal Pediatric Bone Mineral Accrual Study 
(PBMAS) (1991 – 2018). The details of this study have been described thoroughly elsewhere 
(406). In brief, the study was composed of 8 age cohorts (8 to 15 years of age at study entry). A 
total of 228 participants were recruited (115 females and 113 males) in 1991, of whom 220 were 
measured. An additional 31 participants were added between 1992 and 1993. From 1991 to 
1998, participants were measured twice per year. Annual measurements were taken from 2002-
2005, 2010-2011 and again in 2016/2017. After 7 years of data collection (1991-1998), 197 
participants had two or more (median six) data collection points. Between 2002 and 2005, 169 
(77 males) participants returned (median 4 visits). From 2010 to 2011, 123 (49 males) were 
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retested (median 2 visits) and between 2016 and 2017, 61 (28 males) returned for one more visit.   
To be included in the present study, participants had to have a blood draw and a complete set of 
PA, dietary and body composition data during the 2016/17 visit plus a minimum of one visit in 
childhood/adolescence (8-17 years) and at least 2 measures between EA and the forth decade of 
life (18-39 years of age); 54 (25 males) participants met these criteria and were included in the 
present analysis. The sample was racially homogenous; 95% of the 94% for whom race was 
known were white. This study was approved by the Research Ethics board at the University of 
Saskatchewan.  
6.4.2 Anthropometry  
Measures taken at each visit included standing height, sitting height (in 
childhood/adolescence) and weight, using the protocol outlined in Ross and Marfell-Jones (35). 
Height was measured using a wall-mounted stadiometer and recorded to the nearest 0.1 cm 
(Holtain Limited, Crymych, UK). Weight was determined using a calibrated digital scale and 
recorded to the nearest 0.1 kg (Model 1631, Tanita Corp, Tokyo, Japan). Age at peak height 
velocity was determined by fitting a cubic spline to serial height data (GraphPad Prism 5, 
GraphPad Software, San Diego, CA, USA). 
6.4.3 Chronological and Biological Age  
Chronological age (CA) was determined by subtracting the date of birth from the decimal 
date of measurement. 1-year intervals comprised each CA category such that 12 years included 
all those with age at test ranging from 11.5 to 12.49. Body composition changes rapidly during 
adolescence and with significant sex differences: body fat decreases and lean mass increases in 
males; body fat increases in females; and TrF begins to accrue more so in males than females 
(69,149). As such, a biological age (years from peak height velocity; PHV) was used to align 
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individuals up to CA of 17. BA groupings were constructed in the same way as CA groupings 
such that a BA of 1 included all those with a BA at test ranging from -0.5 and 0.49 years from 
PHV.  
6.4.4 Body Composition: 
 Total body fat (TBF, g), trunk fat (TrF, g) and lean mass (FFM, g) were assessed from 
total body dual energy x-ray absorptiometry (DXA) (Hologic QDR –2000 and 4500, Hologic, 
Waltham, MA). Hologic 2000 was used from 1991 to 2007 after which a Hologic 4500 was 
used. The coefficient of variation (%) for short-term precision in vivo for TBF was 3.0% and for 
TrF was 4.9 % (195). Conversion factors were developed to correct for difference in machines 
using data from 9 men and 15 women (410). 
6.4.5 Diet  
 Self-reported 24-hour recall measures of diet were administered 3-4 times in the first 4 
years of the study (1-2 times over the phone), and twice per year until 2007. One recall was 
given in the 2010/2011 wave and 2 recalls (one in person and one over the phone) for the 
2016/2017 wave of measures. Friday and Saturday were not included in the 24-hr recalls. 
Participants were given a 20-minute training session on food portion size estimation with life-
size pictures of portions for reference. Nutrient composition for measures between 1991 and 
1997 was estimated from the 1988 Canadian Nutrient File and analyzed with the NUTS 
nutritional assessment software (version 3.7; Quilchena Consulting Ltd, Victoria, Canada). Food 
Processor version 8.0 and revisions (ESHA Research Inc,. Salem, OR, USA, 2003.) was used to 
estimate total energy and nutrition after 1997. Total 24-hour energy intake (EI) was expressed as 
an annual average in Kjoules-d-1.  
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6.4.6 Physical Activity  
Physical activity was assessed using the Physical Activity Questionnaire for Children 
(PAQ-C), Adolescents (PAQ-A), or Adults (PAQ-AD) a minimum of three times per year for the 
first two years of the study and two times per year for the following years of childhood and 
adolescence. In adulthood, the PAQ-AD was only administered once per year. This family of 
instruments uses a 5-point Likert scale with higher numbers indicating higher levels of PA. 
These tools have demonstrated good internal consistency and validity with moderate 
relationships with 7-day activity recall, teacher evaluations, and Caltrac motion sensors 
(409,461–463). 
6.4.7 Smoking Status 
Participants reported on their past and current smoking history. Classification of 
participants was either non-smoker, past smoker (if they had quit for ≥ 1 year), or current 
smokers. 
6.4.8 Metabolic Assessment 
Blood pressure and heart rate were taken at onsite measurements, after 2002, using a 
standard blood pressure cuff after 5 minutes of rest. In 2016/17 five participants failed to have 
blood pressure recorded at a follow-up appointment and provided a physician’s assessment 
within 6 months of their blood draw. Mean arterial pressure (MAP) was calculated using the 
following formula: ([{2 x diastolic blood pressure} + systolic blood pressure]/3). Participants 
were asked to fast for 12-hours prior to a morning blood draw and a trained phlebotomist 
acquired samples using standard venipuncture procedures. All samples were centrifuged for 15 
minutes, within 20 minutes of blood draw and stored at –70ºC prior to analysis. All analysis took 
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place within 6 months of blood draw. Analysis of total cholesterol (TCHOL), high-density 
lipoprotein (HDL), triglycerides (TG), and C-reactive protein were conducted at the Royal 
University Hospital (Saskatoon, SK, Canada). Fasting glucose and insulin were analyzed in-
house using EnzymeChrom Glucose Assay (Bioassay Systems) and Insulin EIA (ALPCO 
Diagnostics). Homeostasis model assessment for insulin resistance (HOMA) was calculated 
using the following formula: ({{fasting insulin(U/ml)} x {fasting glucose (mmol/l)}}/22.5) 
(464). 
6.4.9  Continuous Cardiometabolic Risk Score 
A continuous cardiometabolic risk (conCMR) score was chosen to represent 
cardiometabolic risk in this cohort as they are relatively young and healthy, and the prevalence of 
metabolic syndrome was likely to be very low. This method has been validated previously 
(169,223). Metabolic syndrome variables (TG, HOMA, TCHOL, HDL-1, and MAP) were 
regressed onto smoking status and age, and the standard residuals were saved. Adding the 
standardized residuals provided a composite continuous risk score for each individual. These 
variables are consistent with those suggested by the National Cholesterol Education Program 
(2001) (182). As trunk fat was a variable of interest in this analysis, waist circumference was not 
included in the risk score. A higher score is indicative of greater health risk. High and low CMR 
group was determined by a median split of conCMR scores.  
6.4.10 Statistical Analysis 
Childhood and adolescence z-scores were used to represent TBF and TrF. This is 
described in more detail elsewhere (433). The childhood and adolescence data included measures 
from -6 to +6 years from PHV (corresponding to CA of 8 years to 17.9 years). Sex and age 
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specific z-scores were assigned to each individual at each measurement, from which a mean z-
score for childhood and adolescence was determined.  
TBF and TrF variables during the period from EA to early adulthood were assessed for 
normality, and violations were amended using natural logarithmic (Ln) transformations. 
Descriptive data are split by sex expressed as means and standard deviations (SPSS version 24, 
SPSS Inc., Chicago, IL). Independent samples t-tests with Bonferroni corrections were used to 
analyze differences between high and low CMR groups for PA, EI, TBF, TrF and CMR factors 
individually (p<0.05). Pearson’s correlations were used to determine the relationships between 
TBF, TrF and individual CMR factors (p<0.05). 
Random effects models were developed and used to construct models for TBF and TrF 
from EA to early adulthood in both low and high CMR groups (MLwiN version 1.0, Multilevel 
Models Project, Institute of Education, University of London, London, UK). This procedure has 
been described in detail previously (402). In brief, FM parameters were measured repeatedly 
within individuals (level 1 of the model) and between individuals (level 2 of the model). Linked 
variables at different levels of a model characterize multilevel random effect regression models. 
In the present analysis, log transformed TBF and TrF mass during emerging and young 
adulthood were described by developing multilevel regression models as follows:  
yij = (α+µj)+ (β+νj )xij + (k1zij + k2zij +…+  knzij) + εij  
which can be reorganized to  
yij   =  (α+βjxij) +( k1zij + k2zij +…+  knzij) +  (µj+ νj xij + εij). 
Where yij is total (trunk) FM at the i
th measure in the jth individual, αj is the constant for the jth 
individual, βjxij is the slope coefficient for FM by age for the jth individual at measurement i (in 
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our model age is centered around 28 years), and k1 to kn are the coefficients for time dependent 
predictor variables (e.g. PA, EI, TBFz-score etc) at the ith measurement in the jth individual. uj, 
vjxij and εij are the random parameters. These parameters are assumed to have a mean of zero and 
follow a normal distribution.  εij~N [0, var(εij)] is the level one within-individual variance for the 
ith measurement in the jth individual and µj~N [0, var(μ)] is the level two intercept between-
individual variance. µj*vjxij~N [0, var(µj*vjxij)] explains the covariance of slope and intercept in 
the model. 
6.4.11 Modelling Strategy  
Predictor variables were added one at a time in a stepwise procedure. Significance of the 
predictor variables as contributors to the new model were determined by changes in the 
loglikelihood ratio statistic between models. A chi-square distribution was used to compare the 
difference in loglikelihood ratios from one model to the next considering the degrees of freedom 
lost by adding variables. If variance at level 1 and 2 was reduced and predictors had estimated 
mean coefficients greater than twice the standard error of the estimate (SEE) (p<0.05) they were 
retained in the model as significant. If these criteria were not met, the predictor was removed 
from the model. Age centered was added to the model as a fixed and random coefficient. Age 
centered was calculated as the participants’ CA age measurement minus mean CA in the EA 
sample (mean CA=28 years).  Age2 was added to the model as fixed effects to better reflect the 
known non-linear pattern of growth. Total body and trunk FM were modeled and PA, dietary, 
and childhood/adolescent TrF and TBF z-scores were incorporated into the models and their 
independent effects were tested.  
Completed models and significant coefficients were used to create TBF and TrF curves 
(Figures 6.1, 6.2, and 6.3). Maximum and minimum values of predictor variables at each BA 
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from the data set were used in the models to create curves (i.e. PA value of 1 and 5; z-scores of -
1 and +2) whilst controlling for the other confounders by using their average values within CA 
bands.  
 
6.5 RESULTS 
 
The median number of testing occasions during emerging and young adulthood (18 to 39 
years) was 7, with a minimum of 2 and a maximum of 10. Age centered for the models was 28 
years. At mean age of 36 years, 55% of the sample was OWO by BMI. Of those who were 
OWO, 13 were females (8 from low CMR, 5 from high CMR) and 16 were males (6 from low 
CMR group and 10 from high CMR group) (26,152,160,162). Recommended criteria for MetS 
diagnosis according to a harmonized standard from the International Diabetes Federation, the 
World Health Federation, International Association for the Study of Obesity and the international 
Atherosclerosis Society include having 3 or more of HDL, glucose, TG, waist circumference and 
blood pressure above cut-offs (221). Two females and 5 males (13% of the sample) were 
classified as having MetS in this cohort. Males had significantly greater APHV, BW, EI, height, 
lean mass, SBP, and TG compared to females in adulthood (p<0.05); and females had greater 
TBF and HDL cholesterol than males (p<0.05). When Bonferroni’s correction was made for 
multiple t-tests only APHV, BW, height, and lean mass remained significant.  
Childhood z-scores and early adult descriptive characteristics (from time of CMR 
measures) are shown in Table 6.1 by high and low CMR groups. There were no significant 
differences in any of the variables between risk groups.  
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In females, TrF was not significantly correlated with the conCMR score but was 
significantly correlated with MAP ( r= 0.61, p<0.0.01), HOMA (r =0 .60), HDL (r = -0.56), and 
SBP (r = 0.53, p<0.01). TBF was correlated with the same factors but with slightly weaker 
relationships. In males, TrF was not correlated with conCMR score, but was significantly 
correlated with HOMA (r = 0.58), HDL (r = -0.57), and SBP (r = 0.55) and DBP (r = 0.51) 
(p<0.01). TBF was correlated with the same factors but with slightly weaker relationships, 
except for HDL which was slightly higher.  Childhood TrF and TBF z-scores were significantly 
correlated with adult values of TrF, and TBF respectively (p<0.01). Child TrF was also 
correlated with adult MAP, and HOMA (p<0.05) in females; and with DBP (p<0.01), HOMA, 
and SBP (p<0.05) in males. Childhood TBF scores were also correlated with adult HOMA in 
females; and with adult SBP, DBP and HOMA in males (p<0.05). 
Table 6.1 Participant descriptives during childhood and at follow-up in early adulthood. 
 
 
Female Male 
Low High Low High 
Childhood     
N 14 15 13 12 
Birthweight(kg) 3.39(0.52) 3.17(0.43) 3.65(0.54) 3.70(0.56) 
TBF z-score -0.09(1.01) 0.22(1.18) 0.10(1.25) 0.15(0.81) 
TrF z-score -0.14(1.03) 0.34(1.31) 0.08(1.26) 0.16(0.89) 
PA z-score -0.04(0.82) 0.21(0.82) -0.16(0.93) 0.09(0.44) 
EI z-score -0.04(0.59) 0.32(0.94) -0.14(0.57) 0.09)0.44) 
Early 
Adulthood 
    
Age 36.0(2.7) 35.8(2.6) 36.0(2.4) 36.3(2.3) 
BMI (kg/m2) 29.9(9.2) 26.4(7.8) 26.2(4.67) 27.8(3.37) 
Height 166.50(7.89) 168.34(6.48) 180.78(7.37) 179.85(6.94) 
 
 
169 
 
Weight 83.45(29.13) 76.43(25.03) 85.63(14.15) 89.84(10.48) 
Lean (kg) 45.66(10.00) 45.11(8.89) 63.05(6.01) 61.32(5.59) 
PA score 2.15(0.75) 2.12(.49) 2.45(0.92) 2.58(0.74) 
EI (kjoules) 7709.49(1892.20) 8812.29(2534.58) 10498.05(3705.50) 11055.05(4694.39) 
TBF(kg) 27.24(9.19) 26.82(13.38) 19.43(9.79) 20.10(7.59) 
TrF(kg) 12.43(5.01) 12.67(6.90) 10.21(6.50) 11.18(5.14) 
TBF z-scores 0.02(0.81) -0.02(1.18) -0.04(1.13) 0.04(0.88) 
TrF z-scores -0.02(0.85) 0.02(1.16) -0.08(1.12) 0.09(0.89) 
MAP (mmHg) 93.24(6.60) 97.36(12.54) 93.44(9.11) 105.83(7.60)Ɨ 
TotChol 
(mmol/L) 
4.45(0.87) 4.65(0.72) 4.52(0.62) 4.41(0.93) 
HDLChol 
(mmol/L) 
1.4(0.3) 1.80(.6) 1.16(0.20) 1.20(0.6) 
CholRatio 
(mmol/L) 
3.26(0.96) 2.98(0.993) 4.01(0.95) 3.92(1.31) 
TG (mmol/L) 0.82(1.1) 1.00(.47) 1.19(0.56) 1.60(1.29) 
Insulin (U/ml) 8.54(5.56) 12.7(10.36) 7.60(4.38) 9.90(6.0) 
Glucose 
(mol/L) 
4.50(0.68) 3.83(0.96) Ɨ 4.31(0.82) 4.07(0.90) 
HOMAIR 1.7(1.0) 2.2(2.3) 1.4(0.7) 1.8(1.1) 
CRP 3.89(5.14) 3.19(3.40) 6.62(21.21) 3.05(3.81) 
ConCMR score -0.85(0.71) 0.81(0.68) Ɨ -0.86(0.57) 0.93(0.79) Ɨ 
Median split used for assigning high and low CMR groups. Median score was 0.341 for females, 
and at -0.297 for males. * significant difference between high and low CMR groups after 
Bonferroni correction. Ɨ significant difference between high and low CMR groups before 
Bonferroni correction. TBF(total body fat, kg); TrF(trunk fat; kg); EI(energy intake; kjoules); 
BMI (body mass index; kg/m2); PA(physical activity score; from 1-low to 5-high); MAP (mean 
arterial pressure ; [{2 x diastolic blood pressure} + systolic blood pressure]/3); TotChol(total 
cholesterol; mmol/L); HDLChol(high density lipoprotein cholesterol; mmol/L); CholRatio(Total 
cholesterol/HDLcholesterol); TG (triglycerides; mmol/L); HOMA (homeostasis model 
assessment for insulin resistance; {{fasting insulin(U/ml)} x {fasting glucose (mmol/l)}}/22.5); 
CRP(C-reactive protein); ConCMR(continuous cardiometabolic risk score; sum of residuals of 
TG, HOMA, TCHOL, HDL-1,and MAP regressed onto smoking status and age).  
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 Results from the multi-level model of LnTBF are summarized in Table 6.2, and LnTrF 
results are summarized in Table 6.3. Age centered was a significant predictor of LnTBF and 
LnTrF. The significance of level 1 variance indicates that TBF and TrF mass significantly 
increased with age from 18-39 years (E>2x standard error of the estimate p<0.05). The 
significance of level 2 variance for constant and age centered indicate that individuals had 
significantly different log TBF curve intercepts (constant*constant; µj) and slopes (age 
centered*age centered; νjXij). The intercepts and slopes were not significantly related to each 
other in the LnTBF model as indicated by the insignificant constant*age centered random effect 
(µj*νjXij). In the LnTrF model however, constant*age centered random effect (µj*νjXij) was 
significant, suggesting that those with higher TrF intercepts had shallower slopes. 
 
Table 6.2 Multi-level regression model for log transformed total body fat accrual aligned by 
chronological age 
Variable Model 2 
Fixed Effects  
Constant 10.06 ± 0.11 
Age Centered 1.61a ± 0.32a 
Age Centered2 -1.31 a ± 0.32a 
Sex -0.44 ± 0.08 
Height  NS  
CMR group  NS  
Lean 0.05b ± 0.02 b 
PA -0.06 ± 0.02 
EI  NS  
Birth weight  NS  
PA z-score  NS  
EI z-score  NS  
TBF z-score 0.28 ± 0.04 
    
Random Effects    
Level 1    
Constant (εij ) 0.03 ± 3.13a 
    
Level 2  
Constant (µj) 0.07 ± 0.01 
Age Centered (νjXij) 0.14a ± 0.07a 
Constant*Age Centered (µj*νjXij)  NS  
Fixed effect values are Estimated Mean Coefficients ± SEE (Standard Error Estimate) of LN 
TBF (g) 
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Random effects values Estimated Mean Variance ± SEE [LN TBF (g)]2 
Age Centered is age in years centered on 28 years.  
Sex: Females=0; Male=1 
PA and EI z-score are composite z scores from all measures from -6 to +7. 
Height (cm); Lean (g); Total Body Fat (TBF) (kg); PA (Physical Activity -Score from 1-5); 
Energy Intake (EI) (KJ).  
a indicates numerical values are multiplied by 10-3, b indicates numerical values are multiplied by 
10-4 
Numerical values are all significant, p < 0.05 (mean > 2*SEE). Non-significant variables are 
indicated as ‘NS’ and removed from the final model. 
 
 When age, birth weight, height and lean mass were controlled, sex was a significant 
predictor of LnTBF and LnTrF. Males will accrue significantly less fat in comparison to females 
(coded as 0), with greater sex differences for TBF than for TrF (Table 6.2 and 6.3). PA was also 
a significant negative predictor of LnTBF (-0.05 ±0.02), suggesting that greater levels of PA 
results in lower fat mass accrual (Table 6.3). PA did not significantly predict LnTrF, although it 
was nearing significance (-0.47±0.36). Birth weight, energy intake, PA and energy intake in 
childhood (z-scores) were not significant in either model (p<0.05). The strongest predictor of 
LnTBF accrual was childhood TBF z-score (0.27 ± 0.04); and the strongest predictor of LnTrF 
accrual was childhood TrF z-score (0.31 ± 0.05) (Table 6.2 and 6.3). 
Table 6.3 Multi-level regression model for trunk fat accrual aligned by chronological age 
Variable Model 2 
Fixed Effects  
Constant 9.04 ± 0.14 
Age Centered 0.03 ± 4.54 a 
Age Centered2 -1.91a ± 0.39 a 
Sex -0.32 ± 0.11 
Height  NS  
CMR group  NS  
Lean 0.06b ± 0.03 b 
PA  NS  
EI  NS  
Birth weight  NS  
PA z-score  NS  
EI z-score  NS  
TrF z-score 0.30 ± 0.04 
    
Random Effects    
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Level 1    
Constant (εij ) 0.05 ± 4.5a 
    
Level 2  
Constant (µj) 0.14 ± 0.03 
Age Centered (νjXij) 0.44a ± 0.15a 
Constant*Age Centered (µj*νjXij) -3.55a NS 1.60 a 
Fixed effect values are Estimated Mean Coefficients ± SEE (Standard Error Estimate) of LN TrF 
(g) 
Random effects values Estimated Mean Variance ± SEE [LN TrF (g)]2 
Age Centered is age in years centered on 28 years.  
Sex: Females=0; Male=1 
PA and EI z-score are composite z scores from all measures from -6 to +7. 
Height (cm); Lean (g); Trunk Fat (TrF) (kg); PA (Physical Activity -Score from 1-5); Energy 
Intake (EI) (KJ).  
a indicates numerical values are multiplied by 10-3, b indicates numerical values are multiplied by 
10-4 
Numerical values are all significant, p < 0.05 (mean > 2*SEE). Non-significant variables are 
indicated as ‘NS’ and removed from the final model. 
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Lower childhood TBF z-scores and higher PA from 18-39 years, resulted in lower TBF accrual 
from 18-39 years (Figure 6.2). Figure 6.1 shows the role of PA alone. Childhood TrF z-score 
predicted TrF accrual from 18-39 years, while PA was not significant (Figure 6.3).  
Figure 1. Total body fat accrual in males and females
from 18-39 years illustrating the difference in trajectories
attributable to physical activity and sex.
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Figure 2. Total fat accrual in males and females from
18-39 years illustrating the differences in trajectories
attributable to sex, childhood z-score and physical
activity.
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Figure 3. Trunk Fat Accrual in males and females from
18-39 years illustrating the difference in trajectory
attributable to sex and childhood z-score.
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Figure 6.1 Total body fat accrual in males and femal s from 18-39 years illustrating 
the differences in trajectories attributable to physical activity and sex. 
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Males had less TBF accrual than females at any level of PA category; for example, high PA 
males had less TBF than low PA and high PA females (Figure 6.1); however, females with high 
PA and low TBF z-scores had lower TBF accrual than males with low PA and high TBF z-scores 
(Figure 6.2). Similarly, females with low TrFz-score had lower TrF accrual than males with high 
TrF z-score, but more fat than males with low TrF-z-score (Figure 6.3).  
 
Figure 1. Total body fat accrual in males and females
from 18-39 years illustrating the difference in trajectories
attributable to physical activity and sex.
20 25 30 35
30000
40000
50000
60000
70000
High PA Male
Low PA Male
High PA Female
Low PA Female
Age(years)
T
B
F
 (
g
)
Figure 2. Total fat accrual in males and females from
18-39 years illustrating the differences in trajectories
attributable to sex, childhood z-score and physical
activity.
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Figure 3. Trunk Fat Accrual in males and females from
18-39 years illustrating the difference in trajectory
attributable to sex and childhood z-score.
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Figure 6.2 Total body fat accrual in males and femal s from 18-39 years illustrating the 
differences in trajectories attributable to sex, childhood TBF z-scores and physical activity 
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Figure 6.3 Trunk fat accrual in males and females from 18-39 years illustrating the difference 
in trajectories attributable to sex and childhood TRF z-score 
 
 
Figure 0.1 Total body fat accrual in males and females from 18-39 years illustrating the 
differences in trajectories attributable to sex, childhood TBF z-scores and physical 
activityFigure 0.2 Trunk fat accrual in males and females from 18-39 years illustrating the 
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6.6 DISCUSSION 
 
This study analyzed accrual of TBF and TrF mass from 18-39 years of age and assessed 
if these trajectories differed between low and high CMR groups. While both TBF and TrF 
increased over the measurement period, CMR group did not alter the trajectories. Continuous 
CMR was not related to TrF or TBF; however, individual CMR components were correlated 
with TrF and TBF at the end of the early adulthood period. Childhood values of TrF and TBF 
were the greatest predictors of TBF and TrF gains. The current analysis re-affirmed previous 
findings from this cohort, indicating that the period of EA is important in the progression of 
OWO. The current findings add to the literature by suggesting that TBF and TrF continue to be 
accrued beyond EA and that fat accrual may relate to individual CMR factors.  
Fat mass tracks moderately well from childhood into adolescence, with greater childhood 
fat mass predicting greater adolescent fat mass, which in turn predicts greater fat mass in 
adulthood (45). Previous work with this cohort demonstrated that childhood fat predicted fat 
gains during EA (18-28 years) (433).  The coefficients for TrF and TBF z-scores in the current 
analysis covering EA to early adulthood (18-39 years) are significant but smaller than in 
previous analyses of only EA. This is likely because tracking of body composition and adiposity 
is stronger between chronologically closer years such that childhood and adolescent fat mass is 
more strongly related to late adolescent and EA fat mass than to early adulthood fat mass 
(455,465).  
The rate of annual increase in TBF did not change (i.e. the coefficient of age centered) 
between the current findings (from 18-39 years) and those by Sherar et al. (2011) (from 8-28 
years). EA is a period of significant fat mass gains but after EA fat mass tends to stabilize. The 
lack of difference observed between studies is unexpected and suggests that this cohort 
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continued to accrue fat mass beyond EA.  The rate of predicted TrF accrual decreased in males 
and increased in females between the two studies. This is surprising as we and others have 
reported that males tend to increase TrF more than females from puberty until menopause 
(90,384,385).  
The current study did not find any evidence that TBF mass accrual in emerging and 
young adulthood was higher in those with higher conCMR in adulthood. The location of 
adiposity can mediate the relationship between OWO and CMR (9,155,156). An example of this 
is NW in individuals who present with CMR clustering; or NW in youth with higher TrF values 
who end up as adults with higher CMR profiles (155,169). The risk conferred by TrF beyond that 
of TBF could explain why TBF accrual was not amplified in the high CMR group in this 
analysis. Yet, the analysis revealed that TrF accrual was also similar between groups.  
Visceral fat, which comprises a portion of TrF, features an elevated level of lipolysis 
which releases free fatty acids into the blood stream, and increases the release of inflammatory 
cytokines (interleukins and tumor necrosis factors- alpha) (444). These cytokines contribute to 
the development of CMR risk factors, atherosclerosis and diabetes (47). DXA-derived measures 
of TrF have demonstrated a relationship with CMR factors including insulin, glucose, TG and C-
reactive protein in both adults and children (5,228). Furthermore, a relationship exists between 
BMI and TrF in childhood, and CMR in adulthood (169,466). As such, this study, like many 
other recent studies, focused on TrF as a variable of interest with the expectation that TrF would 
differentiate high from low CMR risk (60,385,400). The current study did not find any 
significant differences in TrF accrual between CMR groups, contrasting previous literature 
 
 
177 
 
(169,466). The predictive strength of childhood z-scores in this analysis may have washed out 
differences by CMR group. 
Childhood OWO presents an insult to the cardiovascular and metabolic systems 
precipitating the early onset of risk factors and a cascade of adverse processes which lead to 
cardiometabolic consequences in adulthood (8,383,467,468). Internal z-scores were used to 
express childhood fat mass in this analysis and very few of the participants were OWO children. 
This likely contributed to the inability of CMR to influence modeled fat curves in early 
adulthood; furthermore, there was increasing homogeneity in this cohort from the third to forth 
decade of life. This is illustrated in that previous analyses conducted with this PBMAS cohort at 
a mean age of 26 found that TrF was different between high and low adult CMR groups from as 
young as 8 years of age (169); and yet the current analysis found no difference in fat trajectories 
between CMR groups. In the previous analysis by Sherar et al. (2011), the high CMR group had 
higher child and adult fat mass values, and higher blood markers than the low CMR group; and 
the low CMR group had mean waist circumference (WC) values below International Diabetes 
Federation (IDF) cut-offs. In the current analysis, both groups have mean WC values over IDF 
cut-offs. It appears that the high CMR group maintained their level of “un-health” from the 3rd to 
4th decade (i.e. high WC), while the low risk group became less “healthy”. For example, in 
males, mean WC increased from 83 cm to 105 cm in the low risk group, and remained at 89 cm 
in the high CMR group. In females, the waist circumference increased from 74 cm to 93 cm in 
the low CMR group and increased from only 91cm to 92 cm in the high CMR group. As the low 
CMR group caught-up to their high CMR counterparts in terms of TrF mass, differences in CMR 
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profiles disappeared. These observations suggest that having a lower WC and by association a 
lower CMR in one’s 20’s does not preclude future CMR. 
A-posteriori analyses revealed an interesting pattern in which TrF and TBF z-scores in 
childhood and adulthood were slightly (but not significantly) lower in the low CMR groups. 
Between childhood and adulthood, the high CMR females decreased in z-score while the low 
CMR group increased in z-score - the groups became more evenly split in terms of spread of the 
individuals above and below the mean. In males, both high and low CMR decreased in z-score, 
becoming less similar by adulthood. This suggests two things. Firstly, that in females childhood 
fat mass (or z-score) and in males adulthood fat mass (or z-score) may be more predictive of 
future fat mass and CMR. Secondly, that in females the lower risk that is likely linked with a 
lower z-score in childhood is almost completely offset by a greater relative gain in fat mass. 
Changes in fat mass have been shown to predict future CMR. For example, Chantler et al. (2015) 
and Tbor et al. (2011) found that in adult women, the degree of increase in TrF from adolescence 
to adulthood related to increased CMR independent of TrF at the follow-up (469,470). Similarly, 
Park et al. (2010) found that the relationship between insulin resistance and WC increments 
across 20 years was stronger in participants with smaller versus larger WC at baseline (471). 
Studies by Hanson et al. (1995) and Resnick et al. (2000) supported this idea indicating that, the 
risk of type 2 diabetes in OWO adults was associated is weight gain across 2 years and 10 years 
respectively; but that a higher risk presented in those with NW at baseline compared to those 
with overweight at baseline, or in the highest BMI group at baseline (472,473). Pooled 
longitudinal data similarly have revealed higher relative risk ratios of CVD risk factors - type II 
diabetes, hypertension, LDL cholesterol, HDL cholesterol -1, triglycerides and carotid-artery 
intima media thickness - in NW youth (4-18 years) who became OWO adults (23-46 years), 
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compared to youth who remained NW, or OWO youth who became NW adults according to age-
specific and sex-specific BMI cutoff points (459). These results from Juonala et al. (2011) 
suggested that the OWO-to-OWO group had the highest risk. The homogeneity of CMR scores 
in the current sample may be because the low CMR group experienced steeper increases in fat 
gains than the high-risk group over the last 10 years. This is also indicated in the significant 
constant x age centered coefficient - those with higher intercepts at 18 years had shallower slopes 
of fat accrual (Table 6.2 and 6.3). There has perhaps been a meeting-in-the-middle whereby the 
high risk conferred by high childhood fatness is matched by a situation of low childhood fatness 
combined with rapid gains across early and emerging adulthood.  
PA during early adulthood was found to be a significant predictor of TBF but not TrF 
accrual. The relationship with TBF is not surprising as many studies have found similar 
correlations (115,275,474). What was unexpected was the lack of relationship between TrF gains 
and PA, as literature has demonstrated that PA can preferentially deplete trunk fat stores during 
PA weight loss interventions (169,202,205,264,279,286). Furthermore, PA significantly 
predicted TrF gain in this cohort from age 18-28 years in previous analyses, although only in 
males (433). In previous analysis, a separate model was run for males and females and PA was 
only significant in male TrF models. Sex was aggregated in the current analysis and the weaker 
relationship between PA and fat in females may have dominated the model. PA has previously 
demonstrated a weaker effect on body fat in females than in males which may explain the lack of 
significance (392,433,447). For example, in the study by Clement et al. (2017), female university 
students in the lowest, middle two and upper quartiles of percent body fat had significant 
differences in minutes of light PA but no difference in moderate or vigorous PA, suggesting that 
vigorous PA was not associated with a lower fat mass. Males in the same study with the lowest 
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body fat had the highest minutes of vigorous PA, moderate PA, and the 2nd highest light PA 
(392).  
The lack of significance of PA as a predictor of TrF may also speak to the strength of an 
underlying genetic predisposition which upregulates visceral fat accumulation and shunts fat 
away from subcutaneous depots (a “healthier” fat) (129,465). Genetic underpinnings, in addition 
to the strong tracking of TrF suggest stability of a TrF phenotype (129,465). PA may have a 
greater ability to influence TBF while a body type that favors TrF deposition may manifest early 
in life and not be easily thwarted off its trajectory.  
Diet did not demonstrate significance as a predictor in these models. It is well established 
in the literature, however, that a relationship exists between diet and fat mass (232,240).  The 
lack of relationship observed in this study may be explained by recent studies that suggest the 
role of caloric intake is less relevant than the quality of the macronutrients (i.e. respective levels 
of carbohydrates and fats) (238,243,244). As this study only recorded caloric intake, we may 
have missed this important relationship. 
6.6.1 Limitations 
The PBMAS cohort included in the current analysis is not the exact same sample as the 
previous analysis (169). Approximately 65% of the participants from the current analysis were 
part of the analysis from 2011 intake (169), and those that returned for the current assessment 
had a mean BMI in 2011 like that of the high risk CMR group in 2011. This suggests that those 
included in this sample may have had higher BMI’s than the entire cohort. While the prevalence 
of OWO in this sample (42% of females and 64% of males) was almost identical to national 
estimates of OWO (46% of females and 64% of males over 18 years) (26,152,160,162), the 
prevalence of MetS in this sample (13%) was higher than national estimates for this age group 
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(7.8%) (49). While a continuous CMR score has been used previously, it may not be sensitive 
enough to identify differences in younger participants with an absence of manifest disease. At 
this young age, it also appears that not all components of the conCMR score may contribute 
equally (or in the same direction) to the composite score. Because the analysis was modelling 
TrF, WC was not included in the conCMR score but TrF had strong correlations with all but TG 
in females, and TG and MAP in males. Future research may address this by investigating 
individual components of CMR and modeling fat mass trajectories each CMR factor added 
individually. Future longitudinal studies are required that track participants into older ages when 
the MetS and CVD manifest to tease out the independent contribution of childhood, emerging 
adulthood and early adulthood fat accrual.  
  
6.7 CONCLUSION  
 
This study added to the literature by identifying child and adolescent TBF and TrF as 
important risk factors for fat accrual in emerging and early adulthood, but not CMR profiles in 
early adulthood. Rather, findings indicated that in females, CMR may be equally conferred by 
higher childhood fat mass, as by low childhood fatness followed by subsequent rapid gains. In 
males, fat mass in adulthood is likely more important for CMR. Findings also suggested that 
participating in physical activity has the potential to ameliorate total body fat mass accrual in 
young adulthood. Interventions for preventing adult overweight need to focus on reducing 
childhood and adolescent fat mass without neglecting the early adult years.  
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CHAPTER 7  
  
 
DISCUSSION AND CONCLUSION 
 
7.1 DISCUSSION OF STUDY FINDINGS 
 
 Obesity continues to be a major public health concern in Canada as in the rest of the 
world. There has been much attention given to the period of childhood in an attempt to prevent 
the onset of OWO because an early onset of OWO has demonstrated strong stability into 
adulthood (27); however, considering discrepant rates of OWO in children and adults, it can be 
inferred that children with NW also become adult with OWO (1,26). Studies of young adults 
with OWO often focus on weight loss and treatment, with less work being done to identify 
contributing factors and prevent the onset of OWO in EA in previously NW youth. This 
dissertation sought to: 1) investigate the pattern of fat mass accrual during emerging adulthood 
and identify the importance of this period in the onset of OWO; and identify the age at onset by 
different metrics 2) identify the predictors and contributors to fat mass gains and the onset of 
OWO in EA, and 3) to assess the cardiometabolic consequences of fat mass gains in EA and 
early adulthood.  
 There are very few studies which attempt to identify the age of onset of OWO beyond 
childhood and this is the gap that study 1 attempted to fill. Paper 1a was an observational 
analysis using previously collected data from participants of the PBMAS cohort from the age of 
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PHV to the end of EA (approximately 12 to 29 years). This study found that 80% of the 
participants had NW at PHV, but by early adulthood that number had plummeted to just over 
40% in females and just over 50% in males. OWO in childhood was unable to uniquely predict 
OWO in adulthood, highlighting the fact that children with NW will also become adults with 
OWO. The analysis identified the years near the end of adolescence and the beginning of 
adulthood years when the transition to OWO likely occurs. These findings confirmed those of 
Racette et al. (2005), Suglia et al. (2013), and Gropper et al. (2011), which found that fat mass 
was gained during the years of college and university (90,385,387).  Paper 1b from study 1 
identified that the prevalence of OWO was not identical between different metrics. Estimates by 
%TBF are higher in females and estimates by BMI cut-offs are higher in males. Study 1a 
findings generated the questions for Study 1b and 2: Is the age of OWO onset different using 
different metrics? What are the contributing factors to fat mass gains during this period of EA? 
Study 1b asked the question: Can we confirm longitudinally that EA is a period of OWO 
onset? And what are the differences in age at onset and prevalence of OWO by different metrics 
between sexes? The findings from this study confirmed that, for many, the onset of OWO is 
during EA, but that the age is sex- and metric-specific. In females, %TBF is a more conservative 
metric, while in males BMI is a more conservative metric, the onset by both metrics occurring 
between PHV and 25 years. WC does not appear to be an appropriate indicator of OWO in this 
age group, potentially overlooking those with excess adiposity but a below-cut-off WC. BMI 
missed ¼ of the males and ½ the females that were “over-fat” by %TBF criteria.  
 Study 2 investigated lifestyle predictors of fat mass gain in EA, while controlling for 
childhood and adolescent fat mass and PA. Childhood and adolescent fat mass were identified in 
longitudinal modeling as being a very strong contributor to the amount of fat mass gained in EA. 
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Interestingly, children do not typically accumulate large amounts of trunk fat. Rather, trunk fat 
begins to accrue more so in adolescence and early adulthood; and yet, having higher TrF in 
childhood relative to one’s peers predicted having greater TrF gains in EA. PA during EA was 
only significant in males, although it was proposed that some of the female participants may 
have been in the final years of puberty during which TBF and TrF accrual are hormonally 
controlled and, therefore, less influenced by lifestyle choices. While the years of EA were again 
highlighted as being critical for fat mass gains, maintaining a healthy weight (fat mass) in 
childhood and adolescence and being PA were also underscored as being potential mitigating 
factors. The inclusion of TrF in study 2 was primarily due to the known health implications of 
central adiposity. A higher TrF and TrF accrual manifest as a higher health risk which was the 
premise of study 3.  
For study 3, PBMAS participants were invited back for a new wave of measures 
(2016/2017) which included blood profiles. Continuous cardiometabolic risk scores (conCMR) 
were used to create high and low CMR groups in both males and females. Models of TBF and 
TrF from 18-39 years once again identified childhood TrF and TBF z-scores as the strongest 
predictors of TBF and TrF accrual. The analysis did not find any difference in TrF or TBF 
trajectories between those with the upper half compared to the bottom half of sex-specific 
median split of continuous cardiometabolic risk scores. PA was also identified as having a 
positive effect on TBF accrual from 18-39 years. The lack of significant difference of other 
variables such as blood lipids, HOMA, and even waist circumference between CMR groups were 
likely responsible for the lack of difference in conMetS scores  
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7.2 DISCUSSION OF TOPICAL FINDINGS 
 
7.2.1 BMI 
It has been suggested that the use of BMI alone may not be adequate for discerning 
adiposity (99) . The findings from studies 1a and 1b support this idea, as BMI failed to identify 
OWO in 20-50% of individuals, with more females than males being missed. The WHO defines 
obesity as an excess of adipose tissue, and fat mass, more than weight, confers greater 
cardiometabolic health risk; as such, the recommendation from this dissertation is that a measure 
of adiposity such as %TBF be included in clinical assessment of OWO imposed health risk in 
individuals under the age of 40. Future studies with this cohort should explore if earlier onset of 
OWO identified by BMI, %TBF or by WC criteria provides a more accurate predictor of CMR 
in mid to older adulthood.  
7.2.2 Diet 
A large number of individuals acquire OWO in late adolescence and emerging adulthood 
when caloric intake remains unaltered but growth has ceased (107). This explanation of the 
timing of the onset of OWO is supported by findings in this thesis which identified the age at 
onset of OWO to be 18-28 years; however, the “calories in-calories out” theory of excess fat was 
not supported in the current collection of studies. While studies of caloric restriction and 
increased PA have demonstrated weight loss (91,119–121), studies 2 and 3 did not identify 
caloric intake in childhood and adolescence or in emerging adulthood as being significant in 
predicting fat mass accrual. The current findings support the theory that OWO is a multi-factorial 
disease for which there are likely metabolic, genetic, epigenetic, and endocrine contributors 
(15,122,123).  
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7.2.3 PA 
The relationship between PA and fat mass was not found to be as strong as previously 
demonstrated (265,266). PA was identified as a predictor of TBF and TrF in males in study 2, 
and of TBF in males and females in study 3. This was particularly unexpected in regard to TrF as 
many studies have identified that PA preferentially eliminates fat from the trunk 
(169,202,205,264,279,286). PA in childhood and adolescence was not related to fat accrual in 
emerging adulthood, which was also unexpected as longitudinal data has shown that the risk of 
adult OWO is higher in those with low or declining levels of PA from 9-18 years (367). Finally, 
it was unexpected that PA was not different in childhood/adolescence or in early adulthood 
between those with high versus low CMR, as PA has demonstrated a positive effect on 
cardiometabolic health in children and adolescents and as a childhood factor improving adult 
cardiometabolic health (208,264,283,370,372). The findings from the current study highlight PA 
as a concurrent factor mitigating fat mass gains but did not find a connection between childhood 
PA and adult health or fat mass.  
 
7.2.4 Critical periods for Fat mass and health 
Childhood is considered a critical period for the development of OWO. Literature 
suggests that OWO in children is likely to remain stable into adulthood, and that those 
individuals who will come to have obesity have a different trajectory of fat growth, even before 
they have overweight (27,107). This is supported by our findings, as children with higher fat 
mass were also the individuals with higher fat mass accrual in young adulthood. These findings 
were as expected. There are fewer young adults who move from OWO to NW than there are 
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those who move from NW to OWO (107). Canadian statistics demonstrate the same trend - 
OWO increases with age (162).  
OWO has demonstrated a cumulative effect on morbidity, with children with OWO in 
whom OWO remains are more likely to present with higher CVD risk profiles (17,20,140). What 
was unexpected in our study was that those with greater fat mass in childhood, adolescence and 
emerging adulthood, did not have higher CMR profiles - at least not by the age of 40 years. This 
supports the theory that higher childhood BMI may have a protective effect at a given level of 
adult BMI and that the health risk may be just as great for those who rapidly acquired OWO as 
for those with a stable (age-relative) BMI (140). This may be due to an independent risk 
conferred by rapid fat mass gains in the children with NW, or because this cohort was not old 
enough for CVD risk to manifest. There have also been findings that those with metabolically 
normal obesity tend to have an earlier onset, which would explain this unexpected result in Study 
3 of this dissertation (131). It was also surprising that TrF trajectories were not related to EA fat 
accrual as this depot includes visceral fat which is more detrimental to health than either BMI or 
TBF (159). There was, however, a relationship between TrF and individual components of the 
conMetS such as HOMA-IR and MAP. It may be that levels of TrF were not yet high enough in 
this age of cohort to negatively impact all CMR factors, and as such the comprehensive conMetS 
was not representative of all risk. Also possible is that measures of TrF by DXA were unable to 
account for differences in visceral fat in individuals with the same TrF (which includes 
subcutaneous fat). These differences may account for the lack of significant difference in 
conMetS between those with higher versus lower TrF accrual trajectories.  
Childhood and adolescence are critical periods for fat mass and OWO and this was 
confirmed in the current studies which suggest that if fat mass is not controlled in adolescence, 
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then it increases the likelihood of becoming overweight in EA. This collection of studies has also 
highlighted EA as the time when most of our healthy-weight youth come to have OWO, 
suggesting that this period of transition requires substantially more emphasis as a critical period 
for intervention. The instability of EA also provides an opportunity in which alterations can be 
made to health and lifestyle trajectories set earlier in life. According to the habit discontinuity 
hypothesis, positive changes made during EA, alongside a change in context and environment 
may be stable into subsequent periods of life (28,378). Introductions of habits such as regular PA 
and healthy diet are suggested as positive changes that should be encouraged and included in 
interventions for this age group.  Although trajectories of fat mass and OWO beyond emerging 
adulthood are important for health, the current findings suggest that they do not predict 
cardiometabolic risk, at least in the short term.  
 
7.3 FUTURE DIRECTION 
 
A series of interesting observations and questions have arisen out of this series of studies 
and in particular study 3. In study 3 there was a pattern that suggested that the low CMR group 
may not have had any lower risk of CVD and diabetes than the high CMR group, despite slightly 
lower TrF (g), because they also had greater increases in fat z-scores from childhood to 
adulthood, at least in females. There was not enough power in the current analysis, nor was the 
group old enough (potentially) to identify clear cardiometabolic consequences; however, 
previous literature and the pattern seen in the study 3 suggest that this is an area that should be 
more closely explored. Suglia et al. (2013) identified an odds ratio of hypertension 5 times 
higher in those who transitioned from NW to OWO between the years of 16-29 years compared 
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to those who remained NW, or transitioned from OWO to NW (90). OWO to OWO had the 
highest risk. Petkeviciene et al. (2015) identified that a change in BMI increased the odds ratio of 
HDL-1, elevated triglycerides and hypertension in adulthood, independent of childhood BMI 
(456). In adults who are OWO, an inverse association between childhood BMI and blood 
pressure has been demonstrated such that those with the lowest BMI in childhood who become 
OWO in adulthood have the greater risk than children with higher BMI (62,459), again 
emphasizing change in weight as the key component to elevated risk.  
Having more weight or fat mass in childhood may be protective against cardiometabolic 
dysfunction that commences in adulthood. The presence or nature of this protection is unclear 
but it may operate by mechanisms similar to the thrifty genotype hypothesis and the metabolic 
loading hypotheses (see section 2.7.1), in which the body’s metabolic and endocrine systems are 
“primed” early (perhaps in utero) to deal with a certain environment (79,296,318–321). If the 
future load matches the load priming, health detriments are mitigated. Alternatively, when the 
environment has a small initial load (low fat mass) and a high later life load (fat mass gains), the 
systems are ill equipped to deal with the change and dysfunction occurs. Future adequately 
powered longitudinal studies are needed to analyze cardiometabolic risk in adulthood while 
controlling for maternal and intrauterine characteristics, birth weight and early growth, childhood 
fat mass, and CMR risk profiles, and lifestyle characteristics such as PA and diet. This will 
provide further insight into the primed versus exposed load hypothesis.  
Future research questions should explore if different fat distribution in childhood predicts 
adult CVD and diabetes, and, if so, what types of interventions (or exercises) are most effective 
at targeting TrF loss. Future interventions and programs need to be diligent in tailoring programs 
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to youth who were NW as they enter early adulthood, as they may be at even higher risk of 
disease if fat mass is accrued rapidly, but this also needs to be confirmed. 
The lack of difference in fat mass and blood profiles between high and low CMR groups 
in study 3 introduced the idea that indices of cardiometabolic health and health risk that were 
used may be inadequate or inappropriate for this population. Different components of the 
conCMR score may be more salient at different ages as TrF was strongly related to individual 
CMR factors but not to the composite score. Cardiometabolic risk factors are known to have 
different growth curves in youth up to 20 years but there has been little work done on curves of 
CMR factors in young adulthood (435). Abdominal obesity has demonstrated the strongest 
relationship with risk of MetS, but in the current study 3 WC was not included in the conCMR 
score because TrF was being modeled (206). This may also be one of the earlier indicators of 
CMR in those who do not yet have MetS or CVD, arising before adverse levels of HDL’s, 
triglycerides or glucose (206). While the model did not identify WC crossing the cut-off by 40 
years, adult TrF was correlated with multiple individual CMR factors, and both high and low 
female risk groups (92 cm and 93 cm respectively) and low male risk group (105 cm) had WC 
means above recommended levels. Future longitudinal studies with CMR profile data obtained 
through out childhood into adulthood are needed to ascertain the earliest and most significant 
predictors of future CVD and MetS.  
Finally, the findings suggest that the power of PA to exert change on fat mass may be 
contingent on sex and age. While PA was a significant predictor of both TrF and TBF accrual 
from 18-28 years in study 2, this was only in males. In study 3, PA was a significant predictor of 
TBF accrual but not TrF accrual when sex was combined in the model. While some studies cite 
PA as having a weaker effect on body fat in females than in males in early adulthood 
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(392,433,447), other studies in mid adulthood (50-60 years) demonstrate the opposite sex 
difference, in which males have to be more physically active to see changes in abdominal fat. For 
example, two recent studies in 50 to 60-year-old adults found that the percent of time spent in 
moderate-to-vigorous PA determined by accelerometer was more highly (negatively) correlated 
with BMI and WC in women than in men; and that exchanging 1 hour of sedentary time for 1 
hour of light PA had a greater association with both visceral and subcutaneous abdominal fat in 
women than in men (475,476). There is a possibility that the effect of PA on fat mass decreases 
with age in males, perhaps as lean mass accrual slows and lean mass loss begins 
(243,281,460,477), while in females PA has an increased effect with age as biologically 
necessitated gains in fat mass cease (478). Future studies that incorporate objective and 
continuous PA assessments from childhood into later adulthood, using precise measures of 
biological age when appropriate, are required to tease out the effect of PA from that of hormones 
on changes in body composition and health related risk.  
7.4 LIMITATIONS 
 This collection of studies is not without limitation. Each study has specific limitations 
discussed at the end of each chapter. A short summary of limitations follows.  
 This group was homogenous in its ethnicity, being 95% Caucasian. As such, findings 
cannot be generalized to other ethnicities. Specifically, there are ethnic differences in WC cut-
offs (Asians have lower recommended cut-offs), amounts of TBF for a given BMI, ratios of 
visceral-to-subcutaneous fat at given TBF, and predisposition to cardiometabolic diseases  
(211,479).  Furthermore, as with all longitudinal studies, participant baseline measures of 
characteristics that are susceptible to secular change (such as fat mass and obesity prevalence) 
are likely different from the current population. This discrepancy is likely to increase with 
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increasing length of time over which the longitudinal study is carried out. For example, the rates 
of abdominal obesity increased seven times in Canadian adolescents and three times in Canadian 
adults between 1981 and 2007-2009 (198). In 1990, the prevalence of adult obesity was 9.2% 
(480). In 2015, the prevalence of adult obesity was 27% in Canada and 31% in Saskatchewan 
(11). With that said, just over 70% of Canadians currently have OWO and these numbers are 
comparable to current values in the PBMAS cohort (481). 
 In terms of methodological weaknesses, it is acknowledged that the DXA scan analysis 
parameters were originally set for bone mass and not readjusted for measures of TBF. This may 
have underestimated the amount of TBF and TrF in our adult sample. The implication of this 
may be that study 1a and 1b may have demonstrated an earlier age at onset of OW by TBF 
metric; and for study 2 and 3, the significance of predictors may have been somewhat altered, 
e.g. conMetS may have been significant if differences between OW and more extreme values of 
OB TBF were undistinguishable.  
 For study 1b, WC cut-offs used had been developed to transition smoothly to adult values 
of OB by BMI (30kg/m2) rather than OW values. Similarly, pediatric WC cut-offs were 
developed to smoothly transition into adult WC cut-offs aligned with the adult OB BMI cut-offs 
(198,199,220). This likely delayed the identified onset of OW (or elevated risk) by WC 
compared to the age of onset identified by BMI and %BF for which OW cut-offs were used. Had 
OW WC cut-offs been used, the age at onset of elevated risk WC would have been 22 years in 
females and 34 years in males - closer to the age at onset by the other two metrics. This also 
indicates that metrics likely have more overlap in their identification of at-risk morphology than 
reported in study 1b.  
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 Although these studies contained small sample sizes, the power of longitudinal analysis 
comes from the high level of correlation between measurements within individuals. The same 
individuals were serially measured over 20 years, with the majority of included participants of 
each study being measured between 6 and 10 times, comprising over 2000 measurement points  
(see Table 4.1).  
7.5 CONCLUSION 
 
In conclusion, through this series of studies we investigated the time course of the onset of 
OWO in a group of children who were predominantly NW; the potential determinants of TBF 
and TrF mass accrual during the years of emerging and early adulthood; and the effect of fat 
accrual in emerging and early adulthood on the risk factors of CVD and MetS. Our findings 
support the existence of multiple contributing factors in the progression of OWO and the 
pathogenesis of the cardiometabolic risk. Many of these factors begin to influence life course fat 
trajectories in early life. The findings from these studies encourage interventions targeting both 
children and adolescents as well as emerging adults - a previously underserved age group. 
Interventions that focus on maintaining a healthy weight and healthy lifestyle during the 
transitional period from adolescence to adulthood are recommended. Optimizing modifiable risk 
factors such as weight control and physical activity throughout childhood into emerging 
adulthood may prevent the onset of OWO and, therefore, its complications such as MetS and 
CVD.  
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